Search:







Spinal Cord Stimulation Devices Market (2018)
125 Pages | 34 Exhibits | 2018 Analysis | Forecasts Through 2022
This analysis includes a discussion of current Spinal Cord Stimulation (SCS) devices, emerging innovative technologies, competitors, trends, and expected market growth. Market analysis includes a 5-year market forecast by region, drivers/limiters, estimated market share by region, and corporate strategies for success in one of the fastest medical device markets today. SPINAL CORD STIMULATION DEVICES MARKET HIGHLIGHTS The global SCS devices market was valued at more than $2.5bn in 2017 and ... [Read More]




Spinal Motion Preservation Devices (2018)
98 Pages | 34 Exhibits | 2018 Analysis | Forecasts Through 2022
This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for spinal motion preservation devices. Market segments include artificial discs, dynamic stabilization devices, and devices to treat vertebral compression fractures. SPINAL MOTION PRESERVATION DEVICES MARKET HIGHLIGHTS The global market for spinal motion preservation technologies totalled nearly $2.3bn in 2017, with dynamic stabilization devices accounting for... [Read More]




Interventional Cardiology: Atherectomy and Thromboembolectomy (2018)
100 Pages | 54 Exhibits | 2018 Analysis | Forecasts Through 2022
This analysis includes a discussion of products, competitiors, market forecasts, and opportunities in the global market for atherectomy and thromboembolectomy products. INTERVENTIONAL CARDIOLOGY: ATHERECTOMY AND THROMBOEMBOLECTOMY MARKET HIGHLIGHTS Total unit sales for atherectomy and thromboembolectomy products are steadily increasing due to a number of factors, including: the increasing prevalence of CVD, advances in CVD diagnostics, and demand for minimally invasive interventional thera... [Read More]




Drug Delivery: Infusion Products (2018)
76 Pages | 21 Exhibits | 2018 Analysis | Forecasts Through 2022
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global infusion drug delivery devices market, including the volumetric, syringe, ambulatory, disposable, implantable, insulin, and enteral pumps segments. DRUG DELIVERY: INFUSION PRODUCTS HIGHLIGHTS The combined global market for infusion DDT products totaled nearly $9.9bn in 2017, and is expected to climb at a rate of 6.4% over the forecast period. Technological advancements, ... [Read More]




Spinal Fusion Implanted Instrumentation Market (2018)
75 Pages | 23 Exhibits | 2018 Analysis | Forecasts Through 2022
This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for spinal fusion implanted instrumentation. Market segments include anterior column plating systems, intervertebral body fusion devices, and pedicle screw/posterior fixation systems. SPINAL FUSION IMPLANTED INSTRUMENTATION MARKET HIGHLIGHTS The global market for implanted instrumentation for spinal fusion totalled more than $4.1bn in 2017, with pedicle screw s... [Read More]




Emerging Bioelectronic Medicine & Neurostimulation Technologies: Growing and Disrupting Global Medical Device Markets (2018)
300 Pages | 55 Exhibits | 2018 Analysis | Forecasts Through 2023
The global neurostimulation market is projected to increase 13.4% annually from 2017 through 2022 to more than $7.2 billion. Although impressive, this growth will understate the magnitude of the patient populations and clinical applications that will be newly served with the emergence of noninvasive alternatives to expensive neurostimulation implants and the development of new forms of stimulation that will enable less invasive treatment of chronic conditions. It is significant that many of th... [Read More]




Interventional Cardiology: Vascular Stents - Global Markets (2018)
120 Pages | 57 Exhibits | 2018 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for vascular stents. INTERVENTIONAL CARDIOLOGY VASCULAR STENTS MARKET HIGHLIGHTS The global market for vascular stents is steadily increasing in total sales due to a number of factors, including: the increasing prevalence of CVD, advances in CVD diagnostics, and a demand for minimally invasive interventional therapies to treat patients requiring surgical intervention to ma... [Read More]




Pulse Oximetry Devices - Global Markets (2017)
58 Pages | 22 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of pulse oximetry technologies, leading competitors, market value (2016), five-year forecast (2016-2021) by region, and global and regional market share. PULSE OXIMETRY DEVICES MARKET HIGHLIGHTS The global pulse oximetry devices market was valued at more than $1.5bn in 2016 and is expected to grow at CAGR of more than 5% over the next 5 years. The US accounted for nearly 60% of the total market in 2016, although regions outside the US (China, India, Lat... [Read More]




Injection Drug Delivery Devices - Global Markets (2017)
53 Pages | 18 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global needles/syringes (standard and safety) and VADs (short peripheral catheters, midline catheters, PICCs, CVCs, and implantable ports) markets. INFECTION DRUG DELIVERY DEVICES MARKET HIGHLIGHTS Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is regarded as the most accurate, reproducible method of therap... [Read More]




Cardiac Ablation Catheters - Global Markets (2017)
104 Pages | 29 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for cardiac ablation catheters. CARDIAC ABLATION CATHETERS MARKET HIGHLIGHTS The global market for cardiac ablation catheters is seeing strong single-digit compound annual growth due to a number of factors, including: new guidelines encouraging cardiac ablation usage, positive clinical trial data supporting cardiac ablation, and improved catheter ablation technologies. In... [Read More]




Angioplasty Catheters - Global Markets (2017)
138 Pages | 70 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for angioplasty catheters. ANGIOPLASTY CATHETERS MARKET HIGHLIGHTS The global market for angioplasty catheters is seeing low growth due to a number of factors, including: declining average sale price(s) of balloon catheters, earlier identification and treatment of cardiovascular disease, and high costs associated with performing minimally invasive cardiovascular procedures... [Read More]




Transdermal Drug Delivery Devices - Global Markets (2017)
79 Pages | 27 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the market for transdermal patches intended for the management of CVD, neurologic disorders, HRT, pain, and genitourinary disorders. TRANSDERMAL DRUG DELIVERY DEVICES MARKET HIGHLIGHTS The increasing prevalence of CVD, neurological disorders, menopause, chronic pain, overactive bladder, and hypogonadism are increasing as the population ages, creating opportunities for treatments in... [Read More]




Global Ophthalmic Surgical Products Market (2017)
130 Pages | 33 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of medical devices, market forecasts, competitors, and opportunities in the global Ophthalmic Surgical Products Market, which focuses on 4 core segments: 1) ophthalmic surgical systems/equipment; 2) intraocular lenses (IOLs); 3) surgical instruments; and 4) micro-invasive glaucoma surgery (MIGS) devices/implants. OPHTHALMIC SURGICAL PRODUCTS MARKET HIGHLIGHTS The global ophthalmic surgical products market was valued at more than $7.5bn in 2016 and is exp... [Read More]




Global Robotically-Assisted Surgical Devices Market (2017)
101 Pages | 28 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for robotically-assisted surgical systems. Market segments include robotic surgery systems, instruments, and services. ROBOTICALLY-ASSISTED SURGICAL DEVICES MARKET HIGHLIGHTS The global market for robotically-assisted surgical systems totalled more than $3bn in 2016, with instruments and accessories accounting for the largest share of sales. From 2016-21, the ... [Read More]




2018 Emerging Medical Technologies Report (2018)
2018 Analysis
The 2017 Emerging Medical Technologies Report includes discreet details on over 200 of the most promising early-stage emerging medical technology companies recently identified by LSI researchers and analysts. Companies analyzed in this report are developing advanced technologies in various markets including but not limited to: cardiovascular, neurovascular, peripheral vascular, ophthalmology, drug delivery, wound closure, diabetes management, orthopedics/spine, infection control/prevention, dia... [Read More]




Global Specialty Endoscopic Surgery Devices Market (2017)
167 Pages | 75 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of competitors, markets (current and forecast), products, and opportunities in the global market for medical devices used in specialty endoscopic surgery. Specialty endoscopic procedures covered by this report include arthroscopy, cardiovascular surgery, ear, nose, and throat, gastroenterology, neurosurgery, and pulmonary surgery. SPECIALTY ENDOSCOPIC SURGERY DEVICES MARKET HIGHLIGHTS The market for specialty endoscopic surgery devices totalled more t... [Read More]




2017 Opportunities in Global Medical Devices & Diagnostics (2017)
585 Pages | 164 Exhibits | 2017 Analysis | Forecasts Through 2021
The 2017 Opportunities in Global Medical Devices & Diagnostics Report encompasses: A comprehensive analysis of the global medical device & diagnostics industry; 164 detailed exhibits providing econometrically modeled market forecasts and supplier share data; Geographic and competitive assessments for 23 major technology segments; Current and forecast markets for 120 individual products; Current and forecast sales for 10 major national and regional MD&D markets and for industrialized v... [Read More]




Global Diagnostic and Guided Interventional Cardiology Products Market (2017)
174 Pages | 98 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for diagnostic and guided interventional cardiology products. DIAGNOSTIC AND GUIDED INTERVENTIONAL CARDIOLOGY MARKET HIGHLIGHTS Diagnostic interventional cardiology products are being utilized less frequently in the pre-operative work-up of patients with suspected cardiovascular disease. These technologies are primarily utilized to guide minimally invasive therapies (... [Read More]




Global Orthobiologics Market for Musculoskeletal Soft Tissue Replacement and Regeneration (2017)
133 Pages | 50 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration. Markets covered include orthobiologics for cartilage replacement and regeneration, meniscus replacement and regeneration, and ligament and tendon replacement and regeneration. Products include allografts, scaffolds/matrices, and cellular therapies. ORTHOBIOLOGICS MARKET HIGHLIGHTS Th... [Read More]




Global Minimally Invasive Weight Loss (Bariatric) Devices Market (2017)
184 Pages | 54 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of medical devices, market forecasts, competitors, and opportunities in the global minimally invasive weight loss (bariatric) devices market. This market focuses on 3 core segments: 1) laparoscopic adjustable gastric banding systems 2) intragastric balloons, and 3) implantable neuroregulators/gastric stimulators, as well as emerging technologies. MINIMALLY INVASIVE WEIGHT LOSS MARKET HIGHLIGHTS The minimally invasive weight loss devices market was valu... [Read More]




Global Inhalation Drug Delivery Devices Market (2017)
68 Pages | 16 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global inhalation drug delivery devices markets, including MDIs, DPIs, and nebulizers for the treatment of asthma and COPD. INHALATION MARKET HIGHLIGHTS The combined prevalence of asthma and COPD in the countries covered by this report (US, Japan, and five major EU markets of France, Germany, Italy, Spain, and the UK) is 109.3 million. The combined market for inhalation drug ... [Read More]




Global Heart Valve Repair and Replacement Devices Market (2017)
193 Pages | 62 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for heart valve repair and replacement devices. COVERAGE INCLUDES: An overview of heart valve repair and replacement devices, including percutaneous balloon valvuloplasty, heart valve surgery (repair and replacement), transcatheter aortic valve replacement (TAVR), and transcatheter mitral valve regurgitation (TMVrep) products. Global and country/region-specific market f... [Read More]




Global General and Pelvic Endoscopic Surgery Devices Market (2017)
233 Pages | 91 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of competitors, markets (current and forecast), products, and opportunities in the global market for medical devices used in endoscopic general and pelvic surgeries. GENERAL AND PELVIC ENDOSCOPIC SURGERY DEVICES MARKET HIGHLIGHTS The market for endoscopic general and pelvic surgery devices totalled more than $11.6 billion in 2016 and is expected to climb at a rate of 5.7% over the forecast period. The endoscopes market is expected to experience the gre... [Read More]




Global Markets for Electrosurgical Products (2017)
95 Pages | 37 Exhibits | 2017 Analysis | Forecasts Through 2022
Electrosurgery will account for a rising share of surgeries in emerging markets, according to Life Science Intelligence's new report, "Global Markets for Electrosurgical Products in 2017." The report discusses the major forces affecting growth in the markets for electrosurgical generators, handpieces and consumables, and accessory products. Key categories for electrosurgery include aesthetic, dermatological, and plastic surgery; cardiothoracic surgery; otolaryngology; general surgery; gynecology... [Read More]




Biopsy Devices Market (2017)
98 Pages | 41 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for biopsy devices. BIOPSY DEVICES MARKET HIGHLIGHTS Biopsy devices are most commonly utilized in the diagnosis of cancer. The global incidence of cancer continues to increase, driving sales of biopsy devices. Biopsy guidance system sales are expected to account for the largest share of total market sales, while the needle-based biopsy devices segment will register the l... [Read More]




Benign Prostatic Hyperplasia and Prostatitis Device-based Treatments Market (2017)
132 Pages | 16 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices. BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS DEVICE-BASED TREATMENTS MARKET HIGHLIGHTS Symptomatic BPH and prostatitis affect over 100 million men worldwide, resulting in painful symptoms and lower quality of life. Laser-based devices and urethral implants are expected to be the primary segments driving growth in the market. T... [Read More]




Pain Management Devices Market (2017)
59 Pages | 10 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the worldwide TENS, neurostimulators, implantable analgesia infusion pumps, and external analgesia infusion pumps markets. PAIN MANAGEMENT MARKET HIGHLIGHTS More than 100 million people in the US experience chronic pain. In Europe, the prevalence of chronic pain is between 25% and 35%. Pain-related disability represents a significant and costly liability to patients and employer... [Read More]




Global Market for Arthroscopy and Sports Medicine Devices (2017)
106 Pages | 41 Exhibits | 2017 Analysis | Forecasts Through 2021
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for arthroscopy and sports medicine devices. Arthroscopy market segments include arthroscopic visualization products, fluid management products, manual instruments, and powered instruments. Soft tissue fixation segments include the individual markets for meniscal fixation, cruciate ligament fixation, shoulder fixation, and hip fixation devices. ARTHROSCOPY and SPORT... [Read More]




Global Diabetes Management Devices Market (2017)
160 Pages | 42 Exhibits | 2017 Analysis | Forecasts Through 2020
This analysis includes a discussion of medical devices, current/forecast markets, competitors, and opportunities in the global diabetes management devices market, which focuses on glucose monitoring devices and insulin pump systems. DIABETES MANAGEMENT DEVICES MARKET HIGHLIGHTS The substantial and highly competitive global diabetes management devices market was valued at more than $9 billion in 2015 and is expected to grow at a healthy CAGR approaching 5%. The highest growth segment is... [Read More]




U.S. Surgical Procedure Volumes (2016)
565 Pages | 95 Exhibits | 2016 Analysis | Forecasts Through 2021
This report provides U.S. procedure volumes forecasts for 10 surgical categories: 1) cardiovascular/thoracic 2) cosmetic/aesthetic 3) general surgical 4) major organ/stem cell/tissue transplantation 5) neurosurgical 6) obstetric/gynecologic 7) ophthalmic 8) orthopedic/spine 9) urologic 10) misc. procedures U.S SURGICAL PROCEDURE VOLUMES HIGHLIGHTS This report presents the most common surgical procedures performed in the United States (US). Provides a comprehensive overview of t... [Read More]




Women's Health: Market for Female Urinary Incontinence Devices (2016)
104 Pages | 19 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for minimally invasive female urinary incontinence devices. Markets covered include urethral bulking agents, urethral slings, and neuromodulation devices. FEMALE URINARY INCONTINENCE MARKET HIGHLIGHTS Urinary incontinence affects more than 200 million people worldwide. The global market for female urinary incontinence products totaled more than $643.7 million in... [Read More]




Implantable Cardiac Rhythm Management Device Markets (2016)
113 Pages | 43 Exhibits | 2016 Analysis | Forecasts Through 2021
In 2015, the global market for implantable cardiac rhythm management (CRM) devices was valued at $10.2bn. The overall market, which includes cardiac resynchronization therapy, implantable cardioverter defibrillator, and pacemaker systems, is forecast to expand at a moderate compound annual growth rate of 4.8% and reaching an estimated $13.5bn in unit sales. Sales attributable to ICDs accounted for approximately 44.5% of total product sales in 2015. Pacemaker unit sales accounted for the second l... [Read More]




Advanced Wound Care Products Market (2016)
159 Pages | 31 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global tissue-engineered skin replacements/substitutes, active wound repair modulators, advanced wound closure products, and advanced wound dressings markets. ADVANCED WOUND CARE MARKET HIGHLIGHTS Product innovation and robust growth have intensified in the US advanced wound care products market in recent years; however, similar growth patterns have yet to be realized in other... [Read More]




Women's Health: Osteoporosis Diagnostic Products (2016)
91 Pages | 30 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for bone densitometry systems and bone turnover marker tests. OSTEOPOROSIS DIAGNOSTIC MARKET HIGHLIGHTS Fractures from osteoporosis and low bone mass cost approximately $20bn a year in the US, with this figure expected to grow to approximately $25bn by 2025. The estimated cost of osteoporosis in the EU is approximately €37bn [$44.3bn] annually, with fractu... [Read More]




Benign Uterine Conditions Therapy Systems Market (2016)
108 Pages | 12 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the benign uterine condition (BUC) therapy systems market, including global endometrial ablation systems, MR-guided focused ultrasound systems, uterine artery embolization systems, and hysteroscopes/fibroid removal systems. BENIGN UTERINE CONDITION MARKET HIGHLIGHTS Fewer than 15% of the 100m women worldwide with dysfunctional uterine bleeding (DUB) receive treatment. Of the 1.... [Read More]




Global Markets for Non-Hospital-Based Point-of-Care Diagnostic Products (2016)
215 Pages | 55 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for point-of-care (POC) diagnostic products used outside of the hospital environment. POINT-OF-CARE DIAGNOSTICS MARKET HIGHLIGHTS The POC products market is comprised of many testing segments. In 2015, global total sales for these product segments were valued at $10.8 billion. In 2015, the home/self-testing POC products market accounted for approximately 56% of ... [Read More]




Global Markets for Hospital-Based Point-of-Care Diagnostic Products (2016)
220 Pages | 56 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global hospital-based point-of-care (POC) diagnostic products market. POINT-OF-CARE DIAGNOSTICS MARKET HIGHLIGHTS The hospital-based POC products market is comprised of many segments, including: critical care testing, cardiac marker testing, and rapid infectious disease testing, among others. In 2015, global total sales for these products were valued at $3.9 billion. In 2015... [Read More]




U.S. Image-Guided Surgical Neuronavigation & External Beam Radiation Therapy (EBRT) Systems Market (2016)
72 Pages | 12 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in two segments: the US image-guided surgical neuronavigation systems market, and the US external beam radiation therapy (EBRT) systems market for neurological pathologies. IMAGE-GUIDED SURGICAL NEURONAVIGATION & EXTERNAL BEAM RADIATION THERAPY MARKET HIGHLIGHTS The US image-guided surgical neuronavigation & EBRT systems market for neurological pathologies was valued at more than... [Read More]




Global Markets for Assisted Breathing, Airway Management, & Ventilation (2016)
195 Pages | 128 Exhibits | 2016 Analysis | Forecasts Through 2021
The global market for ventilators and airway management products was valued at $5.7 billion during 2015. Important regional differences, such as relative levels of market maturity as well as key demographic factors, are expected to influence growth across a range of product types through 2021. In the U.S., where respiratory caseloads are expected to rise, greater preference is being given to systems that enable use for patients at all levels of acuity as well as those that facilitate the transit... [Read More]




Global Markets for Infection Control and Biosafety Products (2016)
97 Pages | 20 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global medical waste disposal, device reprocessing, standard and safety needle/syringe, sharps disposal, and sterilization equipment and services markets. INFECTION CONTROL HIGHLIGHTS Each year, approximately 2m people in the US and 4m people in the EU acquire a healthcare-associated infection. The most common HAIs are those of the lungs, surgical site, and urinary tract. Abou... [Read More]




Global Markets for Orthobiologic Products for the Repair and Regeneration of Bone (2016)
101 Pages | 37 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global orthobiologic products market for the repair of bone. ORTHOBIOLOGIC MARKET HIGHLIGHTS Musculoskeletal disorders are the second leading cause of disability in the world. Procedures treating musculoskeletal disorders are expected to continue to rise as the elderly population expands. In addition, the global rise in obesity and the prevalence of sedentary lifestyles will a... [Read More]




U.S. Neurointerventional Devices Market (2016)
86 Pages | 19 Exhibits | 2016 Analysis | Forecasts Through 2020
Neurointerventional radiology/surgery, or neurovascular intervention, is a relatively new medical specialty employing minimally invasive endovascular techniques to treat vascular diseases of the brain. Neurointerventional devices, which contributed sales of more than $870m in the US in 2015, involve a variety of standard and application-specific transcatheter tools and techniques for the treatment of cerebrovascular pathologies (such as aneurysms, arteriovenous malformations [AVMs], and acute an... [Read More]




U.S. and European Markets for Joint Arthroplasty Products (2016)
195 Pages | 61 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, and competitors insight into the global joint arthroplasty market. JOINT ARTHROPLASTY MARKET HIGHLIGHTS Osteoporosis, osteoarthritis, and rheumatoid arthritis affected over 64 million adults over the age of 45 in 2015 in the US and 5 major European markets-a demographic that is expected to grow steadily by 2020. A growing number of adults wishing to maintain a physically active lifestyle and increasing joint complic... [Read More]




Global Markets for Neurosurgical Products (2016)
200 Pages | 106 Exhibits | 2016 Analysis | Forecasts Through 2021
Neurosurgical procedure volumes are increasing at a strong pace in emerging markets, according to Life Science Intelligence's new report, "Global Markets for Neurosurgical Products in 2016." The report discusses the major forces affecting growth in the markets for stereotactic radiosurgery systems, embolization products, intracranial shunts, neurosurgical endoscopes, and surgical clipping products for aneurysm and arteriovenous malformations. The main clinical conditions driving the use of these... [Read More]




Global Neurostimulation Devices Market (2016)
313 Pages | 63 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global neurostimulation devices market for more than 20 existing and emerging therapy areas. NEUROSTIMULATION MARKET HIGHLIGHTS The dynamic global neurostimulation devices market was valued at more than $3.9 billion in 2015 and is expected to grow at a healthy CAGR of 8.4% over the forecast period. The U.S. contributed the majority of sales, although the ROW share is climbing. ... [Read More]




International Markets for Vascular Access Site Closure Devices (2016)
99 Pages | 38 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global vascular access site closure devices, or vascular closure devices (VCDs), market. VASCULAR CLOSURE DEVICES MARKET HIGHLIGHTS Cardiovascular diseases (CVDs) are the leading causes of death throughout the world. An estimated 17 million people die each year from CVDs. Global CVD-related procedures are expected to continue experiencing moderate growth as more people aroun... [Read More]




U.S. Markets for Respiratory Care Products (2016)
194 Pages | 67 Exhibits | 2016 Analysis | Forecasts Through 2020
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the U.S. ventilator systems, blood gas monitoring systems, pulmonary function assessment products, sleep apnea management products, and airway management accessories markets. RESPIRATORY CARE MARKET HIGHLIGHTS The annual U.S. economic burden of respiratory disease is more than $106 billion. Appropriate therapy can reduce direct healthcare costs as well as indirect costs such as lo... [Read More]




2016 Opportunities in Global Medical Devices & Diagnostics (2016)
550 Pages | 154 Exhibits | 2016 Analysis | Forecasts Through 2020
The global medical devices and diagnostics (MD&D) industry has been undergoing significant globalization and consolidation to serve industrialized nations seeking to provide more care for fewer dollars and emerging nations striving to better serve the health care needs of the new urban classes driving their economic growth. Although total market growth is not expected to return to former double-digit levels, meaningful opportunities in new technologies, geographies and strategic merger & acquisi... [Read More]




U.S. Markets for Interventional Cardiology Products (2016)
138 Pages | 45 Exhibits | 2016 Analysis | Forecasts Through 2020
In the United States (U.S.), approximately 85.6 million adults have at least one type of cardiovascular disease (CVD), a broad group of disorders that affect the heart and circulatory system. Cardiovascular disease in all its forms accounts for more deaths than any other major cause in the U.S., including cancer, with one of every three deaths in the country due to CVD and over 2,200 people dying from the disease each day (or an average of one death from CVD every 40 seconds). Diseases/disorde... [Read More]




U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (2016)
132 Pages | 30 Exhibits | 2016 Analysis | Forecasts Through 2020
More than 40% of people in the U.S. say they have experienced recent pain, with 8% suffering from chronic pain. Direct healthcare costs associated with the treatment of pain total nearly $300 billion annually, with indirect costs such as reduced worker productivity contributing another $300 billion in costs. Multidisciplinary pain management plans may involve the use of pharmacologic, device-based, or alternative therapies; a combination of these modalities often is required to achieve optimum... [Read More]




Global Markets for Neuromodulation Devices and Implantable Infusion Pumps (2016)
103 Pages | 42 Exhibits | 2016 Analysis | Forecasts Through 2021
A rising number of patients is expected to benefit from the use of neuromodulation devices in the next 5 years according to LSI's new analysis, "Global Markets for Neuromodulation Devices and Implantable Infusion Pumps in 2016." The report discusses the major forces affecting growth in the markets for implantable infusion pumps; neuromodulation devices used for established applications such as chronic pain, sensorineural hearing loss, gastroparesis, urinary incontinence, fecal incontinence, epil... [Read More]




Global Radiation Therapy Systems Market (2016)
117 Pages | 31 Exhibits | 2016 Analysis | Forecasts Through 2020
This report covers the large, highly competitive, technology driven Global Market for Radiation Therapy Systems-valued at nearly $4.3 billion in 2015. Radiation therapy, sometimes called radiotherapy, uses various types of specialized, focused energy to kill cancer cells and shrink tumors, and is commonly used either alone or in combination with surgery or chemotherapy. Radiation therapy is being used to treat a broad and growing number of cancers, and offers a variety of specialized treatme... [Read More]




Global Markets for Specialty Surgical Wound Care Products: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products (2016)
33 Exhibits | 2016 Analysis | Forecasts Through 2020
About the global market: The global market for specialty surgical wound care products-which includes sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.2 billion in 2014. The main factor influencing growth in the market is surgical volumes; rising numbers of surgeries in major global markets will generate greater revenues through 2020, when total sales are projected to reach $4.4 billion. Sales of absorbable hemostats and adhesion prevention produc... [Read More]




Asia-Pacific Disease Incidence and Prevalence (2016)
237 Pages | 66 Exhibits | 2016 Analysis | Forecasts Through 2020
The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam. This report examines the etiology and epidemiology of the most prevalent diseases/disorders in the APAC region. Categories covered by this report include: blood disorders; cancer; cardiovascular diseases/disorders; gastric and metabolic diseases/disorders; musculos... [Read More]




Global Spinal Implants Market (2015)
223 Pages | 51 Exhibits | 2015 Analysis | Forecasts Through 2020
Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma. Degenerative disc disease (DDD) typically is caused by gradual disc damage and often results in disc herniation and chronic back or neck pain; the disease is most common among otherwise healthy people in their 30s or 40s and affects ap... [Read More]




U.S. Markets for Drug and Fluid Delivery Devices (2015)
180 Pages | 52 Exhibits | 2015 Analysis | Forecasts Through 2019
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014. In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumulat... [Read More]




U.S. Markets for Minimally Invasive Benign Prostatic Hyperplasia and Prostatitis Therapies (2015)
74 Pages | 15 Exhibits | 2015 Analysis | Forecasts Through 2019
In the United States (U.S.) benign prostatic hyperplasia (BPH) and prostatitis currently affect over 10 million men, lowering quality of life with painful symptoms that can be difficult to manage. The U.S. market for minimally invasive products for the treatment of BPH and prostatitis includes pharmaceutical and minimally invasive surgical systems aimed at treating the symptoms of BPH/prostatitis. New therapies in development offer the potential to change the way that symptomatic BPH and prost... [Read More]




U.S. Surgical Procedure Volumes (2015)
506 Pages | 95 Exhibits | 2015 Analysis | Forecasts Through 2020
The number of laparoscopic/percutaneous surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings and open surgery. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with an estimated 30% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pace t... [Read More]




U.S. Patient Monitoring Devices Market (2015)
235 Pages | 85 Exhibits | 2015 Analysis | Forecasts Through 2019
This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market, which (for the purposes of this report) includes the following 5 segments: i.) pulse oximetry, ii.) cerebral oximetry, iii.) brain function monitors, iv.) hemodynamic monitoring devices, and v.) multi-parameter vital signs monitoring systems. In 2014, the largest segment-vital signs monitors-comprised the vast majority of sales, at approximately 51.6% of the total market, followed by pulse oximetr... [Read More]




Global Markets for Gastrointestinal and Colorectal Endoscopy, Cystoscopy, Ureteroscopy, and Hysteroscopy (2015)
104 Pages | 67 Exhibits | 2015 Analysis | Forecasts Through 2020
This report explores the underlying forces driving growth in some of the most important endoscopic segments. At a time when healthcare institutions are seeking ways to restrain spending while improving outcomes, endoscopic technologies offer compelling possibilities by presenting improvements in cosmetic outcomes and the potential for faster recoveries-both of which are important considerations in a global market which features a growing middle class and rising awareness of the a... [Read More]




Global Markets for Specialty Surgical Endoscopy Products (2015)
101 Pages | 62 Exhibits | 2015 Analysis | Forecasts Through 2020
The trend toward minimally-invasive surgery has driven rising sales of endoscopy products in a growing range of applications, including orthopedics, pulmonary and respiratory applications, urology, otolaryngology, gastrointestinal and colorectal surgery, neurology, and gynecology. Technological limitations and major anatomical challenges have limited adoption in important categories, however, preventing broader use of endoscopic devices and techniques for life-threatening applications in surgica... [Read More]




Global Markets for Arthroscopy, Bronchoscopy, ENT Endoscopy, Neuroendoscopy, and Spinal Endoscopy (2015)
109 Pages | 73 Exhibits | 2015 Analysis | Forecasts Through 2020
Robust growth is expected for sales of minimally invasive surgical products through 2020. The market, which was valued at $8.4 billion in 2014 and includes arthroscopes, bronchoscopes, endoscopes, instrumentation, access devices, and related products is benefiting from the adoption of new devices and techniques that expand the range of surgical caseloads; patient and clinical preference for less-invasive surgical methods; and rising access to advanced technologies in emerging markets. This analy... [Read More]




Asia-Pacific: Surgical Procedure Volumes (2015)
319 Pages | 127 Exhibits | 2015 Analysis | Forecasts Through 2019
Product areas covered by the scope of this report include a discussion of healthcare trends in the Asia-Pacific countries covered by this report (Japan, China, South Korea, India, Thailand, Vietnam, Malaysia, and Australia), as well as detailed analysis of surgical procedure volumes in the region as a whole and in each individual country. Surgical procedures covered by this report include cardiovascular and peripheral vascular procedures (e.g., CABG, PTCA, congenital heart defect repair, heart ... [Read More]




U.S. Markets for Orthopedic Extremity and Soft Tissue Repair (2015)
138 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2019
The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury. Innovation in the treatment of bone, joint, and soft tissue of the extremities will primarily be seen in biologics, as new products are designed harnessing cellular therapies, such as stem cells, to reg... [Read More]




Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies (2015)
106 Pages | 44 Exhibits | 2015 Analysis | Forecasts Through 2020
A new report from LSI, "Global Markets for Drug Delivery: Transdermal and Inhalation Drug Delivery Technologies in 2015," explores the dynamic market for transdermal drug patches, iontophoresis devices, dry powder inhalers, metered dose inhalers, and nebulizers. The market, which was valued at $8.2 billion in 2014, is being driven by powerful regional and economic forces; key among these are the introduction and adoption of generic products, rising caseloads, the pursuit of new and expanded ther... [Read More]




U.S. Markets for Stroke Management (2015)
170 Pages | 44 Exhibits | 2015 Analysis | Forecasts Through 2019
The United States (U.S.) market for stroke management products, which encompasses diagnostic and therapeutic systems, is a market composed of old and new technologies that are often used together in order to prevent and treat stroke. Improvements in stroke diagnostic systems will facilitate the delivery of timely stroke therapies within the optimum treatment window for patients suffering from stroke. Topics covered in this report include: •    Diagnostic, interventional,... [Read More]




U.S. Markets for Advanced Wound Care Products (2015)
143 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019
Over the past 20 years, there has been an explosion of knowledge regarding the basic science of wound healing and a trend toward more evidence-based medicine. Advanced wound care technologies that have been developed include tissue-engineered skin replacement/substitutes, active wound repair modulators, advanced wound closure products, and advanced wound dressings. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportu... [Read More]




European Surgical Procedure Volumes (2015)
463 Pages | 84 Exhibits | 2015 Analysis | Forecasts Through 2019
This report presents the most common surgical procedures performed in select European countries, as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends. European countries covered by this report include France, Germany, Italy, Spain, and the United Kingdom. The forecast period covered by this report is for the years 2014 through 2019. Surgical procedures covered by this repor... [Read More]




2015 Global Opportunities in Endovascular Management of Chronic Venous Insufficiency & Deep Vein Thrombosis (2015)
200 Pages | 2015 Analysis | Forecasts Through 2019
Chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) are complex and challenging peripheral vascular conditions that affecting large segments of the global adult population. Although not usually as immediately life-threatening as a stroke or heart attack, their progressive nature can have serious long-term implications for affected individuals, who may develop debilitating secondary conditions that can be costly to treat and, in some cases, become life-threatening. Aside from life... [Read More]




U.S. Neurostimulation Devices Market (2015)
277 Pages | 67 Exhibits | 2015 Analysis | Forecasts Through 2019
An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime. Among the many neurological disorders are chronic pain (including migraine headache), epilepsy, hearing loss, incontinence, major depression, Parkinson's disease, sleep apnea, and visual impairment/blindness. Typically, the initial treatment option for these conditions is standard pharmacotherapy or surgery; however, neurostimulation is gaining in popular... [Read More]




Global Molecular Diagnostics Market (2015)
272 Pages | 59 Exhibits | 2015 Analysis | Forecasts Through 2020
The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019. This growth is forecast to occur in spite of relatively modest growth in the overall worldwide market for IVD products, which is estimated to be expanding at a compound annual rate of 4.2% for the same period. To some extent, growth of t... [Read More]




2015 Opportunities in Global Medical Devices & Diagnostics (2015)
557 Pages | 200 Exhibits | 2015 Analysis | Forecasts Through 2019
The $379 billion global medical devices and diagnostics (MD&D) industry has been undergoing significant globalization and consolidation as industrialized nations seek to provide more care for fewer dollars and emerging nations strive to better serve the health care needs of new urban classes driving their economic growth. Although market growth is unlikely to return to former double-digit levels, significant opportunities in new technologies, geographies and strategic merger & acquisition (M&A) ... [Read More]




U.S. Markets for Orthopedic Biologic and Tissue Engineered Products (2015)
116 Pages | 27 Exhibits | 2015 Analysis | Forecasts Through 2019
Biologics and cellular therapies for musculoskeletal injuries-including hard tissue (i.e., bone) and soft tissue (i.e., cartilage, ligaments, and tendons)-represent a billion dollar market that is showing the potential for continued growth. Over the forecast period covered in this report, the estimated value of the U.S. market for orthopedic biologic and tissue engineered products is expected to grow by approximately $984.4 million at a compound annual growth rate (CAGR) of 8.2%; of this holist... [Read More]




Global Markets for Surgical Drapes, Gowns, Gloves, Masks, and Fluid Management Products (2015)
94 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2020
The global market for surgical drapes and gowns, gloves, masks, and fluid management products was valued at $9.5 billion in 2014. As analyzed in this detailed new analysis by LSI, the market will be influenced by efforts to limit health care costs through the reduction of infections and product expenditures as well as the need to accommodate the rising number of surgeries in key markets. Trends in product utilization, such as double-gloving, will generate growth in the number of units sold each ... [Read More]




U.S. Markets for Infection Control and Biosafety Products (2015)
96 Pages | 32 Exhibits | 2015 Analysis | Forecasts Through 2019
Each year, approximately two million hospital patients in the United States (U.S.) acquire a healthcare-associated infection, or HAI. The most common HAIs are those of the lungs, surgical site, and urinary tract. Approximately one-third of all HAIs are considered preventable. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for infection control and biosafety products. Product areas cov... [Read More]




2015 Global Opportunities in the Interventional Management of Symptomatic Peripheral Artery Disease (2015)
200 Pages | 66 Exhibits | 2015 Analysis | Forecasts Through 2019
This report focuses on the novel drug-coated balloon and drug-eluting stent technologies that are expected to revolutionize the treatment of limb- and life-threatening symptomatic peripheral artery disease and drive the development of a new, multi-billion dollar market. It also covers revascularization-enabling peripheral atherectomy systems and dedicated refractory CTO crossing devices that are likely to see above-average growth through 2019. Epidemiological, procedure and market data are pre... [Read More]




2015 Global Opportunities in Interventional Acute Stroke Therapies (2015)
200 Pages | 2015 Analysis | Forecasts Through 2019
The report covers emerging and existing neurointerventional technologies used in the management of patients with intracranial hemorrhage and acute cerebral ischemia. Special emphasis is given to novel left atrial appendage systems for the prevention of cardiogenic stroke (which accounts for about 20% of all acute ischemic stroke cases), and cerebral thrombectomy systems that address a large unmet need in the emergent treatment of acute ischemic stroke patients (less than 5% of the latter qualif... [Read More]




2015 Global Opportunities in Endovascular Management of Aortic Aneurysm Disease (2015)
200 Pages | 2015 Analysis | Forecasts Through 2019
This report is focused on primary and ancillary technologies employed in endovascular aortic aneurysm repair (EVAR). Commercially introduced about two decades ago, less invasive EVAR techniques quickly emerged as the preferred treatment modality for life-threatening, rupture-prone abdominal and thoracic aortic aneurisms in the U.S. and as a viable alternative to highly invasive and risky surgery in Europe and other regions of the world. By the end of 2014, cumulative global EVAR device revenues ... [Read More]




2015 Hypertension and Resistant Hypertension Disease Dynamics Report (2015)
2015 Analysis
In this report, Dymedex provides a detailed landscape of diseases far beyond what is currently available in the public domain. While individual clinical papers provide specific snapshots of a disease or strive to understand its epidemiology or other dimensions, no single clinical paper attempts to aggregate the hundreds of pieces of information that exist about a given disease and synthesize them into an integrated perspective. This report details the progression of a patient from undiagno... [Read More]




U.S. Markets for Biologic and Tissue Engineered Devices - Cardiovascular and Neurological Products (2015)
110 Pages | 13 Exhibits | 2015 Analysis | Forecasts Through 2020
Tissue engineering, or regenerative medicine, represents a promising therapeutic possibility for the treatment of aggressive and deadly diseases. Cellular therapies for cardiovascular disease (CVD) and neurological disease represent potential billion dollar markets that could offer a viable therapeutic option for a sizable patient population that has exhausted other therapeutic alternatives. Over 35 novel cellular therapies for cardiovascular and neurological disease are currently in developme... [Read More]




Global Markets for Drug Delivery: Infusion and Injection Technologies (2015)
111 Pages | 71 Exhibits | 2015 Analysis | Forecasts Through 2020
Infusion and injection technologies generated $14.2 billion in global sales during 2014. As discussed in LSI's new report, "Global Markets for Drug Delivery: Infusion and Injection Technologies in 2015," the market for these products-which include infusion systems, vascular access devices, and injection products- will be affected by critical regional factors that include initiatives to expand access to healthcare, limit the cost of expensive critical and long-term care, and improve convenience a... [Read More]




U.S. Markets for Obesity Drugs & Devices (2015)
178 Pages | 56 Exhibits | 2015 Analysis | Forecasts Through 2020
According to National Health and Nutrition Examination Survey (NHANES), approximately 35%, or nearly one out of three adults age 20 years or older were classified as obese in 2012 (the latest available statistics) based on a BMI of 30 kg/m2 or greater. This translates to more than 100 million obese people in the U.S.-a staggering number. Obesity has become such as concern due to increasing prevalence and the rise of serious health-related co-morbidities, such as type 2 diabetes, that it has rece... [Read More]




U.S. Markets for Cardiac Rhythm Management (2015)
118 Pages | 33 Exhibits | 2015 Analysis | Forecasts Through 2019
Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%, wh... [Read More]




U.S. Markets for Anesthesia and Ventilation Products (2015)
184 Pages | 62 Exhibits | 2015 Analysis | Forecasts Through 2018
Respiratory care and anesthesia represent a significant element of healthcare delivery within the U.S. In 2013, the U.S. anesthesia and ventilation products market totaled approximately $3.5 billion. The overall market is expected to experience 4.5% growth over the forecast period, with the most growth anticipated in the heat/moisture exchangers and supraglottic airways segments. Factors contributing to growth in this market include the aging of the population (with an associated increase... [Read More]




2015 Worldwide Markets and Emerging Technologies for Point-of-Care Testing (2015)
307 Pages | 129 Exhibits | 2015 Analysis | Forecasts Through 2019
The market for point-of-care (POC) diagnostic products comprises 28% of the total in-vitro diagnostics market. The market is projected to grow at a considerably slower rate than the overall IVD market over the 2014-2019 interval, primarily due to stagnant sales in the whole blood glucose self-testing segment, which accounts for more than half (53%) of the total market. However, most other segments of the POC diagnostics market are growing at rates well in excess of the overall POC market, and in... [Read More]




Global Markets for Oxygen Therapy and Inhalation Devices (2015)
94 Pages | 57 Exhibits | 2015 Analysis | Forecasts Through 2020
The global market for oxygen therapy and inhalation devices was valued at $1.0 billion in 2014. As analyzed in this detailed new report by LSI, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which wi... [Read More]




Emerging Global Markets for Novel Peripheral Interventional and Neurointerventional Therapeutic Systems (2015)
189 Pages | 49 Exhibits | 2015 Analysis | Forecasts Through 2018
Peripheral vascular disease and acute stroke are major public health problems worldwide, and the incidence and prevalence of these conditions is rising, reflecting both the aging of the population in many regions of the world, and continuing growth in the incidence of problematic risk factors such as diabetes, hypertension and obesity. In recent years, device manufacturers have developed a number of novel and highly promising percutaneous revascularization technologies including peripheral drug... [Read More]




Global Markets for Peripheral Endovascular and Vascular Closure Devices (2015)
344 Pages | 171 Exhibits | 2015 Analysis | Forecasts Through 2019
Percutaneous transluminal angioplasty will lead the way with double-digit annual growth, driving expansion in U.S. and international markets. Robust market growth is expected for several peripheral endovascular and vascular closure devices on a global basis. Endovascular therapies have seen rising adoption due to new product introductions, the increasing prevalence of peripheral artery disease, developing healthcare systems in emerging markets, and the desire to utilize minimally invasive in... [Read More]




International Markets for Specialty Peripheral Vascular Products (2015)
85 Pages | 41 Exhibits | 2015 Analysis | Forecasts Through 2019
The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the effe... [Read More]




U.S. Markets for Specialty Peripheral Vascular Products (2015)
72 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019
Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated balloons (DCBs), ... [Read More]




U.S. Markets for Critical Care Patient Management Products (2014)
179 Pages | 50 Exhibits | 2014 Analysis | Forecasts Through 2018
Critical care in the U.S. is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Hospitals are evolving into critical care centers to which only the most seriously ill patients are admitted. Virtually every hospital unit has a significant percentage of patients benefiting from advanced technologies and equipment necessary for sustaining life, or for rapidly identifying severe clinical conditions.... [Read More]




Global Markets for Peripheral Vascular Stent Products (2015)
82 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2019
The global market for peripheral vascular stents, which was valued at $1.1 billion in 2013, has entered into a dynamic phase which will be characterized by the rising prevalence of peripheral artery disease (PAD), growing availability in key regional markets, and the adoption of potentially competitive products, such as drug-coated balloons (DCBs). In the U.S., where DCBs became commercially available in October 2014, the use of stents will continue to be driven by the availability of products t... [Read More]




Global Markets for Vascular Closure Devices (2015)
105 Pages | 53 Exhibits | 2015 Analysis | Forecasts Through 2019
The global market for vascular closure devices (VCDs), which are often used following arterial puncture for cardiac catheterizations and other procedures, was valued at $706 million in 2013. As analyzed in a new report by Life Science Intelligence, the use of these devices, which include implantables as well as external compression products, will be strongly influenced by regional and global trends toward the implementation of cost-effective care as well as the rising use of transradial access-f... [Read More]




U.S. Disease Incidence and Prevalence (2014)
380 Pages | 122 Exhibits | 2014 Analysis
This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013. Categories covered by this report include: Blood disorders (anemia and hemophilia); Cancer (breast, colon/rectum, lung, nervous system, ovaries, pancreas, prostate, and skin); Cardiovascular diseases/disorders (atherosclerosis, heart failure, high blood ... [Read More]




Global Markets for Assisted Breathing, Airway Management, and Ventilation in 2014 (2014)
137 Pages | 80 Exhibits | 2014 Analysis | Forecasts Through 2019
Ventilators and airway management products generated $4.8 billion in global revenues during 2013. As discussed extensively in LSI's new report, the global market for these products will be affected by key regional differences. In the U.S., where respiratory caseloads are expected to rise, greater preference will be given to systems that enable use for patients at all levels of acuity as well as those that facilitate the transition from costly intensive care settings. The European market will be ... [Read More]




U.S. Markets for Sports Medicine Products (2014)
176 Pages | 52 Exhibits | 2014 Analysis | Forecasts Through 2018
Each year in the U.S., approximately 30 million children and teens participate in organized sports, and more than 200 million adults participate in non-work-related sports or recreational activities. Although these activities are generally beneficial to one's health, they do involve the risk of injury and associated healthcare costs. Each year, nearly 5 million people in the U.S. receive medical treatment for sports injuries including sprains/strains, dislocations/fractures, knee injuries, sho... [Read More]




U.S. Markets for Diagnostic Oncology-Related Magnetic Resonance and Nuclear/Molecular Medicine Imaging Systems (2014)
180 Pages | 37 Exhibits | 2014 Analysis | Forecasts Through 2018
It is estimated that nearly 1.7 million people in the United States (U.S.) will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. Despite advancements in oncology (the branch of medicine that deals with cancer), the disease remains the second-leading cause of death in the country after heart disease. Today, a constellation of methods are used in the fight against cancer, including diagnostic imaging modalities such as magnetic resonance imaging (MRI) a... [Read More]




U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products (2014)
264 Pages | 66 Exhibits | 2014 Analysis | Forecasts Through 2018
In the next decade, the number of people living in the United States (U.S.) with diseases/disorders of the heart and vascular system is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic conditions such as cardiovascular disease (CVD), diabetes, and obesity, which are exacerbated by unhealthful behaviors such as physical inactivity and tobacco smoking. Diagnostic interventional cardiology procedures ... [Read More]




U.S. Markets for Neurosurgical and Neurointerventional Products (2014)
116 Pages | 36 Exhibits | 2014 Analysis | Forecasts Through 2018
This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market. Specifically, this report covers neurosurgical, neurointerventional and image-guided surgical navigation and brain radiotherapy systems used for the treatment of several acute and chronic disorders such as benign and malignant neoplasms... [Read More]




Japan - Medtech Opportunity Assessment Report 2014 (2014)
416 Pages | 334 Exhibits | 2014 Analysis | Forecasts Through 2017
Japan - Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in Japan. The study quantifies, analyzes, and forecasts the Japanese medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013, and foreca... [Read More]




U.S. Markets for Specialty Endoscopic Surgery Products (2014)
173 Pages | 59 Exhibits | 2014 Analysis | Forecasts Through 2018
Over the past several decades, a revolutionary transition has occurred among many surgical procedures that has taken them from an invasive open approach to minimally invasive/endoscopic methods due to advances in medical technology and surgical techniques. The adoption of endoscopy for many procedures has greatly benefited patients, as it reduces pain, recovery time, and scarring as well as hospital costs. The emergence of small-incision and incisionless procedures has resulted in the availabi... [Read More]




International Markets for Vascular Access Site Closure Devices (2014)
179 Pages | 58 Exhibits | 2014 Analysis | Forecasts Through 2018
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have coronary and peripheral vascular disease is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in th... [Read More]




U.S. Surgical Procedure Volumes (2014)
410 Pages | 95 Exhibits | 2014 Analysis | Forecasts Through 2019
The number of laparoscopic/percutaneous surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings and open surgery. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with an estimated 30% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pace t... [Read More]




U.S. Markets for Pharmacologic and Device-Based Approaches to Pain Management (2014)
192 Pages | 43 Exhibits | 2014 Analysis | Forecasts Through 2018
Pain is the single most common reason patients seek medical care, accounting for approximately half of all physician office visits in the United States (U.S.); some studies suggest that more than one-third of people in the U.S. suffer from a chronic pain condition at some point in their lives. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. market for pain management products. Product areas covere... [Read More]




Global Markets for Neonatal/Perinatal Monitoring and Treatment Products in 2014: Infant Ventilation, Jaundice Management, and Neonatal and Perinatal Monitoring Technologies, 2014 (2014)
133 Pages | 67 Exhibits | 2014 Analysis | Forecasts Through 2019
Global revenues from infant ventilators, jaundice management products, and neonatal and perinatal monitoring technologies reached $706 million in 2013. Explored in LSI's report, the market for these technologies will develop as a result of the global forces that are affecting the status of neonatal care, which include powerful regional and demographic trends; the transformation of institutional healthcare in emerging markets; trends in information technology and connectivity; and marketing and m... [Read More]




U.S. Markets for General & Pelvic Endoscopic Surgery Products (2014)
305 Pages | 123 Exhibits | 2014 Analysis | Forecasts Through 2018
The rapid expansion of general laparoscopic surgery in the U.S. has been driven by patient demand for less invasive procedures as well as by the introduction of innovative endoscopic devices that have allowed many surgeons to become proficient in laparoscopic techniques. The laparoscope has been the most significant device affecting these changes, enabling procedures that are less invasive, low in cost, and require less time compared with open surgery. Surgical advances enabling small-incisio... [Read More]




United States - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 371 Exhibits | 2014 Analysis | Forecasts Through 2017
Life Science Intelligence announces the availability of a detailed new report, United States Medtech Opportunity Assessment (MOA) 2014, detailing the country's demographic, economic, healthcare industry and device market opportunities and challenges, and forecasting nearly 200 surgical procedure volumes across 12 key medical specialty areas, through 2017. This valuable resource, containing more than 450 pages of timely, current data and analysis, provides your company with the key information n... [Read More]




Global Markets for Neonatal/Perinatal Monitoring and Treatment Products in 2014: Infant Warmers and Incubators (2014)
84 Pages | 37 Exhibits | 2014 Analysis | Forecasts Through 2019
Infant warmers, incubators, and hybrid systems generated $486 million in global revenues during 2013. The market for these devices, which is analyzed in LSI's new report, will continue to be shaped by regional and local trends in annual births and the delivery of neonatal care. As such, it will differ strikingly between developed and emerging markets, especially in countries where many births continue to take place outside of healthcare institutions; furthermore, limited purchasing resources as ... [Read More]




2014 Global Opportunities in Medical Devices & Diagnostics (2014)
550 Pages | 154 Exhibits | 2014 Analysis | Forecasts Through 2018
The global medical devices and diagnostics (MD&D) market made further albeit modest progress in 2013-growing 2.0% to $365 billion-despite continued capital constraints and global economic challenges. Europe saw a modest rebound, whereas growth slowed considerably in the Asia-Pacific region as those nations regrouped. Acquisitions, many of which further consolidated the industry, continued as companies sought to increase sales and expand their penetration of focal and emerging segments ... [Read More]




U.S. Markets for Interventional Cardiology Products (2014)
270 Pages | 68 Exhibits | 2014 Analysis | Forecasts Through 2018
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from coron... [Read More]




U.S. Ophthalmic Surgical Systems Market (2014)
84 Pages | 13 Exhibits | 2014 Analysis | Forecasts Through 2018
In the United States (U.S.), serious ophthalmic disease affects more than 35 million. This number is expected to significantly increase due to the aging of the population and disorders such as diabetes that may result in progressive vision loss. Alarmingly, the number of patients with cataracts is expected to increase significantly over the next decade, contributing a substantial increase in the number of cataract surgeries. The development of new, minimally invasive energy-based (laser/pha... [Read More]




U.S. Markets for Respiratory Care Products (2014)
200 Pages | 67 Exhibits | 2014 Analysis | Forecasts Through 2018
In the United States (U.S.), more than 35 million people suffer from some form of respiratory disorder and 1 in 6 deaths are caused by chronic lung disease. According to the American Lung Association, the annual economic burden of lung disease in the U.S. is estimated at $154 billion, consisting of $95 billion in direct healthcare costs and $59 billion in indirect costs including lost work days. This dynamic new report from Medtech Insight includes analyses of products, current/forecast ma... [Read More]




France, Disease Incidence and Prevalence (2014)
236 Pages | 22 Exhibits | 2014 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in France. Incidence and prevalence figures are for the year 2012, the most recent year for which data are available. This report is the f... [Read More]




European Markets for Spinal Motion-Preserving Devices (2014)
171 Pages | 43 Exhibits | 2014 Analysis | Forecasts Through 2017
An estimated 34 million people in the 5 major European Union markets (France, Germany, Italy, Spain, and the United Kingdom) and the Benelux and Nordic regions suffer from chronic back pain, and the incidence is expected to increase over the next several years, largely due to an expanding elderly population and the growing incidence of degenerative disc disease. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunitie... [Read More]




Women's Health: U.S. Markets for Female Urinary Incontinence Therapies (2014)
191 Pages | 52 Exhibits | 2014 Analysis | Forecasts Through 2017
Incontinence may be defined as the involuntary loss of bladder or bowel control. In the United States (U.S.), urinary incontinence (UI) is highly prevalent. According to the National Association for Continence (NAFC), the condition affects more than 200 million people worldwide, with a conservative estimate of 25 million adults in the U.S. experiencing chronic or transient UI. The NAFC estimates that 75% to 80% of the UI population comprises women, with 9 million to 13 million suffering sever... [Read More]




Global Markets for Wound Closure Devices in 2014: Sutures, Stapling Products, Hernia Meshes, and Negative Pressure Wound Therapy (2014)
114 Pages | 54 Exhibits | 2014 Analysis | Forecasts Through 2018
Sales of sutures, stapling products, hernia meshes, and negative pressure wound therapy (NPWT) reached $9.7 billion in 2013. The global market for these wound closure and management devices, as analyzed in LSI's new report, is expected to see important changes through 2018, influenced by critical regional trends in surgical caseloads, purchasing resources, and the state of development with respect to outpatient and post-acute care. Competitive forces and strained financial resources among hospit... [Read More]




U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders (2014)
273 Pages | 62 Exhibits | 2014 Analysis | Forecasts Through 2017
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism. In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment of ... [Read More]




U.S. Cancer Statistics Update 2014 (2014)
76 Pages | 18 Exhibits | 2014 Analysis
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that in 2014 nearly 1.7 million people in the country will be diagnosed with cancer and that approximately 585,720 will die from the disease in the same year. This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014. Covered topics in this report include an overview of cancer in the U.S. including discussio... [Read More]




U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products (2014)
261 Pages | 38 Exhibits | 2014 Analysis | Forecasts Through 2017
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. In the fight against cancer, diagnostic ultrasound imaging, minimally invasive biopsy, and tissue screening are among the methods that allow physicians to detect malignancies at their earliest and most treatable stages. In 2012, approximately ... [Read More]




Global Opportunities in Obesity Management Technologies (2013)
238 Pages | 110 Exhibits | 2013 Analysis | Forecasts Through 2018
An estimated 1.3 billion people--representing nearly 30% of the global adult population--are overweight or obese, and the share is more than twice that in the U.S., Mexico, and selected nations of Europe and Middle East. Including its contribution to diabetes and cardiovascular disease, this epidemic is placing heavy demands on nations' health delivery systems and shining a bright light on the unmet need for new approaches and products that can manage and reverse this trend. Diet, exercise prog... [Read More]




International Markets for Soft Tissue Repair and Sports Medicine (2015)
2015 Analysis | Forecasts Through 2020
This 2015 report provides a detailed assessment of the current and forecast market. The study also provides a detailed assessment of the competitive landscape including established companies and disruptive emerging companies. The analysis quantifies current and forecast patient populations, procedure volumes, and market size. Competitor sales, unit volumes, ASPs, and market shares are provided for each segment.... [Read More]




The U.S. Market for Soft Tissue Repair and Sports Medicine (2015)
2015 Analysis | Forecasts Through 2020
This 2015 report provides a detailed assessment of the current and forecast market. The study also provides a detailed assessment of the competitive landscape including established companies and disruptive emerging companies. The analysis quantifies current and forecast patient populations, procedure volumes, and market size. Competitor sales, unit volumes, ASPs, and market shares are provided for each segment.... [Read More]




U.S. Markets for Nonfusion Spinal Technologies and Disc Diagnostic Devices (2013)
227 Pages | 75 Exhibits | 2013 Analysis | Forecasts Through 2017
Degenerative disc disease affects approximately half of the United States (U.S.) population age 40 and older. Caused by gradual disc damage, degenerative disc disease often results in disc herniation and chronic back or neck pain. This new report from Medtech Insight includes analyses of products, competitors, and opportunities in the U.S. market for nonfusion spinal technologies and disc diagnostic devices. This market, as covered by the scope of this report, includes artificial discs, m... [Read More]




United Kingdom, Surgical Procedure Volumes (2013)
382 Pages | 91 Exhibits | 2013 Analysis | Forecasts Through 2018
Of the nearly 63.4 million population in the United Kingdom (U.K.), the number of those age 65 and older comprise an estimated 17.3%. The sovereign state is expected to experience modest growth in the age 65 and older group over the coming years, with this population projected to comprise an estimated 18.5% by the year 2020. According to World Health Organization estimates, 9.4% of the U.K.'s gross domestic product was spent on healthcare in 2011. This dynamic new report from Medtech Ins... [Read More]




Spain, Surgical Procedure Volumes (2013)
375 Pages | 91 Exhibits | 2013 Analysis | Forecasts Through 2018
Of Spain's 46.8 million population, the number of those age 65 and older comprise an estimated 17.5%. The country is expected to experience gradual growth in the age 65 and older group over the coming years, with this population projected to comprise an estimated 18.5% by the year 2020. According to World Health Organization estimates, 9.4% of Spain's gross domestic product was spent on healthcare in 2011. This dynamic new report from Medtech Insight presents an overview of selected medi... [Read More]




Italy, Surgical Procedure Volumes (2013)
374 Pages | 91 Exhibits | 2013 Analysis | Forecasts Through 2018
Of Italy's 61.3 million population, the number of those age 65 and older comprise an estimated 20.5%. The country is expected to experience modest growth in the age 65 and older group over the coming years, with this population projected to comprise an estimated 22.1% by the year 2020. According to World Health Organization estimates, 9.2% of Italy's gross domestic product was spent on healthcare in 2011. This dynamic new report from Medtech Insight presents an overview of selected medic... [Read More]




U.S. Markets, Trends, and Opportunities in Patient Monitoring Products (2013)
193 Pages | 44 Exhibits | 2013 Analysis | Forecasts Through 2017
Critical care in the United States (U.S.) is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. These factors mean that noninvasive and minimally invasive patient monitoring products will be in great demand during the forecast period covered by this report, particularly those that provide memory storage, remote access, smart alarms, wireless capabilities, and other advanced features. In 2012, co... [Read More]




Germany, Surgical Procedure Volumes (2013)
381 Pages | 92 Exhibits | 2013 Analysis | Forecasts Through 2018
Of Germany's 80.2 million population, the number of those age 65 and older comprise an estimated 20.9%. Due mainly to declining birth rates, the country's population is not expected to experience much (if any) growth over the coming years; however, the older population is expected to expand and by the year 2020, it is estimated that 23.0% of the population of Germany will be age 65 and older. According to World Health Organization estimates, 11.3% of Germany's gross domestic product was spent ... [Read More]




Women's Health: U.S. Markets for Reproductive Management Products (2013)
132 Pages | 31 Exhibits | 2013 Analysis | Forecasts Through 2017
The U.S. market for reproductive management products is large and robust, estimated at more than $3.7 billion in 2013. This market, which includes a broad range of contraceptive drugs, contraceptive devices/implants, and fertility drugs, is expected to expand at a healthy compound annual growth rate of more than 7%, increasing by more than $1.5 billion over a span of 5 years. Despite a sluggish economy, intense competition, pricing pressures, litigation, and the significant impact of generic... [Read More]




Women's Health: Trends and Opportunities in the U.S. Osteoporosis Management Market (2013)
150 Pages | 37 Exhibits | 2013 Analysis | Forecasts Through 2017
In the United States (U.S.), the rate of osteoporosis is expected to grow significantly as the population ages. It is estimated that approximately 9 million adults in the U.S. have osteoporosis and more than 48 million have low bone mass, placing them at risk for developing osteoporosis. Assuming that prevalence of osteoporosis and low bone mass remains unchanged, by the year 2020, it is projected that 10.7 million adults in the U.S. will have osteoporosis and 58.2 million will have low bone... [Read More]




France, Surgical Procedure Volumes (2013)
375 Pages | 93 Exhibits | 2013 Analysis | Forecasts Through 2018
France, with a population of more than 65.9 million, has one of the highest levels of healthcare spending in Europe. France represents the leader among the European Union (EU) countries of France, Germany, Italy, Spain, and the United Kingdom in terms of healthcare spending as a percentage of gross domestic product (GDP), with approximately 11.6% of the country's GDP spent on healthcare in 2011. This dynamic new report from Medtech Insight presents an overview of selected medical specialti... [Read More]




Global Markets for Specialty Surgical Wound Care Products in 2013: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products (2013)
111 Pages | 52 Exhibits | 2013 Analysis
The global market for specialty surgical wound care products-which include sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.1 billion in 2012. Growth is being largely driven by the markets of Asia-Pacific and the Rest-of-the-World, where greater product availability, new indications, and underlying market dynamics-such as rising surgical procedure volumes-are helping to offset sluggishness in the U.S. market. While global revenues are expected to reach $4.... [Read More]




European Markets for Prosthetic Vascular Grafts (2013)
182 Pages | 39 Exhibits | 2013 Analysis | Forecasts Through 2017
The number of patients in Europe receiving prosthetic grafts for aneurysm repair, coronary and peripheral vessel reconstruction, and hemodialysis access is expected to increase over the forecast period covered by this report due to the prevalence of both diabetes and cardiovascular disease in the region. In 2012, European sales of prosthetic vascular grafts totaled approximately $865 million; of this, endovascular stent-grafts for aortic aneurysm repair accounted for nearly 87% of sales, foll... [Read More]




U.S. Markets for Orthopedic Biomaterials for Viscosupplementation and Cartilage, Ligament/Tendon, and Meniscal Repair and Regeneration (2013)
231 Pages | 66 Exhibits | 2013 Analysis | Forecasts Through 2017
In the United States (U.S.), aging baby boomers are causing an increase in the prevalence of osteoarthritis and other degenerative joint disorders. In addition, the large and growing Millennial generation is contributing to an increasing number of sports-related injuries. This dynamic new report from Medtech Insight includes analyses of products, competitors, and opportunities in the U.S. market for orthopedic biomaterials for viscosupplementation and cartilage, ligament/tendon, and meniscal... [Read More]




U.S. Surgical Procedure Volumes (2013)
410 Pages | 95 Exhibits | 2013 Analysis | Forecasts Through 2018
The number of laparoscopic/percutaneous surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings and open surgery. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with an estimated 30% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pace t... [Read More]




U.S. Benign Uterine Conditions Therapy Systems Market (2013)
151 Pages | 53 Exhibits | 2013 Analysis | Forecasts Through 2017
The U.S. market for therapy systems for the treatment of benign uterine conditions has grown significantly over the past decade, reaching nearly $600 million in 2012. This growing medical device market-which includes: global endometrial ablation (GEA) devices, uterine artery embolization (UAE) systems, hysteroscopes and related products, as well as new and innovative single-insertion hysteroscopic morcellator systems-is expected to expand at a healthy compound annual growth rate of approximatel... [Read More]




U.S. Markets for Orthopedic Biomaterials for Bone Repair and Regeneration (2013)
180 Pages | 49 Exhibits | 2013 Analysis | Forecasts Through 2017
In the United States (U.S.), more than 430,000 spinal fusions are performed each year, and approximately 20% of the more than 5 million fractures that occur are associated with healing difficulties. This dynamic new report from Medtech Insight includes analyses of products, competitors, and opportunities in the U.S. market for biomaterial products for bone healing/regeneration and spinal fusion indications. This market, as covered by the scope of this report, includes bioresorbable fixatio... [Read More]




Opportunities in Global Medical Devices & Diagnostics (2013)
550 Pages | 154 Exhibits | 2013 Analysis | Forecasts Through 2017
The global medical devices and diagnostics (MD&D) market made further yet modest gains in 2012-growing to $357 billion-despite continued capital constraints and economic challenges in both Europe and the U.S. Gains continue to be concentrated in emerging nations, although the U.S. also saw a modest rebound. Acquisitions, many of which further consolidated the industry, continued as companies sought to increase sales and expand their penetration of focal and emerging segments. Going forwar... [Read More]




U.S. Disease Incidence and Prevalence (2013)
368 Pages | 121 Exhibits | 2013 Analysis
Major diseases/disorders in the United States (U.S.) such as cancer and cardiovascular diseases/disorders, acquired immune deficiency syndrome, and reproductive disorders take their toll in terms of lost days from work, Medicare expenditures, and out-of-pocket costs. Along with the aging of the U.S. population and increasing life spans, the incidence and prevalence of major diseases/disorders are expected to significantly impact the healthcare industry. This new report from Medtech Insight... [Read More]




U.S. Markets for Compression Therapy & Pressure Reduction/Relief Products Used for Wound Management (2013)
122 Pages | 36 Exhibits | 2013 Analysis | Forecasts Through 2016
Over the past two decades, dramatic advances have been made in the management of wound patients. These factors have greatly improved the ability of clinicians to overcome many of the previously irresolvable issues associated with the treatment of acute and chronic wounds. In 2011, U.S. sales of compression therapy and pressure reduction and relief products used for wound management totaled approximately $1.4 billion; of this, pressure reduction and relief products accounted for an estimated ... [Read More]




Global Markets for Surgical Ophthalmology (2013)
235 Pages | 116 Exhibits | 2013 Analysis | Forecasts Through 2017
The global market for products used in surgical ophthalmology-which includes diagnostic devices, surgical systems (e.g., lasers and phacoemulsification machines), intraocular lens (IOL) implants and disposables, accessories, and aftermarket revenues from services and parts-was valued at $7.4 billion in 2012. Growth is expected through 2017, when the market reaches $9 billion, due to continued penetration of the population with cataracts (especially in emerging markets) as a result of efforts amo... [Read More]




Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Therapies (2013)
305 Pages | 59 Exhibits | 2013 Analysis | Forecasts Through 2016
Heart disease is the leading cause of death in the United States (U.S.), killing one person nearly every minute. Coronary heart disease-a group of disorders that result in a reduction in blood flow through the heart-affects approximately 16 million people in the U.S., while an estimated 670,000 new cases of heart failure are diagnosed each year. This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities in the... [Read More]




U.S. Markets for Diagnostic Oncology-Related X-Ray-Based Imaging Products (2013)
235 Pages | 47 Exhibits | 2013 Analysis | Forecasts Through 2017
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2013, and that approximately 580,350 will die from the disease. In the fight against cancer, X-ray-based imaging modalities allow physicians to detect malignancies at their earliest and most treatable stages. In 2012, approximately 279.4 million diagnostic oncology-related X-ray-based imaging procedures-in... [Read More]




U.S. Neurostimulation Devices Market (2013)
167 Pages | 49 Exhibits | 2013 Analysis | Forecasts Through 2017
The U.S. market for implantable neurostimulation devices has grown significantly over the past decade, reaching nearly $1.9 billion in 2012. This unusually high-growth medical device market-which includes implantable neurostimulators or neuromodulation devices for deep brain stimulation (DBS), gastric nerve stimulation (GNS), sacral nerve stimulation (SNS), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS); as well as one of the original neurostimulation markets, cochlear implant... [Read More]




U.S. Markets for Skin Replacements and Substitutes and Active Wound Repair Modulators (2013)
121 Pages | 22 Exhibits | 2013 Analysis | Forecasts Through 2016
In 2011, U.S. sales of tissue-engineered skin replacements/substitutes and active wound repair modulators totaled approximately $404.8 million; of this, skin replacements/substitutes (including traditional products that are used for a broad range of indications including cosmetic and reconstructive surgery, as well as future introductions of tissue-engineered skin replacement/substitute products for a variety of wound healing applications) accounted for an estimated 78.1% of sales, and active wo... [Read More]




Worldwide Markets and Emerging Technologies for Tissue Engineering and Regenerative Medicine (2013)
272 Pages | 75 Exhibits | 2013 Analysis | Forecasts Through 2017
The market for tissue engineering and regenerative medicine products used in human therapeutics is one of the most rapidly growing sectors within the medical products market, and has reached only a small fraction of its long-term potential. The market is based on new biomaterials technologies, including synthetic materials, biologically derived materials, and genetically engineered materials, as well as stem cell technology, cell culture technology, and immunopassivation and immunomodulation. ... [Read More]




United Kingdom - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
United Kingdom – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in the United Kingdom.  The study quantifies, analyzes, and forecasts the UK medical devices market.  Historical data is for 2010-2012, most recent actual year data is... [Read More]




Medical Device Market Opportunities in the U.K., 2012 (2012)
395 Pages | 328 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in the U.K., 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Brittish medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in the U.K. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2... [Read More]




U.S., Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2013)
106 Pages | 24 Exhibits | 2013 Analysis | Forecasts Through 2017
Neurological impairment encompasses a diverse range of progressive central nervous system disorders that often are associated with significant psychiatric morbidity and reduced quality of life. This report presents the prevalence and number of hospital discharges in the United States as well as the surgical procedure volumes for selected neurological diseases/disorders. Among the disorders covered by this report are Alzheimer's disease, amyotrophic lateral sclerosis, bipolar disorder, cerebral a... [Read More]




Global Markets for Neurosurgical Products (2012)
204 Pages | 104 Exhibits | 2012 Analysis | Forecasts Through 2018
The global market for neurosurgical products will exceed $2.7B in sales in 2013. The market is characterized by the existence of different tiers of development among mature and emerging markets. Growth in the developed markets is being driven by trends in the frequency of key conditions, such as hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors, while economic constraints will continue to play an important role in product pricing and the adoptio... [Read More]




Opportunities in Global Medical Devices & Diagnostics (2012)
520 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2016
The global medical devices and diagnostics (MD&D) market made further gains in 2011-growing to $345 billion-despite continued capital constraints and other limiters associated with the global economic slump. As in 2010, gains were concentrated in middle-income and developing nations, although the adoption of selected new technologies in developed nations also contributed. The trend to consolidation-including several multi-billion acquisitions in 2011-continued as companies sought to increase s... [Read More]




U.S. Markets for Osteobiologic and Bone Growth Stimulation Products for Spine Surgery (2012)
160 Pages | 43 Exhibits | 2012 Analysis | Forecasts Through 2016
According to the United States (U.S.) Department of Health & Human Services, back pain accounts for approximately 13.4 million physician office visits and 3.7 million emergency room visits annually. Degeneration of an intervertebral disc that results in functionally limiting low back pain is a common condition that prompts patients to seek treatment. To eliminate or reduce pain and restore quality of life, patients with acute, debilitating pain may require spinal fusion. During the fore... [Read More]




The Worldwide Clinical Diagnostics Market (2012)
331 Pages | 95 Exhibits | 2012 Analysis | Forecasts Through 2017
Major Topics •  Trends in the global Clinical Diagnostics market and 2011-2017 market analysis by segment •  Factors driving growth in clinical diagnostic testing •  Assessment of regulatory environment by country/region •  Clinical chemistry market analysis, including chemistry, critical care testing, whole blood glucose monitoring and urinalysis •  Immunodiagnostics market analysis including general-purpose and specialty immunoassays and... [Read More]




Global Markets for Patient Monitoring Technologies in 2012 (2012)
468 Pages | 200 Exhibits | 2012 Analysis | Forecasts Through 2017
Patient monitoring products are used across multiple care settings to gather and track physiological information. These devices are either highly specialized, tracking just a single parameter, or they may be capable of measuring, displaying, and documenting multiple parameters at the same time. Monitored parameters include oxygen saturation of hemoglobin (pulse oximetry), exhaled or end-tidal carbon dioxide (capnography), the heart's electrical activity (electrocardiography), the electrical ac... [Read More]




U.S. Markets for Percutaneous Vertebroplasty and Vertebral Augmentation Products and Thermal Intradiscal Devices (2012)
139 Pages | 40 Exhibits | 2012 Analysis | Forecasts Through 2016
Back pain is one of the most common medical problems in the United States (U.S.), affecting 8 out of 10 people at some point during their lives. Degeneration of an intervertebral disc that results in functionally limiting low back pain is a common condition that prompts patients to seek treatment. For the appropriate patient subset, a percutaneous thermal intradiscal procedure may be employed to treat chronic low back pain. In addition, vertebral compression fractures are a leading cause of d... [Read More]




U.S. Markets for Current and Emerging Wound Closure Technologies (2012)
149 Pages | 40 Exhibits | 2012 Analysis | Forecasts Through 2016
In 2011, nearly 100 million wounds were treated in U.S. hospitals; these included amputations; arterial, diabetic, pressure, and venous ulcers; burns, surgical wounds; and traumatic wounds. In the same year, treatment of these wounds generated more than $3.8 billion in wound closure product sales (including traditional products such as sutures, stapling systems, and wound closure strips, as well as emerging products such as surgical sealants and glues, energy-based closure devices, automated su... [Read More]




United Kingdom Disease Incidence and Prevalence (2012)
342 Pages | 97 Exhibits | 2012 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in the United Kingdom (U.K.) and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, ... [Read More]




Spain Disease Incidence and Prevalence (2012)
339 Pages | 97 Exhibits | 2012 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in Spain and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the ... [Read More]




European Electrosurgical Devices Market (2012)
204 Pages | 67 Exhibits | 2012 Analysis | Forecasts Through 2016
Traditional electrosurgery involves the use of electric current to cut, cauterize, and ligate tissue and luminal structures using radiofrequency generators and instrumentation. Radiofrequency-based surgical products-including generators, instruments, accessories, and thermal ligature/vessel sealing systems-represent a half a billion-dollar market in the Top 5 most populous European countries of France, Germany, Italy, Spain and the United Kingdom, and are utilized in several million surgeries pe... [Read More]




European Markets for Chronic Obstructive Pulmonary Disease Products (2012)
203 Pages | 52 Exhibits | 2012 Analysis | Forecasts Through 2016
Respiratory diseases affect all age groups, with more than 65 million people in Europe being affected and 1 in 7 deaths being caused by chronic lung disease. Chronic obstructive pulmonary disease (COPD) is the most common chronic lung disorder and the fourth leading cause of death in Europe. For the purposes of this report, COPD is defined as chronic airway obstruction that results from chronic bronchitis, emphysema, or a combination of these diseases. COPD treatment products covered by this ... [Read More]




China - Medtech Opportunity Assessment Report 2014 (2014)
419 Pages | 349 Exhibits | 2014 Analysis | Forecasts Through 2017
China – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in China.  The study quantifies, analyzes, and forecasts the Chinese medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and fo... [Read More]




Medical Device Market Opportunities in China, 2012 (2012)
372 Pages | 319 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in China, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Chinese medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in China. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007-20... [Read More]




Italy Disease Incidence and Prevalence (2012)
338 Pages | 97 Exhibits | 2012 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in Italy and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the ... [Read More]




U.S. Markets for Image-Guided Surgery Products (2012)
270 Pages | 56 Exhibits | 2012 Analysis | Forecasts Through 2016
Imaging plays a crucial role in the growing domain of image-guided surgery (IGS) and endoluminal interventions. Advances in imaging technologies and graphic data management capabilities are expected to expand the scope of practical clinical applications of IGS/interventional techniques and expedite their broader acceptance by increasingly cost-conscious healthcare providers. The United States (U.S.) market for IGS products comprises two categories: imaging systems that are used in conjuncti... [Read More]




U.S. Thermal Ablation Devices Market (2012)
228 Pages | 77 Exhibits | 2012 Analysis | Forecasts Through 2016
In the medical devices industry, the term "ablation"-primarily referring to radiofrequency or RF ablation-has become a common description attached to devices that "kill or remodel selective tissue without vaporizing the major structures themselves." Today, minimally invasive thermal ablation involves not only RF, but laser, microwave and high-intensity focused ultrasound (HIFU) technologies, and is commonly utilized in several established, growing, technology-driven medical treatment areas, suc... [Read More]




Global Markets for Aesthetic Products in 2012 (2012)
142 Pages | 71 Exhibits | 2012 Analysis | Forecasts Through 2017
The global market for the aesthetic devices analyzed in this report was valued at nearly $4.3 billion in 2011. The market has fluctuated in recent years and saw declines in 2009. The year 2011, however, was marked by higher sales volumes than in historical years, largely due to the growing popularity of aesthetic procedures as a means to improve appearance or restore a youthful look as well as the growing availability of non-surgical treatments. The emergence of markets in Asia and South America... [Read More]




Germany Disease Incidence and Prevalence (2012)
339 Pages | 97 Exhibits | 2012 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in Germany and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and t... [Read More]




U.S. Markets for Drug and Fluid Delivery Devices (2012)
277 Pages | 73 Exhibits | 2012 Analysis | Forecasts Through 2016
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2011. In the same year, U.S. pharmacies processed approximately 3.6 billion prescriptions, generating an estimated $300.0 billio... [Read More]




France Disease Incidence and Prevalence (2012)
341 Pages | 97 Exhibits | 2012 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in France and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and th... [Read More]




European Disease Incidence and Prevalence (2012)
1705 Pages | 485 Exhibits | 2012 Analysis
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in France, Germany, Italy, Spain, and the United Kingdom and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries ... [Read More]




U.S. Markets for Instrumented Spinal Fusion and Posterior Dynamic Stabilization Products (2012)
167 Pages | 43 Exhibits | 2012 Analysis | Forecasts Through 2016
The growing number of older people living in the United States (U.S.) with age-related degenerative disorders of the spine will continue to play a large part in driving the demand for spinal fusion and posterior dynamic stabilization procedures. It is projected that between the years 2010 and 2020, the population in the U.S. age 65 and older will increase 8.6%, from 309.2 million to 336.0 million. Instrumented spinal fusion and posterior dynamic stabilization procedures generated an estim... [Read More]




India - Medtech Opportunity Assessment Report 2014 (2014)
432 Pages | 354 Exhibits | 2014 Analysis | Forecasts Through 2017
India – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in India.  The study quantifies, analyzes, and forecasts the Indian medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and for... [Read More]




Medical Device Market Opportunities in India, 2012 (2012)
372 Pages | 315 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in India, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Indian medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in India. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007-201... [Read More]




U.S. Electrosurgical Devices Market (2012)
151 Pages | 60 Exhibits | 2012 Analysis | Forecasts Through 2016
Traditional electrosurgery in the United States (U.S.) involves the use of electric current to cut, cauterize, and ligate tissue and luminal structures using radiofrequency generators and instrumentation. Radiofrequency-based surgical products-including generators, instruments, accessories, and thermal ligature/vessel sealing systems- represent a billion-dollar market in the U.S. and are utilized in several million surgeries performed annually across a broad spectrum of surgical areas, cardiovas... [Read More]




Mexico - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Mexico – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in Mexico. The study quantifies, analyzes, and forecasts the Mexican medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013, and for... [Read More]




Brazil - Medtech Opportunity Assessment Report 2014 (2014)
435 Pages | 362 Exhibits | 2014 Analysis | Forecasts Through 2017
Brazil – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Brazil.  The study quantifies, analyzes, and forecasts the Brazilian medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, an... [Read More]




Russia - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Russia – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Russia.  The study quantifies, analyzes, and forecasts the Russian medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and... [Read More]




France - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
France – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in France.  The study quantifies, analyzes, and forecasts the French medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and f... [Read More]




Germany - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Germany – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Germany.  The study quantifies, analyzes, and forecasts the German medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and... [Read More]




Italy - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Italy – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Italy.  The study quantifies, analyzes, and forecasts the Italian medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and fo... [Read More]




Spain - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Spain – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Spain.  The study quantifies, analyzes, and forecasts the Spanish medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and fo... [Read More]




Australia - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Australia – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Australia.  The study quantifies, analyzes, and forecasts the Australian medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2... [Read More]




Turkey - Medtech Opportunity Assessment Report 2014 (2014)
430 Pages | 355 Exhibits | 2014 Analysis | Forecasts Through 2017
Turkey – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Turkey.  The study quantifies, analyzes, and forecasts the Turkish medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and ... [Read More]




Global - Medtech Opportunity Assessment Report 2014 (2014)
1720 Pages | 1420 Exhibits | 2014 Analysis | Forecasts Through 2017
GLOBAL - Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in GLOBAL. The study quantifies, analyzes, and forecasts the GLOBAL medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013, and foreca... [Read More]




Medical Device Market Opportunities in BRIC, 2012 (2012)
1200 Pages | 600 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in BRIC, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the BRIC medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in BRIC. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007-2014) ... [Read More]




Medical Device Market Opportunities in Mexico, 2012 (2012)
300 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2014
Mexico – Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region.  This in-depth report is an essential resource for current and hopeful competitors selling medical products in Mexico.  The study quantifies, analyzes, and forecasts the Mexican medical devices market.  Historical data is for 2010-2012, most recent actual year data is for 2013, and ... [Read More]




Medical Device Market Opportunities in Brazil, 2012 (2012)
378 Pages | 328 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in Brazil, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Brazillian medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Brazil. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (20... [Read More]




Medical Device Market Opportunities in Russia, 2012 (2012)
300 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in Russia, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Russian medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Russia. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007-... [Read More]




Medical Device Market Opportunities in Europe, 2012 (2012)
1500 Pages | 750 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in Europe, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the European medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Europe. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007... [Read More]




Medical Device Market Opportunities in France, 2012 (2012)
300 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in France, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the French medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in France. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007-2... [Read More]




Medical Device Market Opportunities in Germany, 2012 (2012)
300 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in Germany, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the German medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Germany. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007... [Read More]




Medical Device Market Opportunities in Italy, 2012 (2012)
300 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in Italy, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Italian medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Italy. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: •  Key Population Data, Trends, Indicators (2007-20... [Read More]




Medical Device Market Opportunities in Spain, 2012 (2012)
300 Pages | 150 Exhibits | 2012 Analysis | Forecasts Through 2014
Medical Device Market Opportunities in Spain, 2012 quantifies, analyzes, and forecasts the trends and opportunities in the Spanish medical devices market. The report provides a complete roadmap and essential data for current and hopeful competitors selling medical devices and products in Spain. Historical data covers 2007-2010, most recent actual year data is for 2011, and forecasts extend through 2014. Coverage in This Report: Key Population Data, Trends, Indicators (2007-2014) Key ... [Read More]




U.S. Markets for Small Joint Implants & Hardware for The Extremities (2012)
142 Pages | 62 Exhibits | 2012 Analysis | Forecasts Through 2017
Despite continued economic challenges, the U.S. market for small joint implants and extremities' hardware will experience healthy growth through 2017. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare. In the U.S., growth will be influenced by the continued adoption ... [Read More]




OUS Markets for Small Joint Implants & Hardware for The Extremities (2012)
194 Pages | 105 Exhibits | 2012 Analysis | Forecasts Through 2017
Despite continued economic challenges, the OUS market for small joint implants and extremities' hardware will experience healthy growth through 2017. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare. In the U.S., growth will be influenced by the continued adoption o... [Read More]




U.S. Markets for Current and Emerging Technologies for the Treatment of Heart Failure (2012)
256 Pages | 54 Exhibits | 2012 Analysis | Forecasts Through 2016
Demographics, the aging of the population, and accompanying rates of heart failure are the main drivers of the United States (U.S.) market for heart failure-specific diagnostic and therapeutic technologies. In the U.S., approximately 6.6 million adults age 18 and older (or 2.8% of the population) have heart failure, and it is estimated that by the year 2030, an additional 3.0 million people will have the disease, representing a 25.0% increase in prevalence. The condition is the most common Med... [Read More]




U.S. Long-Term Acute Care Markets (2012)
140 Pages | 58 Exhibits | 2012 Analysis | Forecasts Through 2017
Faced with escalating costs, acute hospitals require alternative care locations to accommodate the needs of extended-stay patients, who account for a substantial proportion of healthcare expenditures. Long-term acute care hospitals (LTACHs) are designed to accommodate the complex needs of these patients. These hospitals offer a range of services that includes mechanical ventilation and respiratory therapy, wound care, dialysis, and cardiopulmonary monitoring. LTACHs offer an attractive, niche... [Read More]




U.S. Markets for Large Joint Replacement Technologies (2012)
94 Pages | 34 Exhibits | 2012 Analysis | Forecasts Through 2017
The U.S. market has seen strong economic headwinds in recent years, limiting sales of hip and knee replacement technologies. Other factors, such as the shift away from metal-on-metal total hip arthroplasty devices and the introduction of patient-matched knee replacement products, have had significant effects on market growth and product preferences. While clinical preferences and the advanced features of recent product introductions will influence trends in the market, the main factors aff... [Read More]




OUS Markets for Large Joint Replacement Technologies (2012)
118 Pages | 52 Exhibits | 2012 Analysis | Forecasts Through 2017
Opportunities for suppliers of hip and knee replacement technologies outside of the U.S. vary by country. International regions include mature markets such as Western Europe and Japan as well as the emerging economies of Brazil, China, and India. While economic conditions have had negative effects on the European market, the rising prevalence of osteoarthritis, obesity, and an aging population will continue to generate opportunities for suppliers. The market will continue to be influenced by ... [Read More]




Global Markets for Large Joint Replacement Technologies (2012)
154 Pages | 78 Exhibits | 2012 Analysis | Forecasts Through 2017
Economic constraints and unemployment have had adverse effects on sales of large joint replacement technologies in developed markets. However, the underlying factors driving the performance of hip and knee replacement surgeries - such as rising disease prevalence and aging populations - will continue to generate opportunities for device suppliers. In particular, the growing adoption of these products in emerging markets should help to offset weaker conditions in the U.S. and Western Europe. ... [Read More]




U.S. Surgical Procedure Volumes (2012)
440 Pages | 95 Exhibits | 2012 Analysis | Forecasts Through 2017
The number of outpatient surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with less than 33% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pace than in previous years. Complex, hi... [Read More]




U.S. Urinary Stone Management Devices Market (2012)
152 Pages | 67 Exhibits | 2012 Analysis | Forecasts Through 2016
Kidney stones are one of the most common disorders that affect the urinary tract, with approximately 5% to 7% of women and 10% to 12% of men in the United States (U.S.) being diagnosed with a kidney stone every year. According to the National Institute of Diabetes and Digestive and Kidney Diseases, an estimated 2.0 million to 2.7 million cases of urolithiasis are diagnosed annually in the U.S., with this number expected to steadily increase along with an aging population prone to diseases and a... [Read More]




Global Markets for Small Joint Implants & Hardware for the Extremities (2012)
252 Pages | 148 Exhibits | 2012 Analysis | Forecasts Through 2017
Despite continued economic challenges, the global market for small joint implants and extremities' hardware will experience healthy growth through 2017. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare. In the U.S., growth will be influenced by the continued adop... [Read More]




European Markets for Nonvascular Stents (2012)
111 Pages | 27 Exhibits | 2012 Analysis | Forecasts Through 2015
In recent years, there have been considerable advances both in product design and materials used for all forms of nonvascular stents. Significant changes in the structure and design of nonvascular stents have been made through proprietary technologies, which have helped prevent stent migration and improve flexibility. In 2010, nonvascular stents (including biliary, esophageal, trachobronchial, and urologic) stents were used in more than 56,550 interventional procedures in the countries covered... [Read More]




U.S., Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
95 Pages | 23 Exhibits | 2012 Analysis | Forecasts Through 2017
This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal diseases/disorders and interventional procedures in the United States (U.S.). Among the disorders covered by this report are arthritis, carpal tunnel syndrome, muscular dystrophy, and osteoporosis. Among the covered surgical procedures are anterior cruciate ligament reconstruction, carpal tunnel release, fracture repair, joint arthroplasty, rotator cuff repair, and spine surger... [Read More]




U.S., Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
178 Pages | 37 Exhibits | 2012 Analysis | Forecasts Through 2017
This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/thoracic diseases/disorders and interventional procedures in the United States (U.S.). Among the disorders covered by this report are atherosclerosis, heart failure, hypercholesterolemia, hypertension, ischemic heart disease, pacing disorders, and valvular heart disease. Among the covered surgical procedures are aortic aneurysm repair, cardiac resynchronization therapy, congenit... [Read More]




France, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
124 Pages | 22 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/peripheral vascular disorders and interventional procedures in France; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, G... [Read More]




Germany, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
124 Pages | 22 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/peripheral vascular disorders and interventional procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, ... [Read More]




European Thermal Ablation Devices Market (2012)
267 Pages | 77 Exhibits | 2012 Analysis | Forecasts Through 2016
In the medical devices industry, the term "ablation"-primarily referring to radiofrequency or RF ablation-has become a common description attached to devices that "kill or remodel selective tissue without vaporizing the major structures themselves." Today, minimally invasive thermal ablation involves not only RF, but laser, microwave and high-intensity focused ultrasound (HIFU) technologies that are commonly utilized in several established, growing, technology-driven medical treatment areas suc... [Read More]




Italy, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
124 Pages | 22 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/peripheral vascular disorders and interventional procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Fr... [Read More]




Global Markets for Specialty Surgical Wound Care Products in 2012: Surgical Sealants, Glues, Absorbable Hemostats, and Adhesion Prevention Products (2012)
113 Pages | 52 Exhibits | 2012 Analysis
The global market for surgical sealants, glues, absorbable hemostats, and adhesion prevention products was valued at $2.9 billion in 2011. Absorbable hemostats accounted for the largest share of product sales, followed by surgical sealants, adhesion prevention products, and glues. Growth is expected in all segments through 2017 while strong regional differences will influence the market for these products. This dynamic, new report from Life Science Intelligence (LSI) includes analyses of product... [Read More]




United Kingdom, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
124 Pages | 22 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/peripheral vascular disorders and interventional procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, ... [Read More]




France, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
98 Pages | 19 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in France; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hun... [Read More]




Germany, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
98 Pages | 19 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Greece, Hun... [Read More]




Italy, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
98 Pages | 19 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ir... [Read More]




Spain, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
98 Pages | 19 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in Spain; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ir... [Read More]




U.S. Markets for Wound Dressings and Wound Cleansing and Debridement Products (2012)
163 Pages | 48 Exhibits | 2012 Analysis | Forecasts Through 2016
In 2011, the U.S. market for wound dressings and wound cleansing/debridement products was valued at approximately $1.2 billion. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 4.4%, reaching approximately $1.5 billion in the year 2016. Factors contributing to growth in the wound dressings and wound cleansing/debridement products market include the aging of the population, the introduction of advanced wound dressing technologies, and ... [Read More]




United Kingdom, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
98 Pages | 19 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in the United Kingdom (U.K); incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, ... [Read More]




Spain, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
124 Pages | 22 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected cardiovascular/peripheral vascular disorders and interventional procedures in Spain; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Fr... [Read More]




France, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
101 Pages | 26 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in France; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hungary, Ire... [Read More]




Germany, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
101 Pages | 26 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Greece, Hungary, Ire... [Read More]




Italy, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
101 Pages | 26 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hunga... [Read More]




United Kingdom, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
102 Pages | 26 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in the United Kingdom (U.K.); incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Ge... [Read More]




Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes (2012)
101 Pages | 26 Exhibits | 2012 Analysis | Forecasts Through 2016
This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Spain; incidence and prevalence figures are compared with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (EU) countries of Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hunga... [Read More]




European Markets for Heart Valve Repair and Replacement Products (2012)
340 Pages | 81 Exhibits | 2012 Analysis | Forecasts Through 2015
It is projected that between the years 2010 and 2020, the population in the European Union (EU) will increase from approximately 502 million to an estimated 511 million, and that by the year 2020, 20.2% of the population will be age 65 or older. The growing pool of older people living in the EU with heart valve disorders such as age-related aortic valve degeneration and symptomatic mitral valve regurgitation will continue to boost demand for heart valve repair and replacement procedures in the ... [Read More]




European Markets for Bone Graft Substitute Products for Spinal Fusion (2011)
112 Pages | 51 Exhibits | 2011 Analysis | Forecasts Through 2016
The European market for bone graft substitute products for spinal fusion is projected to experience significant growth over the next half-decade due to a number of factors, particularly an increased prevalence of degenerative disc disease. This new report from Medtech Insight/Elsevier Business Intelligence provides market forecasts and analysis of the European market for bone graft substitute products including bone morphogenetic proteins, demineralized bone matrix, and synthetic bone graft sub... [Read More]




Global Markets for Vascular Closure Devices (2011)
103 Pages | 53 Exhibits | 2011 Analysis | Forecasts Through 2015
The global market for vascular closure devices, analyzed in a new report by Life Science Intelligence, will be influenced by a mix of opposing forces through 2015, when sales are expected to reach more than $800 million. Traditionally concentrated in the U.S. and Western Europe, these devices, which include implantable technologies and external compression products, have received broad adoption during cardiac catheterization procedures. Despite their ability to replace or augment manual compre... [Read More]




United Kingdom, Surgical Procedure Volumes (2011)
383 Pages | 89 Exhibits | 2011 Analysis | Forecasts Through 2016
Of the European Union (EU) countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.), the U.K., with a population of approximately 62.4 million, has one of the lowest levels of healthcare spending, with approximately 8.7% of its gross domestic product spent on healthcare in 2008. This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the U.K. Topics covered by this report include c... [Read More]




U.S. Erectile Dysfunction Therapies Market (2011)
119 Pages | 33 Exhibits | 2011 Analysis | Forecasts Through 2015
Erectile dysfunction (ED) is estimated to affect more than 150 million men worldwide and the number of men with ED is expected to double by the year 2030. Although most cases are not reported, it is estimated that more than 30 million men affected in the United States (U.S). While ED is more common in men older than age 65, most men older than age 40 experience occasional difficulty; it is estimated that more than 50% of men older than age 40 report periodic episodes of ED. Despite the hi... [Read More]




European Markets for Spinal Fusion Instrumentation Products (2011)
162 Pages | 70 Exhibits | 2011 Analysis | Forecasts Through 2016
Growth in spinal fusion procedure volumes is a key factor spurring growth in the European market for spinal fusion instrumentation products. The aging of the population and a corresponding increase in the number of people with degenerative disc disease will contribute to a rise in the number of spinal fusion surgeries performed in Europe over the next half-decade. In 2010, sales of spinal fusion instrumentation products in Europe totaled approximately $528.9 million; over the forecast period... [Read More]




European Markets for Peripheral Vascular Stents (2011)
151 Pages | 41 Exhibits | 2011 Analysis | Forecasts Through 2014
First introduced in the early 1990s as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications within noncoronary vasculature. In 2010, peripheral vascular stents were used in more than 148,300 interventional procedures (including iliac artery stenting, fem-pop stenting, TIPS procedures, renal artery stenting, endovascular AAA repair, and carotid artery sten... [Read More]




Market Agent: 2011 U.S. Markets for Critical Care Patient Monitoring in the ICU (2011)
50 Pages | 2011 Analysis
2011 U.S. MARKETS FOR CRITICAL CARE PATIENT MONITORING IN THE ICU is a comprehensive, regularly updated total market intelligence solution designed for senior executives who are looking for: •    High quality, granular, deeply segmented data •    Regular updates reflecting real-time changes in the market •    Access to senior LSI analysts to conduct proprietary modeling and custom market simulations •    Acces... [Read More]




Market Agent: 2011 U.S. Markets for Critical Care Intra Aortic Balloon Pumps (2011)
50 Pages | 2011 Analysis
2011 U.S. MARKETS FOR CRITICAL CARE INTRA AORTIC BALLOON PUMPS is a comprehensive, regularly updated total market intelligence solution designed for senior executives who are looking for: •High quality, granular, deeply segmented data •Regular updates reflecting real-time changes in the market •Access to senior LSI analysts to conduct proprietary modeling and custom market simulations •Access to useable source data for in-house customization and adoption of market mode... [Read More]




Spain, Surgical Procedure Volumes (2011)
379 Pages | 89 Exhibits | 2011 Analysis | Forecasts Through 2016
Of the European Union (EU) countries of France, Germany, Italy, Spain, and the United Kingdom, Spain, with a population of approximately 46.7 million, has the lowest level of healthcare spending, with approximately 8.7% of the country's gross domestic product spent on healthcare in 2008. This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the EU country of Spain. Topics covered by this report ... [Read More]




Italy, Surgical Procedure Volumes (2011)
376 Pages | 89 Exhibits | 2011 Analysis | Forecasts Through 2016
Italy, with a population of approximately 61 million, parallels the United Kingdom (U.K.) in terms of level of healthcare spending in Europe, ranking just behind France and Germany among the European Union (EU) countries of France, Germany, Italy, Spain, and the U.K., with approximately 9.0% of the country's gross domestic product spent on healthcare in 2008. Topics covered by this report include cardiovascular/peripheral vascular surgery, cosmetic surgery, major organ transplantation, neuros... [Read More]




U.S. Markets for Arthroscopic and Osteoconductive/Osteoinductive Products (2011)
180 Pages | 51 Exhibits | 2011 Analysis | Forecasts Through 2015
The aging of the population and longer and more active lifestyles are some of the factors that are driving the United States (U.S.) market for arthroscopic and osteoconductive and osteoinductive products. This market, as covered by the scope of this report, includes arthroscopy devices; bone growth stimulation products; and allografts, bone morphogenetic proteins (BMPs), and synthetic bone substitutes. During the forecast period covered by this report, the value of the U.S. market for allog... [Read More]




U.S. Minimally Invasive Urinary Incontinence Therapy Systems Market (2011)
156 Pages | 49 Exhibits | 2011 Analysis | Forecasts Through 2015
Incontinence may be defined as the involuntary loss of bladder or bowel control. In the United States (U.S.), urinary incontinence (UI) afflicts an estimated 50 million people. According to the National Association for Continence (NAFC), approximately 75% to 80% of the UI population are women, with 9 million to 13 million suffering severe symptoms. Although UI is an extremely common problem, and has a significant impact on quality of life, the vast majority of those who experience the con... [Read More]




U.S. Opportunities in Drug Delivery Technologies (2011)
235 Pages | 81 Exhibits | 2011 Analysis | Forecasts Through 2015
Drug delivery devices represent a substantial market in the U.S. Combined sales of injection, infusion and vascular access products were estimated at $7.8 billion in 2011, of which the largest share was infusion products. The market will continue to be driven by the need for drugs, nutritionals, hydration and other solutions to treat an aging, increasingly debilitated population. Obesity and its partners, diabetes and renal failure, will contribute to this debilitation, necessitating expanded... [Read More]




Germany, Surgical Procedure Volumes (2011)
380 Pages | 89 Exhibits | 2011 Analysis | Forecasts Through 2016
Germany, with a population of more than 81 million, has one of the highest levels of healthcare spending in Europe. Of the EU countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.), Germany has the second highest level of healthcare spending, after France. According to World Health Organization estimates, 10.5% of Germany's GDP was spent on healthcare in 2008. Topics covered by this report include cardiovascular/peripheral vascular surgery, cosmetic surgery, major organ t... [Read More]




U.S. Markets for Fracture Fixation Products (2011)
123 Pages | 36 Exhibits | 2011 Analysis | Forecasts Through 2015
Demographics, the aging of the population, and the accompanying incidence of osteoporosis and osteoporotic fractures are the primary factors driving the United States (U.S.) market for fracture fixation products. Fractures account for an estimated 10.2 million visits a year to hospitals and physician offices in the U.S., with fractures of the lower limbs accounting for the greatest proportion of visits (approximately 5.0 million), followed by those of the hand and fingers (2.9 million), and the... [Read More]




U.S. Markets for Pharmacologic and Device-Based Therapeutic Approaches to Pain Management (2011)
268 Pages | 62 Exhibits | 2011 Analysis | Forecasts Through 2014
Pain is the single most common reason patients seek medical care, accounting for approximately half of all physician office visits in the U.S. The estimated economic impact of pain in the U.S., including disability and lost productivity costs, totals approximately $100 billion annually. In 2010, combined U.S. sales of pain management products (pharmaceuticals and devices) totaled approximately $33.1 billion. Over the forecast period covered by this report, total sales of pain management pro... [Read More]




U.S. Markets for Joint Replacement and Reconstruction Products (2011)
163 Pages | 50 Exhibits | 2011 Analysis | Forecasts Through 2015
Demographics, the aging of the population, and accompanying rates of arthritis are primary factors driving the United States (U.S.) market for joint replacement/reconstruction implants. In the U.S., 52.1 million adults (or 1 in 5) have physician-diagnosed arthritis; this number is expected to increase to an estimated 67.0 million adults in the year 2030. According to the Centers for Disease Control and Prevention, arthritis is the most common cause of disability in the U.S., with nearly 19 mil... [Read More]




Statistical Overview of Healthcare in Selected European Countries (2011)
103 Pages | 30 Exhibits | 2011 Analysis
With more than 500 million inhabitants, the European Union (EU) represents one of the world's largest and most profitable markets for medical products manufacturers. To compete effectively in this market, medical products suppliers must be familiar with the healthcare organization, reimbursement practices, and regulatory requirements of countries in the region. This dynamic, new report from Medtech Insight analyzes healthcare systems in France, Germany, Italy, Spain, and the United Kingdo... [Read More]




U.S. Minimally Invasive Benign Prostatic Hyperplasia (BPH) Therapy Systems Market (2011)
118 Pages | 31 Exhibits | 2011 Analysis | Forecasts Through 2015
Benign prostatic hyperplasia (BPH), or the noncancerous enlargement of the prostate gland, is a common condition associated with aging. While the prostate grows throughout a man's lifetime, bothersome growth typically begins at age 40, and by approximately age 60 more than half of men will have experienced at least some symptoms of BPH; by age 80, up to 80% to 90% of men become symptomatic. It is estimated that nearly 15 million men in the United States and 30 million men worldwide experience ... [Read More]




Market Agent: Global Markets for External Radiation Therapy in 2011 (2011)
130 Pages | 82 Exhibits | 2011 Analysis | Forecasts Through 2015
Three (3) types of radiation are used to deliver external radiation therapy and stereotactic radiosurgery to patients: 1. X-rays; 2. Gamma-rays; and 3. Particles. X-rays and gamma-rays, both of which are types of photons, are well-established and have been used in hospitals and freestanding clinics for decades. These systems are used to treat a range of patients with intracranial or extracranial conditions. Particle therapy systems are used much less frequently. Until the first hospit... [Read More]




Opportunities in Global Medical Devices and Diagnostics (2011)
559 Pages | 145 Exhibits | 2011 Analysis | Forecasts Through 2015
The global medical devices and diagnostics (MD&D) market rebounded more than expected in 2010 to generate $327 billion in revenues following flat sales in 2009 occurring secondary to the global economic downturn. Much of the rebound reflected growth in middle-income and developing nations, although the adoption of new technologies in developed nations also contributed. Significantly, the rebound was accompanied by increased profit margins for many of the leading suppliers, which boosted sales ... [Read More]




France, Surgical Procedure Volumes (2011)
380 Pages | 90 Exhibits | 2011 Analysis | Forecasts Through 2016
France, with a population of more than 65 million, has one of the highest levels of healthcare spending in Europe. France represents the leader among the European Union (EU) countries of France, Germany, Italy, Spain, and the United Kingdom in terms of healthcare spending as a percentage of gross domestic product (GDP), with approximately 11.2% of the country's GDP spent on healthcare in 2008. Topics covered by this report include cardiovascular/peripheral vascular surgery, cosmetic surger... [Read More]




U.S. Markets for Neurosurgical and Neurointerventional Surgical Products (2011)
274 Pages | 83 Exhibits | 2011 Analysis | Forecasts Through 2015
Medical conditions affecting the brain and associated branches of the central nervous system (CNS) afflict millions of people in the United States (U.S.) each year and are associated with high mortality rates and billions of dollars of direct and indirect medical costs. This new report from Medtech Insight provides an analyses of products, current and forecast markets, and suppliers of neurosurgical and neurointerventional devices in the U.S. Covered product markets in this report include cer... [Read More]




U.S. Market for Minimally Invasive Bariatric Surgical Devices (2011)
232 Pages | 87 Exhibits | 2011 Analysis | Forecasts Through 2016
An estimated 200 million adults in the U.S. (a staggering 68% of the adult population) are categorized as overweight or obese. Obesity is the, second-leading cause of preventable death in the U.S. resulting in nearly 112,000 deaths annually. The condition is a leading cause of type 2 diabetes, disability, and heart disease, and is a significant contributor to rising healthcare costs. Despite the dire need for weight loss in the majority of the adult population, research has found that diet and... [Read More]




U.S. Markets for Heart Valve Repair and Replacement Products (2011)
183 Pages | 29 Exhibits | 2011 Analysis | Forecasts Through 2015
In the United States (U.S.), heart valve disorders are diagnosed in approximately 4 million people each year. Over the next half-decade, the total U.S. population will continue to expand, as will the percentage of the total population that is age 65 and older. The incidence of congenital heart disease and the steadily growing pool of older people living in the U.S. with age-related heart valve disorders will boost demand for heart valve repair/replacement procedures and products for the forese... [Read More]




U.S. Markets for Nonvascular Stents (2011)
140 Pages | 37 Exhibits | 2011 Analysis | Forecasts Through 2014
Nonvascular stenting has been used for decades in the palliation of transient and chronic obstructions of natural circulatory pathways that enable the transfer of air, bodily fluids, and other substances involved in systemic metabolic and energy exchange. These circulatory pathways include the biliary tree as well as the gastrointestinal (GI), pulmonary, and urinary tracts. In 2010, nonvascular stenting systems were used in approximately 516,500 endoluminal recanalization procedures in the U.S... [Read More]




U.S. Disease Incidence and Prevalence (2011)
370 Pages | 120 Exhibits | 2011 Analysis
Major diseases/disorders in the United States (U.S.) such as cancer and cardiovascular diseases/disorders, acquired immune deficiency syndrome, and reproductive disorders take their toll in terms of lost days from work, Medicare and Medicaid expenditures, and out-of-pocket costs. Along with the aging of the U.S. population and increasing lifespans, the incidence and prevalence of major diseases/disorders are expected to significantly impact the healthcare industry. This dynamic new report ... [Read More]




U.S. Markets for Peripheral Vascular Stents (2011)
191 Pages | 39 Exhibits | 2011 Analysis | Forecasts Through 2014
First introduced in the early 1990s as a bailout technique for suboptimal or failed iliac angioplasty, peripheral vascular stenting gradually emerged as a valuable and versatile tool for a variety of primary and adjuvant applications within noncoronary vasculature. In 2009, peripheral vascular stents were used in approximately 487,300 interventional procedures in the U.S., generating approximately $1.2 billion in corresponding product sales. Over the forecast period covered by this report, the... [Read More]




U.S. Market for Obesity Drugs (2010)
139 Pages | 26 Exhibits | 2010 Analysis | Forecasts Through 2014
An estimated 200 million adults in the U.S. (or a staggering 68% of the adult population) are categorized as overweight or obese. Obesity has become a significant contributor to rising healthcare costs in the country (total annual healthcare costs for treating obese adults now amount to nearly $150 billion). The condition is a leading cause of type 2 diabetes, disability, heart disease, morbidity, and mortality, resulting in nearly 112,000 deaths in the U.S. annually. Due to the rising ob... [Read More]




Tissue Engineering and Cell Transplantation: U.S. Markets for Skin Replacements and Substitutes (2010)
118 Pages | 20 Exhibits | 2010 Analysis | Forecasts Through 2014
Skin replacements and substitute products currently represent one of the most promising applications of tissue engineering. In 2009, the potential United States (U.S.) market for tissue-engineered skin replacements and substitutes totaled approximately $18.9 billion, based on a target patient population of approximately 5.0 million. By the year 2019, the total potential target population for the use of tissue-engineered skin replacements and substitutes is expected to increase to 6.4 million, ... [Read More]




Tissue Engineering and Cell Transplantation: U.S. Markets for Organ Regeneration Products (2010)
122 Pages | 13 Exhibits | 2010 Analysis | Forecasts Through 2019
This new report from Medtech Insight analyzes the potential United States (U.S.) market for organ regeneration products. During the forecast period covered by this report, this market is projected to increase from approximately $15.3 billion in 2009 to an estimated $23.9 billion in the year 2019 (based on a potential patient caseload of 1.1 million). The largest opportunities for organ regeneration lie in diseases/disorders of the bone marrow, kidneys, liver, pancreas, and small intestine.... [Read More]




U.S. Markets for Interventional Cardiology Products (2010)
323 Pages | 86 Exhibits | 2010 Analysis | Forecasts Through 2013
Every 25 seconds someone in the U.S. will suffer a coronary event, and every 60 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, nearly 18 million adults age 20 or older in the U.S. suffer from ... [Read More]




European Markets for Image-Guided Surgery Products (2010)
377 Pages | 147 Exhibits | 2010 Analysis | Forecasts Through 2013
Image-guided surgery (IGS) refers to any surgical procedure involving the intraoperative use of a representation of patient anatomy obtained via imaging techniques or computerized methods. These representations are used for real-time visualization of targeted tissues and structures, as well as physical alteration with surgical tools and instruments. In 2008, the European IGS products market totaled approximately $1.0 billion; of this, interventional imaging systems (including interventional/ s... [Read More]




The Worldwide Clinical Diagnostics Market (2010)
300 Pages | 94 Exhibits | 2010 Analysis | Forecasts Through 2015
Major Topics Trends in the global clinical diagnostics market and 2009-2015 market analysis by segment Factors driving growth in clinical diagnostic testing Assessment of regulatory environment by country/region Clinical chemistry market analysis, including chemistry, critical care testing, whole blood glucose monitoring and urinalysis Immunodiagnostics market analysis including general-purpose and specialty immunoassays and blood screening tests Hematology, flow cytometry and coagulat... [Read More]




U.S. Markets for Neurostimulation Products (2010)
228 Pages | 58 Exhibits | 2010 Analysis | Forecasts Through 2014
One of the most promising medical device markets to date is neurostimulation. This newest report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the United States (U.S.) neurostimulation products market. This market, as defined in this report, includes several types of implantable neurostimulation devices including cochlear implants and systems for deep brain stimulation, gastric nerve stimulation, sacral nerve stimulation, spinal cord stimulation, ... [Read More]




U.S. Markets for General and Pelvic Endoscopic Surgery Products (2010)
350 Pages | 121 Exhibits | 2010 Analysis | Forecasts Through 2013
Endoscopic surgery is a minimally invasive, closed procedure (as opposed to invasive open surgery where the surgeon cuts open the body to reach diseased tissue or organs). In endoscopic and laparoscopic procedures the targeted surgical site is accessed via natural orifices of the body or through access ports created by the surgeon at selected positions. The surgeon must abandon a direct, open view of the surgical site for images acquired by an endoscope that combines lighting and optics. Howe... [Read More]




U.S. Opportunities in Acute Cardiac Assist Technologies (2010)
200 Pages | 80 Exhibits | 2010 Analysis | Forecasts Through 2015
Acute cardiac assist technologies, encompassing intra-aortic balloon pumps (IABPs), percutaneous ventricular assist devices (pVADs) and external ventricular assist devices (eVADs), are designed to rapidly and effectively restore coronary circulation and stabilize cardiac hemodynamics in emergent and critical situations. These clinical goals encompass a broad range of applications, from high risk revascularization and cardiac surgery to cardiogenic shock and acutely decompensated heart failure, a... [Read More]




Global Markets for Neonatal Hearing Screening (2010)
59 Pages | 24 Exhibits | 2010 Analysis | Forecasts Through 2013
In 2009, the global market for neonatal hearing screening technologies reached $76.2 million. The U.S. accounted for the majority of these revenues, as neonatal hearing screening programs have been broadly adopted in the country. Heavy growth is expected through 2013, however, due to several factors including increased adoption in Europe, Asia-Pacific and other ROW countries. This new report provides a global analysis of the neonatal hearing screening technologies market with detailed geo... [Read More]




Neonatal Care Technologies in Brazil, Russia, India, & China (2010)
154 Pages | 101 Exhibits | 2010 Analysis | Forecasts Through 2013
Brazil, Russia, India, and China (BRIC) represent attractive markets for neonatal care technologies due to favorable demographics and the growing adoption of advanced technologies. The markets in these countries present unique challenges, however, and are characterized by the presence of local and regional suppliers, the availability of low-price products, and different levels of access to healthcare resources. The combined market for neonatal care technologies in the BRIC countries were $98.2... [Read More]




U.S. Markets for Infection Control and Biosafety Products (2010)
350 Pages | 74 Exhibits | 2010 Analysis | Forecasts Through 2013
Infectious diseases, particularly those acquired in the hospital (nosocomial infections), were among the top 10 causes of death in the U.S. in 2008, as they have been for the past several decades. Bacteria, parasites, and viruses are among the organisms that cause infectious diseases, many of which have only recently been identified. In 2008, U.S. sales of infection control and biosafety products totaled approximately $9.6 billion, with injection devices and related products accounting for an ... [Read More]




Market Agent: 2010 U.S. Markets for Critical Care Ventilators in the ICU (2010)
50 Pages | 23 Exhibits | 2010 Analysis | Forecasts Through 2013
2010 U.S. MARKETS FOR CRITICAL CARE VENTILATORS IN THE ICU is a comprehensive, regularly updated total market intelligence solution designed for senior executives who are looking for: •High quality, granular, deeply segmented data •Regular updates reflecting real-time changes in the market •Access to senior LSI analysts to conduct proprietary modeling and custom market simulations •Access to useable source data for in-house customization and adoption of market models ... [Read More]




Market Agent: 2010 U.S. Markets for Critical Care Infusion Pumps in the ICU (2010)
50 Pages | 28 Exhibits | 2010 Analysis | Forecasts Through 2014
2010 U.S. MARKETS FOR CRITICAL CARE INFUSION PUMPS IN THE ICU is a comprehensive, regularly updated total market intelligence solution designed for senior executives who are looking for: •High quality, granular, deeply segmented data •Regular updates reflecting real-time changes in the market •Access to senior LSI analysts to conduct proprietary modeling and custom market simulations •Access to useable source data for in-house customization and adoption of market model... [Read More]




U.S. Markets for Specialty Endoscopic Surgery Products (2010)
288 Pages | 106 Exhibits | 2010 Analysis | Forecasts Through 2014
Specialty endoscopic procedures-defined by the scope of this report as including arthroscopic; ear, nose and throat (ENT); neurologic/spine; and thorascopic procedures-continue to expand at a healthy pace, driven by increased demand for higher volume arthroscopic and ENT procedures but also by several advantages of endoscopic surgery, including reduced trauma, reduced scarring, and shorter patient recovery and cost. The U.S. specialty endoscopic surgery products market (which primarily inclu... [Read More]




U.S. Markets for Cardiac and Vascular Tissue Engineering Products (2010)
174 Pages | 26 Exhibits | 2010 Analysis | Forecasts Through 2014
Due to the large number of potential patients targeted by tissue engineering and cell transplantation technologies/products under development for cardiac and vascular indications, as well as the major healthcare costs associated with existing treatments for these patients, the potential dollar volume for these technologies/products is substantial, with many applications representing multibillion-dollar opportunities. In the United States (U.S.), the total potential market for tissue engineering... [Read More]




European Markets for Wound Dressings and Wound Cleansing and Debridement Products (2010)
207 Pages | 53 Exhibits | 2010 Analysis | Forecasts Through 2013
Over the past two decades, dramatic advances have been made in the management of wound patients. These factors have greatly improved the ability of clinicians to overcome many of the previously irresolvable issues associated with the treatment of acute and chronic wounds. In 2008, European sales of wound dressings and wound cleansing/debridement products totaled approximately $1.6 billion, with wound dressings accounting for 92% of sales and wound cleansing/debridement products accounting for t... [Read More]




U.S. Markets for Musculoskeletal Tissue Engineering and Cell Transplantation Products (2010)
156 Pages | 24 Exhibits | 2010 Analysis | Forecasts Through 2014
This new report from Medtech Insight analyzes the market potential for tissue engineering products for musculoskeletal indications. The United States (U.S.) market for tissue engineering products for musculoskeletal applications is substantial, with many segments representing multibillion-dollar opportunities. In the U.S., the total potential market for these products is expected to exceed $39 billion in the year 2019. Market segments covered by this report include products for the repair... [Read More]




U.S. Markets for Cardiac Rhythm Management Products (2010)
333 Pages | 115 Exhibits | 2010 Analysis | Forecasts Through 2014
Cardiac rhythm disorders-also called arrhythmias or dysrhythmias-encompass a variety of relatively common chronic conditions characterized by recurrent distortions in the electrical and contractile activity of the heart, which may cause clinically significant and progressive hemodynamic deficits and cardiopulmonary impairment, and lead to the onset of catastrophic events such as stroke or cardiac arrest. Acute and chronic arrhythmias afflict cumulatively more than 8 million people in the U.S., ... [Read More]




U.S. Opportunities in Heart Failure Technologies (2010)
460 Pages | 161 Exhibits | 2010 Analysis | Forecasts Through 2015
Chronic heart failure (HF) remains a significant untapped market in the U.S. Although numerous innovative technologies have been investigated over the past 5 years, most have lacked the effectiveness to warrant broad adoption, or complex regulatory requirements-set against a tight capital environment-have delayed or slowed their commercialization. In addition, sophisticated ventricular assist devices and total artificial hearts target patients with advanced disease, who represent a small share... [Read More]




Tissue Engineering and Cell Transplantation: U.S. Markets for Urogenital Products (2010)
91 Pages | 15 Exhibits | 2010 Analysis | Forecasts Through 2019
This new report from Medtech Insight analyzes the potential United States (U.S.) market for tissue engineering products for urogenital indications. This market is projected to be substantial, reaching an estimated $9.1 billion in the year 2019, based on a potential caseload of 2.2 million patients. Market segments covered by this report include tissue engineering and cell transplantation products for bladder repair and replacement, incontinence treatment, penile replacement and prostheses,... [Read More]




Market Agent: The U.S. Market for Critical Care Infusion Systems in The ICU: October 2010 Update (2010)
46 Pages | 32 Exhibits | 2010 Analysis | Forecasts Through 2014
Infusion devices are essential for the care of critically ill patients. In recent years, these technologies have developed from basic devices to complex care systems capable of interfacing with other critical care products, storing data, and providing therapeutic information. As their functions have evolved, infusion systems have become central to hospitals' efforts to ensure patients' safety by minimizing the risk of medication errors.... [Read More]




U.S. Surgical Procedure Volumes (2010)
440 Pages | 96 Exhibits | 2010 Analysis | Forecasts Through 2016
Over the past decade, the number of outpatient surgical procedures performed in the United States (U.S.) has been steadily expanding, reflecting the gradual migration of patients from acute care settings. By the end of 2009, outpatient procedures accounted for more than one-half of all surgeries performed in the U.S.; this compares to less than one-third at the beginning of the decade. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slow... [Read More]




U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products (2010)
192 Pages | 33 Exhibits | 2010 Analysis | Forecasts Through 2014
In the United States (U.S.), the single largest cause of death--and also the greatest cause of premature and permanent disability in the labor force--is coronary heart disease (CHD). Nearly 18 million adults age 20 or older in the U.S. suffer from CHD, which is responsible for more than 50% of all cardiovascular events in men and women younger than age 75, and for 1 out of every 6 deaths in the country. The morbidity and mortality rates associated with CHD continue to fuel the demand for percu... [Read More]




European Markets for Compression Therapy & Pressure Reduction & Relief Products Used for Wound Management (2010)
171 Pages | 38 Exhibits | 2010 Analysis | Forecasts Through 2013
Over the past two decades, dramatic advances have been made in the management of wound patients. These factors have greatly improved the ability of clinicians to overcome many of the previously irresolvable issues associated with the treatment of acute and chronic wounds. In 2009, European sales of compression therapy and pressure reduction and relief products used for wound management totaled approximately $963.4 million; of this, pressure reduction and relief products accounted for an estima... [Read More]




Current and Emerging Markets for Neurologic Tissue Engineering and Cell Transplantation Products (2010)
131 Pages | 19 Exhibits | 2010 Analysis | Forecasts Through 2019
This new report from Medtech Insight analyzes the market for tissue engineering products for neurology indications. The potential United States (U.S.) market for tissue engineering products for neurology applications is substantial, with some segments representing multibillion-dollar opportunities. In the U.S., the total potential market for these products is expected to exceed $13.6 billion in the year 2019. Market segments covered by this report include tissue engineering and cell trans... [Read More]




U.S. Opportunities in Pulmonary Medicine Technologies (2010)
325 Pages | 111 Exhibits | 2010 Analysis | Forecasts Through 2015
Pulmonary medicine is poised to replace cardiology as the significant new opportunity for medical device manufacturers as options for diagnosing, monitoring and treating the substantial patient populations with chronic obstructive pulmonary disease, asthma, lung cancer and other pulmonary conditions transform from clinical trials to commercialization and adoption. These emerging technologies will increase their share of the pulmonary technologies market from 10% in 2009 to 56% in 2015, with gain... [Read More]




European Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products (2010)
373 Pages | 89 Exhibits | 2010 Analysis | Forecasts Through 2014
Coronary heart disease (CHD) is responsible for more than 1.9 million deaths in Europe each year, accounting for 21.0% of deaths in men and 22.2% of deaths in women. In the 27 member countries comprising the European Union (EU), CHD accounts for approximately 741,833 deaths annually, with 16.0% and 14.8% of deaths in men and women attributable to the disease, respectively. The morbidity and mortality rates associated with CHD continue to fuel the demand for percutaneous transluminal coronary a... [Read More]




European Markets for Skin Replacements/Substitutes and Active Wound Repair Modulators (2010)
168 Pages | 29 Exhibits | 2010 Analysis | Forecasts Through 2013
Over the past two decades, dramatic advances have been made in the management of wound patients. These factors have greatly improved the ability of clinicians to overcome many of the previously irresolvable issues associated with the treatment of acute and chronic wounds. In 2009, European sales of skin replacements and substitutes and active wound repair modulators totaled approximately $391 million, with skin replacements and substitutes accounting for 48% of sales and active wound repair mo... [Read More]




Market Agent: The U.S. Market for Critical Care Ventilators in 2009 (2010)
51 Pages | 34 Exhibits | 2010 Analysis | Forecasts Through 2014
Ventilators are well-established in critical care settings such as adult intensive care units (ICUs), neonatal ICUs, and pediatric ICUs. In addition to ICUs, these devices may be used in a variety of sub-acute settings such as step-down units, long-term acute care hospitals (LTACHs), and skilled nursing facilities (SNFs). This section focuses on the high-acuity segment, which includes ICUs.... [Read More]




U.S. Surgical Procedure Volumes (2009)
448 Pages | 106 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adver... [Read More]




European Markets for Cardiovascular Disease Diagnostic Imaging Products (2009)
496 Pages | 171 Exhibits | 2009 Analysis | Forecasts Through 2011
In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronary heart disease (which by itself is the most common cause of death in the region). Cardiovascular conditions result in direct and indirect costs that exceed €192 billion annually in the countries that comprise the European Union. In 2008, nearly 43 million cardiovascular disease-related invasive and noninvasive diagnostic imaging procedures were performed in Europe--wh... [Read More]




Breast Disease Diagnosis and Therapy Markets: Europe and Asia-Pacific (2009)
241 Pages | 95 Exhibits | 2009 Analysis | Forecasts Through 2014
The market for breast cancer detection, diagnosis, and treatment is well-developed in the U.S. and much of Europe. It has remained relatively under-developed in the Asia-Pacific region, however, although recent trends suggest that the opportunities for device manufacturers are improving, driven by the growing prevalence of breast disease in these countries. In the U.S. and Europe, mammography is the standard of care for the early detection of breast cancer. Broader adoption is expected in ... [Read More]




Opportunities in Global Medical Devices and Diagnostics (2009)
572 Pages | 151 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as eco... [Read More]




U.S. Markets for Anesthesia and Ventilation Products (2009)
381 Pages | 124 Exhibits | 2009 Analysis | Forecasts Through 2013
Respiratory care and anesthesia represent a significant element of healthcare delivery within the U.S. According to the National Center for Health Statistics, more than 46 million inpatient surgical procedures were performed in 2008; of these, more than half utilized general anesthesia, requiring intensive intraoperative respiratory monitoring and postoperative respiratory support. In 2008, the U.S. anesthesia and ventilation products market totaled approximately $2.9 billion. Factors contrib... [Read More]




U.S. Markets for Diabetes Management Products (2009)
247 Pages | 78 Exhibits | 2009 Analysis | Forecasts Through 2013
Diabetes affects nearly 24 million people in the U.S. and an estimated 246 million adults worldwide and is the 5th leading cause of death by disease in the U.S. It is also one of the most expensive diseases, costing the U.S. healthcare system more than $130 billion per year. In order to constrain spiraling healthcare costs and limit the progression of full-blown type 2 diabetes and its complications among an aging and increasingly obese population, the development of more affordable and effect... [Read More]




European Markets for Airway Management and Ventilation Products (2009)
138 Pages | 44 Exhibits | 2009 Analysis | Forecasts Through 2013
As the prevalence of chronic respiratory diseases continues to rise within Europe, so does the demand for airway management and ventilation products. In 2008, sales of these products in the European countries of France, Germany, Italy, Spain, and the United Kingdom totaled approximately $451.1 million; over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 3.4%, reaching an estimated $533.8 million in the year 2013. This forthcoming Med... [Read More]




European Markets for Drug Delivery Products and Technologies (2009)
455 Pages | 200 Exhibits | 2009 Analysis | Forecasts Through 2013
Pharmacotherapy represents the predominant first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in Europe. This report covers oral, transdermal, inhalation, transmucosal, and injectable drug delivery devices. In 2007, European sales of these products totaled approximately $25 billion; over the forecast period covered by this report, sales are expected to increase at a compound annual growth rate of 11.2%, reaching more than... [Read More]




U.S. Markets for Current and Emerging Wound Closure Technologies (2009)
192 Pages | 44 Exhibits | 2009 Analysis | Forecasts Through 2013
In 2008, more than 100 million wounds were treated in U.S. hospitals; these included surgical wounds; traumatic wounds; pressure, arterial, venous, and diabetic ulcers; burns; and amputations. In the same year, treatment of these wounds generated nearly $3.5 billion in wound closure product sales. Over the forecast period covered by this report, sales of traditional and emerging wound closure products are expected to increase at a compound annual rate of 3.5%, reaching approximately $4.1 billi... [Read More]




U.S. Markets for Home Healthcare Products (2009)
522 Pages | 45 Exhibits | 2009 Analysis | Forecasts Through 2012
The U.S. population is aging at a steady pace, increasing the demand for home healthcare products. According to the U.S. National Institutes of Health National Institute for Aging, in 2010 there will be an estimated 21.5 million people in the 65- to 74-year-old age group and 17 million in the 75- to 84-year-old age group. However, by 2025 there will be an estimated 35 million in the 65- to 74-year-old age group and 23 million in the 75- to 84-year-old age group. Efforts to contain rising h... [Read More]




Global Neurosurgical Product Markets (2009)
193 Pages | 106 Exhibits | 2009 Analysis | Forecasts Through 2015
Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors. Intracranial shunts are often used to treat hydrocephalus. Aneurysms and AVMs may be treated using surgical clips or, increasingly, embolization products that may be deployed during endovascular procedures. Pituitary and intracranial tumors may be removed during open surgery, endoscopic surgery, or stereotactic radiosurgery... [Read More]




U.S. Long-Term Acute Care Markets (2009)
142 Pages | 61 Exhibits | 2009 Analysis | Forecasts Through 2013
Faced with escalating costs, acute hospitals require alternative care locations to accommodate the needs of extended-stay patients, who account for a substantial proportion of healthcare expenditures. Long-term acute care hospitals (LTACHs) are designed to accommodate the complex needs of these patients. These hospitals offer a range of services that includes mechanical ventilation and respiratory therapy, wound care, dialysis, and cardiopulmonary monitoring. LTACHs offer an attractive, niche... [Read More]




Worldwide Markets and Emerging Technologies for Tissue Engineering and Regenerative Medicine (2009)
262 Pages | 78 Exhibits | 2009 Analysis | Forecasts Through 2013
The tissue engineering and regenerative medicine market first emerged in the mid-1990's with the introduction of products for wound care and orthopaedic applications. The market has since expanded substantially, and approached $1.5 billion in 2008. The market is projected to grow at a 16.2% compound annual rate from 2008 through 2013, approaching $3.2 billion by 2013. This in-depth new market and technology report analyzes the following key topics: Tissue engineering and regenerative med... [Read More]




European Markets for ECG and Cardiovascular Disease-Related In Vitro Diagnostic Near-Patient Testing Products (2009)
277 Pages | 94 Exhibits | 2009 Analysis | Forecasts Through 2013
In Europe, more than 4.3 million people die every year from cardiovascular diseases/disorders such as stroke and coronary heart disease (which by itself is the most common cause of death in the region). Cardiovascular conditions result in direct and indirect costs that exceed €192 billion annually in the countries that comprise the European Union. In 2008, the combined European market for electrocardiography products and cardiovascular disease-related in vitro diagnostic near-patient te... [Read More]




European Markets for Critical Care Blood Gas Monitoring Products (2009)
117 Pages | 35 Exhibits | 2009 Analysis | Forecasts Through 2013
Blood gas measurements are a valuable tool used by clinicians to monitor patients with respiratory distress symptoms as well as those undergoing prolonged anesthesia. Each year in Europe, nearly 240 million arterial blood gas tests are performed; of these, approximately half are performed on patients in critically ill or unstable conditions. In 2008, sales of blood gas monitoring products in the European countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.) totaled approx... [Read More]




U.S. Opportunities in Transcatheter Heart Valve Technologies (2009)
250 Pages | 105 Exhibits | 2009 Analysis | Forecasts Through 2015
Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine over the coming decade and are expected to drive a multi-billion dollar market. However, questions remain about: The timing of adoption based on clinical trial designs and outcomes to date; The numbers and types of patients these technologies will ultimately benefit and how reimbursement will impact those caseloads; The timing and degree to which the transcatheter... [Read More]




U.S. Opportunities in Surgical Heart Valve Technologies (2009)
320 Pages | 105 Exhibits | 2009 Analysis | Forecasts Through 2015
Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine over the coming decade and are expected to drive a multi-billion dollar market. However, questions remain about: The timing of adoption based on clinical trial designs and outcomes to date; The numbers and types of patients these technologies will ultimately benefit and how reimbursement will impact those caseloads; The timing and degree to which the transcathete... [Read More]




European Markets for Temperature Management Products for Hospitals (2009)
125 Pages | 34 Exhibits | 2009 Analysis | Forecasts Through 2013
Temperature management is a life-saving tool in hospital critical care units. Hypothermia occurs in 21% to 66% of all trauma patients, and it is estimated that 60% to 70% of the 15 million patients who undergo surgery with anesthesia annually in Europe become hypothermic; another 2 million patients per year become hypothermic due to accidents, adverse environmental conditions, or drowning. In 2008, sales of temperature management products to hospitals in the European countries of France, G... [Read More]




Germany, Surgical Procedure Volumes (2009)
314 Pages | 66 Exhibits | 2009 Analysis | Forecasts Through 2013
The number of people age 65 and older comprises 20% of Germany's population of more than 82 million; by the year 2018, it is estimated that 22% of the country's population will be age 65 and older. In most European Union (EU) member states, acceptance of innovative technologies, along with an aging population, patient demand for an improved quality of life, and surgical procedures receiving reimbursement code listing have been driving the trend away from traditional open and invasive surgical p... [Read More]




Italy, Surgical Procedure Volumes (2009)
312 Pages | 66 Exhibits | 2009 Analysis | Forecasts Through 2013
In 2008, the population of Italy reached approximately 58.1 million, with the number of people age 65 and older comprising 20.0% of the total population; this represented an increase of 16.0% over the number of people in this age group in 1998. By the year 2018, it is estimated that 22.6% of the population of Italy will be age 65 and older. According to the World Health Organization, approximately 8.9% of Italy's gross domestic product was spent on healthcare in 2005. The aging population, al... [Read More]




Spain, Surgical Procedure Volumes (2009)
313 Pages | 66 Exhibits | 2009 Analysis | Forecasts Through 2013
In 2008, the population of Spain reached approximately 40.5 million, with the number of people age 65 and older comprising 17.9% of the total population; this represented an increase of 10.6% over the number of people in this age group in 1998. By the year 2018, it is estimated that 20.2% of the population of Spain will be age 65 and older. A combination of factors including the aging of the population in the region, the introduction of innovative technologies, patient demand for improved qual... [Read More]




United Kingdom, Surgical Procedure Volumes (2009)
314 Pages | 66 Exhibits | 2009 Analysis | Forecasts Through 2013
In 2008, the population of the United Kingdom (U.K.) reached approximately 60.9 million, with the number of people age 65 and older comprising 16.0% of the total population; this represented an increase of 5.2% over the number of people in this age group in 1998. By the year 2018, it is estimated that 18.5% of the population of the U.K. will be age 65 and older. The latest statistics from the World Health Organization indicate that total healthcare expenditures in the U.K. were equivalent to... [Read More]




U.S. Markets for Breast Cancer Detection and Diagnostic Technologies (2009)
351 Pages | 120 Exhibits | 2009 Analysis | Forecasts Through 2013
According to the American Cancer Society (ACS), breast cancer is the most common cancer among women (excluding non-melanoma skin cancers), accounting for more than 1 in 4 cancers diagnosed in United States (U.S.) women. In 2009, approximately 192,370 women will be diagnosed with breast cancer and approximately 40,170 will die of the disease. However, due to the increased awareness, availability, and adoption of highly effective breast cancer screening technologies, the average 5-year relative ... [Read More]




Worldwide Markets and Emerging Technologies for Point-of-Care Testing (2009)
308 Pages | 130 Exhibits | 2009 Analysis | Forecasts Through 2014
Major Topics Include: • Trends in the global clinical diagnostics market and 2008-2014 market analysis by segment • Factors driving growth in point-of-care testing • Hospital POC testing market analysis, including critical care testing, bedside whole blood glucose monitoring, rapid tests, POC coagulation testing, POC cardiac markers, and drugs of abuse rapid tests • Self-testing market assessment, including whole blood glucose monitoring, coagulation self-testing, preg... [Read More]




U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies (2009)
240 Pages | 65 Exhibits | 2009 Analysis | Forecasts Through 2013
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. These conditions include aneurysm, chronic venous insufficiency, deep-vein thrombosis, peripheral artery disease, and pulmonary embolism. In 2008, approximately 3.6 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an ... [Read More]




European Markets for Transfusion Management Products (2009)
114 Pages | 28 Exhibits | 2009 Analysis | Forecasts Through 2013
In Europe, approximately 2 million patients lose a sufficient amount of blood annually to require the transfusion of at least 1 unit of blood. Blood transfusions most often are required for cases of acute blood loss (e.g., surgery or trauma) or for cases in which the patient is receiving ongoing treatment for cancer or diseases that result in chronic anemia. Approximately 50% to 65% of open heart surgery patients receive blood transfusions. In 2008, sales of transfusion management products... [Read More]




European Markets for Drug/Fluid Infusion Therapy Products (2009)
138 Pages | 43 Exhibits | 2009 Analysis | Forecasts Through 2013
Drug/fluid infusion involves the use of either the force of gravity or fluid compression generated by a pump to move liquids from their containers into a patient's vascular system or other targeted anatomic sites. Wound pain management via intraoperative site infusion has been successfully used for a variety of surgical procedures including bowel resection, cesarean section, hysterectomy, mastectomy, open hernia repair, open thoracotomy, plastic surgery, prostatectomy, and saphenous vein remova... [Read More]




European Markets for Cardiopulmonary Support Products (2009)
139 Pages | 41 Exhibits | 2009 Analysis | Forecasts Through 2013
This dynamic, new report from Medtech Insight includes analyses of products, markets, competitors, and opportunities in the area of cardiopulmonary support. Cardiopulmonary support products are indicated for the treatment of heart failure and to assist with patient support during open heart surgery. Heart failure is a major public health problem in Europe, with a patient population of at least 10 million in the European countries covered by this report (France, Germany, Italy, Spain, and the Un... [Read More]




U.S. Markets for Computer-Aided Diagnostic Imaging Products (2009)
241 Pages | 45 Exhibits | 2009 Analysis | Forecasts Through 2013
In 2008, approximately 370 million noninvasive and minimally invasive imaging procedures were performed in the United States (U.S.); noninvasive and minimally invasive imaging tools are widely employed for screening, diagnostics, treatment planning, and therapy monitoring in virtually all areas of medicine including cardiology, emergency medicine, gastroenterology, neurology, obstetrics/gynecology, oncology, orthopedics and spine, pulmonology, trauma, and urology. Sales of computer-aided diag... [Read More]




Opportunities in Cardiovascular Devices: Global Market Overview (2009)
165 Pages | 55 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Dental Devices: Global Market Overview (2009)
112 Pages | 35 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Endoscopy Devices: Global Market Overview (2009)
103 Pages | 35 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Imaging Technologies: Global Market Overview (2009)
117 Pages | 41 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Infection Control Technologies: Global Market Overview (2009)
104 Pages | 34 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Neuromodulation Devices: Global Market Overview (2009)
114 Pages | 38 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Ophthalmology Devices: Global Market Overview (2009)
116 Pages | 36 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Orthopedic/Spine Devices: Global Market Overview (2009)
125 Pages | 45 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Home Respiratory Devices: Global Market Overview (2009)
116 Pages | 36 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Urology/Renal Devices: Global Market Overview (2009)
117 Pages | 41 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




Opportunities in Wound Care Devices: Global Market Overview (2009)
120 Pages | 40 Exhibits | 2009 Analysis | Forecasts Through 2012
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with continued gains in 2008 reflecting both organic growth and currency fluctuations. However, as of late 2008, sales have declined in selected markets due to cutbacks in hospital budgets and reductions in hospital admissions and elective surgeries. This situation is being exacerbated by the global financial crisis, which is placing severe cost constraints on health care systems as econo... [Read More]




U.S. Cardiovascular Surgical Procedure Volumes (2009)
92 Pages | 20 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Obstetric/Gynecologic Surgical Procedure Volumes (2009)
36 Pages | 9 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Urologic Surgical Procedure Volumes (2009)
33 Pages | 6 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Cosmetic Surgical Procedure Volumes (2009)
24 Pages | 6 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Ophthalmic Surgery Procedure Volumes (2009)
36 Pages | 7 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. General Surgery Procedure Volumes (2009)
40 Pages | 10 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Organ and Tissue Transplantation Procedure Volumes (2009)
57 Pages | 20 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Neurosurgical Procedure Volumes (2009)
36 Pages | 6 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due adverse ... [Read More]




U.S. Orthopedic/Spine Surgical Procedure Volumes (2009)
74 Pages | 15 Exhibits | 2009 Analysis | Forecasts Through 2015
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician offices. Office-based procedures are projected to grow at a compound annual rate of 5.4% over the forecast period covered by this report; this is a slower rate than during the past decade due to the curtailment in demand for elective surgery during the 2009 to 2010 period due advers... [Read More]




European Surgical Procedure Volumes (2009)
1566 Pages | 330 Exhibits | 2009 Analysis | Forecasts Through 2013
France France, with a population of more than 64 million, has one of the highest levels of healthcare spending in Europe. France represents the leader among the European Union (EU) countries of France, Germany, Italy, Spain, and the United Kingdom in terms of healthcare spending as a percentage of gross domestic product (GDP), with approximately 11.2% of the country's GDP spent on healthcare in 2005. In most EU member states, acceptance of innovative technologies, along with an aging popul... [Read More]




Global Small Joint Implant Markets (2009)
229 Pages | 124 Exhibits | 2009 Analysis | Forecasts Through 2015
The global market for small joint implants will experience healthy growth through 2015. Regional markets, such as the U.S., Europe, Asia-Pacific (AP) and the Rest-of-the-World (ROW) will be distinguished by the prevalence of conditions that contribute to small joint disease, the availability of different products, and factors influencing the provision of healthcare. In the U.S., growth will be influenced by the adoption of products that have only been available overseas, preference for mot... [Read More]




U.S. Ventilator Market Models (2008)
50 Pages | 30 Exhibits | 2008 Analysis | Forecasts Through 2012
These Market Models represent the most accurate and recent data for US Ventilator Product Markets. The models are data driven (vs. text based) and are derived from a variety of sources including: proprietary databases, population data, government statistics, insurance audits, clinical literature, manufacturer publications, SEC documents, brokerage reports, interviews with leading clinicians, interviews with industry personnel, and attendance at key congresses and meetings. Each segment is econ... [Read More]




U.S. Disease Incidence and Prevalence (2008)
335 Pages | 116 Exhibits | 2008 Analysis
Major diseases/disorders in the United States (U.S.)--from cancer and cardiovascular diseases/disorders to acquired immune deficiency syndrome and reproductive disorders--take their toll in terms of lost days from work, Medicare and Medicaid expenditures, and out-of-pocket costs. Along with the aging of the U.S. population and increasing life spans, the incidence and prevalence of major diseases/disorders are expected to significantly impact the healthcare industry. This dynamic new report... [Read More]




European Markets for Heart Valve Repair and Replacement Products (2008)
309 Pages | 98 Exhibits | 2008 Analysis | Forecasts Through 2013
As the sizable European population both grows and ages, the number of people in the region living with congenital or acquired heart valve disorders continues to increase. In 2007, more than 81,000 heart valve repair/replacement procedures were performed in Europe. These procedures generated approximately $246.4 million in total sales of annuloplasty devices for heart valve repair, and mechanical and tissue heart valves for heart valve replacement. Growing at a compound annual rate of 3.9%, comb... [Read More]




Women's Health: U.S. Markets for Osteoporosis Management Products (2008)
129 Pages | 30 Exhibits | 2008 Analysis | Forecasts Through 2010
In 2007, the United States (U.S.) market for osteoporosis management products totaled approximately $7.6 billion. Sales of these products are expected to increase at a compound annual rate of 6.6%, reaching an estimated $9.3 billion in the year 2010. This new report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. osteoporosis management products market. According to the first-ever U.S. Surgeon General... [Read More]




Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies (2008)
348 Pages | 63 Exhibits | 2008 Analysis | Forecasts Through 2011
Heart disease is the leading cause of death in the U.S., killing one person nearly every minute. Coronary heart disease--a group of disorders that result in a reduction in blood flow through the heart--affects more than 15.8 million people in the country, while heart failure has become the main reason that more than 5 million people endure 12 million to 15 million medical visits and 6.5 million to 7.0 million days spent in the hospital each year. Current and emerging products enabling CABG an... [Read More]




European Markets for Total Joint Replacement Products (2008)
601 Pages | 374 Exhibits | 2008 Analysis | Forecasts Through 2014
In 2007, European sales of total joint replacement products totaled approximately $2.9 billion. Over the forecast period covered by this report, sales of these products are expected to grow at a compound annual rate of 5.8%, reaching an estimated $4.3 billion in the year 2014. This new report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European total joint replacement products market. These products are us... [Read More]




Women's Health: U.S. Markets for Reproduction Management Products (2008)
132 Pages | 29 Exhibits | 2008 Analysis | Forecasts Through 2010
To avoid unwanted or an excessive number of pregnancies, many fertile couples practice some form of contraception. Other couples who are unable to conceive invest significant time and resources in infertility management techniques in an effort to achieve pregnancy. Products used for female contraception include contraceptive drugs (e.g., film, foam, gel/cream, implantable, injectable, oral, patch-based, and suppository formulations) and contraceptive devices (e.g., cervical caps, diaphragms, int... [Read More]




Women's Health: U.S. Markets for Urinary Incontinence Management Products (2008)
153 Pages | 35 Exhibits | 2008 Analysis | Forecasts Through 2010
Urinary incontinence affects more than 15 million people in the U.S.; of these, an estimated 85% are women. The most prevalent types of incontinence are stress, urge, mixed, and overflow incontinence. In 2007, U.S. sales of incontinence products (including drugs and diagnostic and therapeutic products) totaled approximately $1.9 billion, with drugs accounting for 75% of sales, therapeutic products accounting for 16% of sales, and diagnostic products accounting for the remaining 9% of sales. Over... [Read More]




European Markets for Erectile Dysfunction Drugs, Devices, and Therapies (2008)
175 Pages | 39 Exhibits | 2008 Analysis | Forecasts Through 2011
Erectile dysfunction (ED) affects more than 150 million men worldwide, including more than 20 million in Europe and 30 million or more in the U.S. The number of men suffering from ED is expected to double by the year 2025. Due to their effectiveness and convenience, prescription oral medications remain the first-line-of-treatment for the majority of men with ED, generating a worldwide market for oral ED drugs that is worth more than $3 billion. Problems with the current oral ED drug therapy inc... [Read More]




European Markets for Benign Prostatic Hyperplasia Drugs, Devices and Therapies (2008)
175 Pages | 39 Exhibits | 2008 Analysis | Forecasts Through 2011
Benign prostatic hyperplasia (BPH), or an enlarged prostate, is an extremely common condition for men, affecting more than half of all men by age 60 and up to 90% of men by age 80. It is estimated that more than 28 million men in Europe suffer from some form of BPH. Due to their effectiveness and convenience, prescription BPH medications remain the first line of treatment for the majority of men with BPH. In many men, however, BPH drugs produce undesirable side effects and most do not provide a... [Read More]




U.S. Markets for Directed Energy-Based Surgical Systems (2008)
418 Pages | 102 Exhibits | 2008 Analysis | Forecasts Through 2011
Tissue-altering directed energy-based surgical systems utilizing cryogenic, laser, microwave, radiofrequency, or ultrasound technologies are widely used in an array of applications including aesthetic, cardiovascular, dental, gynecologic, oncologic, orthopedic, otorhinolaryngologic, and urologic surgical procedures. In 2007, approximately 16.2 million procedures involving directed energy-based surgical systems were performed in the U.S. Expanding at a compound annual rate of 7.4%, sales of dire... [Read More]




U.S. Markets for Spinal Disc Repair and Replacement Technologies (2008)
103 Pages | 40 Exhibits | 2008 Analysis | Forecasts Through 2013
To date, the growth of the U.S. market for artificial disc replacements has been disappointing. Initially, these technologies were expected to rapidly penetrate the market for spinal fusion patients due to their potential to: preserve motion, limit further degeneration, and avoid the need for fusion. Since the approval of DePuy Spines' Charite for lumbar disc replacement in October 2004 however, growth has been restrained by reimbursement challenges, limited long-term data, and the need to use a... [Read More]




Global Vascular Closure Device Markets (2008)
185 Pages | 85 Exhibits | 2008 Analysis | Forecasts Through 2013
As analyzed in this report by Life Science Intelligence, the global market for vascular closure devices will reach nearly $1 billion by 2013. The market for vascular closure technologies, which includes implantable devices and external compression products,has traditionally been concentrated in the U.S. and Western Europe. These technologies are used to replace or augment manual compression following diagnostic catheterizations. By reducing time to hemostasis and facilitating more rapid recovery... [Read More]




Global Markets for Neonatal/Perinatal Monitoring and Treatment Products (2008)
150 Pages | 66 Exhibits | 2008 Analysis | Forecasts Through 2013
According to this report, the $1.2 billion 2008 global market for products used to monitor and treat neonatal and perinatal patients will grow at a CAGR of 5.2% reaching over $1.5 billion by 2013. Growth in Asia-Pacific and other international markets will be driven by expanding populations and increasing birth rates, greater demand for these products, and the growing availability of low-cost or locally manufactured technologies. Developing countries account for the vast majority of annual b... [Read More]




European Disease Incidence and Prevalence (2008)
334 Pages | 92 Exhibits | 2008 Analysis
Major diseases in Europe (from cancer and cardiovascular disease to neurologic and psychiatric disorders) take their toll in terms of lost days from work, hospital expenditures, and out-of-pocket costs. As the aging population in Europe increases and life spans lengthen, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the etiology and epidemiology of the most pr... [Read More]




European Markets for Urinary Stone Removal Devices and Equipment (2008)
225 Pages | 65 Exhibits | 2008 Analysis | Forecasts Through 2011
Kidney stones are one of the most common disorders of the urinary tract, affecting approximately 5%-7% of all women and 10%-12% of men. An estimated 5 million or more kidney stone cases are diagnosed annually worldwide, and an estimated 1 million diagnosed in Europe alone. The incidence of kidney stones is increasing; while reasons for the increase are unclear, it is believed the number of cases will increase significantly if the climate continues to warm. While many people pass very small ... [Read More]




The U.S. Minimally Invasive Aesthetics Market (2008)
105 Pages | 44 Exhibits | 2008 Analysis | Forecasts Through 2016
This report provides deep insight into the minimally invasive cosmetics/aesthetics retail market and supplier industry in the U.S. as defined by three technologies: • Botox and its analogs; • Dermal fillers (all forms), and; • Cosmetic (Class IV) lasers (all types and wavelengths). This unique analysis was completed using publicly available information combined with the application of systems theory and population dynamics to understand and quantify the various market s... [Read More]




U.S. Dental Implant Model: Patients, Procedures & Revenues (2008)
18 Pages | 2008 Analysis | Forecasts Through 2012
... [Read More]




European Markets for Critical Care Patient Monitoring Products (2008)
275 Pages | 76 Exhibits | 2008 Analysis | Forecasts Through 2011
In 2007, sales of critical care patient monitoring products in the European countries of France, Germany, Italy, Spain, and the United Kingdom totaled approximately $1.4 billion, with vital signs monitoring systems accounting for an estimated 82.4% of sales, level of consciousness monitoring systems accounting for 8.9% of sales, hemodynamic monitoring systems accounting for 6.1% of sales, and neurologic monitoring systems accounting for the remaining 2.6% of sales. Over the forecast period cover... [Read More]




U.S. Markets for Patient Monitoring Products (2008)
207 Pages | 47 Exhibits | 2008 Analysis | Forecasts Through 2012
In 2007, U.S. sales of patient monitoring products totaled approximately $1.5 billion, with vital signs monitoring systems accounting for an estimated 81.1% of sales, hemodynamic monitoring systems accounting for 8.5% of sales, neurologic monitoring systems accounting for 5.6% of sales, and level of consciousness monitoring systems accounting for the remaining 4.9% of sales. Over the forec... [Read More]




Opportunities in Chinese Cardiovascular Device Markets (2008)
244 Pages | 98 Exhibits | 2008 Analysis | Forecasts Through 2013
CHINESE MARKET FOR CARDIOVASCULAR DEVICES FORECAST TO GROW 18% ANNUALLY THROUGH 2013, DRIVEN BY EXPANDED SERVICES AND PROCEDURES The combination of a large, aging population and strong economic growth has focused significant attention on China as the health care market of the future. Reports and analyses predict substantial growth for that nation's medical device markets; however, rarely do they provide hard data regarding epidemiological and procedure trends driving demand, the domestic healt... [Read More]




Japanese Ventilator Market Models (2008)
24 Pages | 14 Exhibits | 2008 Analysis | Forecasts Through 2015
These Market Models represent the most accurate and recent data for Japanese Ventilator & Accessories Product Markets. The models are data driven (vs. text based) and are derived from a variety of sources including: proprietary databases, population data, government statistics, insurance audits, clinical literature, manufacturer publications, SEC documents, brokerage reports, interviews with leading clinicians, interviews with industry personnel, and attendance at key congresses and meetings. Ea... [Read More]




U.S. Opportunities in Atrial Fibrillation Technologies (2007)
500 Pages | 156 Exhibits | 2007 Analysis | Forecasts Through 2011
The medical industry has clearly realized that atrial fibrillation (AF) represents a major market opportunity, as the affected population is both large and inadequately managed by current options. However, discretely defining the magnitude of opportunity for individual non-pharmacologic treatment options is made difficult by three challenges: 1) the lack of well designed epidemiological data on the prevalence of AF and the distribution of patients by type of AF; 2) the still evolving clinical u... [Read More]




European Markets for New and Emerging Wound Closure Products and Techniques (2007)
262 Pages | 108 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2006, the European new and emerging wound closure products market (including ligating clips, mechanical stapling devices, resorbable and nonresorbable sutures, surgical sealants, tissue glues/adhesives, and wound closure strips) totaled approximately $1.4 billion. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 4.9%, reaching approximately $1.9 billion in the year 2012. This new report from Medtech Insight includes analyses of prod... [Read More]




European Markets for Skin Replacements/Substitutes and Active Wound Repair Modulators (2007)
207 Pages | 54 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2005, the European skin replacements/ substitutes and active wound repair modulators market totaled approximately $252 million, with skin replacements/substitutes accounting for 21% of sales and active wound repair modulators accounting for the remaining 79% of sales. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 6.6%, reaching approximately $395 million in the year 2012. This report from Medtech Insight includes analy... [Read More]




European Markets for Compression Therapy and Pressure Reduction/Relief Products Used for Wound Management (2007)
248 Pages | 92 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2005, the European compression therapy and pressure reduction/relief products market totaled approximately $932 million, with pressure reduction/relief products accounting for 71% of sales and compression therapy products accounting for the remaining 29% of sales. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 5.3%, reaching approximately $1.3 billion in the year 2012. This report from Medtech Insight includes analyses ... [Read More]




U.S. Markets for Obesity Drugs and Bariatric Surgical Devices (2007)
402 Pages | 98 Exhibits | 2007 Analysis | Forecasts Through 2010
Obesity is a global epidemic, afflicting more than 66 million people in the United States (U.S.) and an estimated 300 million people worldwide. Obesity directly contributes to several life-threatening conditions, including cardiovascular disease, cancer, diabetes, hypertension and stroke and costs for treating obesity in the U.S. surpass $120 billion. This report discusses current and emerging anti-obesity drugs and bariatric surgical devices. In 2005, the U.S. market for obesity drugs and... [Read More]




Current and Emerging Technologies for the Management of Heart Failure in the U.S. (2007)
368 Pages | 67 Exhibits | 2007 Analysis | Forecasts Through 2010
More than 5 million people in the U.S. are now being managed for heart failure, with 550,000 new cases occurring annually. Heart failure is the primary reason for 12 million to 15 million medical visits, 6.5 million to 7.0 million days spent in the hospital each year. In 2005, heart failure-specific diagnostic and therapeutic modalities were employed in approximately 13.2 million procedures in the U.S., which generated approximately $2.4 billion in corresponding product revenues. The numbe... [Read More]




U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products (2007)
269 Pages | 61 Exhibits | 2007 Analysis | Forecasts Through 2011
Percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting represent the device-based, non-surgical treatments of choice for patients with advanced coronary heart disease that cannot be adequately managed with medical therapy. Sales of PTCA products and coronary stents/stent systems in the U.S. reached approximately $4.1 billion in 2006. In recent months, growth in this market has been negatively affected by a combination of factors including reports of the rare but life-threate... [Read More]




U.S. Spinal Surgery Markets: Advances in Spinal Fusion and Dynamic Stabilization Products (2007)
179 Pages | 38 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2006, more than $1.8 billion was spent on spinal fixation and dynamic stabilization devices in the United States (U.S.). Sales of these products are expected to grow at a compound annual rate of 10.4% during the forecast period covered by this report, reaching more than $3.2 billion in the year 2012. This dynamic report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. spinal fusion and dynamic stabi... [Read More]




The U.S. Market for Spinal Fusion Orthobiologics, Bone Growth Stimulation, Disc Nucleus Altering Devices, and Vertebroplasty/Kyphoplasty Products (2007)
201 Pages | 57 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2006, more than $1.8 billion was spent on orthobiologics for spinal fusion, as well as bone growth stimulation, intradiscal electrothermal nucleoplasty, and vertebroplasty/kyphoplasty products in the United States (U.S.). Sales of these products are expected to grow at a compound annual rate of 12.3% during the forecast period covered by this report, reaching more than $3.7 billion in the year 2012. This new report from Medtech Insight includes analyses of products, technologies, current and... [Read More]




U.S. Markets for Orthopedic Implant, Reconstruction, and Trauma Products (2007)
317 Pages | 112 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2006, U.S. sales of orthopedic implant, reconstruction, and trauma products totaled approximately $12.2 billion. Over the forecast period covered by this report, sales of these products are expected to increase at a compound annual rate of 6.9%, reaching more than $18.1 billion in the year 2012. This new report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. orthopedic implant, reconstruction, and trau... [Read More]




U.S. Markets for Drug and Fluid Delivery Devices (2007)
311 Pages | 74 Exhibits | 2007 Analysis | Forecasts Through 2011
Pharmacotherapy represents the predominant first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. In 2006, U.S. pharmacies processed approximately 3.5 billion prescriptions, generating an estimated $275.0 billion in cumulative pharmaceutical sales and representing nearly 15% of the nation's total healthcare spending. This report covers injection/infusion, transdermal, and inhalation drug delivery devices. In 2006, U... [Read More]




Women's Health: U.S. Markets for Benign Uterine Condition Management Products (2007)
133 Pages | 29 Exhibits | 2007 Analysis | Forecasts Through 2010
Endometriosis, fibroid tumors, and menorrhagia are the most common benign conditions affecting the uterus. Products used in the treatment of these disorders include disposable uterine manipulators and hybrid tips, fibroid removal systems, fluid management systems and tubing sets, global endometrial ablation systems, and hysteroscopes and accessories. In 2006, combined sales of these products totaled approximately $415.6 million; over the forecast period covered by this report, sales are expected... [Read More]




U.S. Markets for Diagnostic Oncology Products (2007)
447 Pages | 97 Exhibits | 2007 Analysis | Forecasts Through 2010
It is estimated that 1.4 million people in the U.S. will be diagnosed with cancer in 2007--this does not include basal or squamous cell skin cancers, which will account for another million new cancer cases. In the fight against cancer, which is the second-leading cause of death in the U.S. after heart disease (one in four people will die from cancer this year), remarkable advancements have been made in developing sophisticated tools to detect malignancies at their earliest and most treatable sta... [Read More]




Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S. (2007)
355 Pages | 66 Exhibits | 2007 Analysis | Forecasts Through 2016
Due to the large number of potential patients targeted by tissue engineering and organ regeneration products, and the major healthcare costs associated with existing treatments for these patients, the potential dollar volume for tissue engineering and organ regeneration products is great, with many applications representing multibillion-dollar opportunities. In the U.S. alone, the total potential market for all applications of tissue engineering and organ regeneration exceeds $85 billion. Althou... [Read More]




European Markets for the Surgical Treatment of Male Urinary Incontinence (2007)
168 Pages | 45 Exhibits | 2007 Analysis | Forecasts Through 2011
Urinary incontinence (UI) afflicts more than 50 million people in the United States (U.S.) and Europe. Stress urinary incontinence (SUI), the most common form of UI, afflicts an estimated 2 million men in Europe, and is defined as involuntary urine loss during physical exertion (e.g., coughing, laughing, sneezing, lifting, and physical activity) coincident with an increase in intra-abdominal pressure in the absence of detrusor contraction or an overdistended bladder. In men, SUI most often occur... [Read More]




U.S. Markets for Diagnostic and Therapeutic Prostate Disease/Disorder Management Products (2007)
335 Pages | 81 Exhibits | 2007 Analysis | Forecasts Through 2011
Millions of men in the U.S. are now being actively managed for prostate disorders such as benign prostatic hyperplasia (BPH), prostate cancer, and prostatitis, with approximately 3.3 million new prostate disorder cases occurring annually. In 2006, prostate disorder diagnostic and therapeutic modalities were employed in approximately 35.5 million diagnostic procedures and 5.0 million therapeutic procedures in the U.S., which generated approximately $4.5 billion in corresponding product revenues.... [Read More]




U.S. Markets for General and Pelvic Endoscopic Surgery Products (2007)
509 Pages | 138 Exhibits | 2007 Analysis | Forecasts Through 2015
Nearly 6 million general and pelvic endoscopic surgical procedures were performed in the U.S. in 2006. The advantages of endoscopic surgery over open surgery include lower overall treatment costs, reduced patient trauma, shorter hospital stays, and faster recovery times. These benefits have resulted in the conversion of many types of open surgery procedures to endoscopic procedures, a continuing trend enabled by advancements in the array of products used to perform endoscopic surgery. The U.S... [Read More]




U.S. Markets for Image-Guided Surgery Products (2007)
353 Pages | 59 Exhibits | 2007 Analysis | Forecasts Through 2011
Over the past decade, image-guided surgery has become a recognized standard of care in the management of a number of cranial, otorhinolaryngologic, spine, orthopedic, and cardiovascular disorders. In many cases, image-guided surgery offers significant clinical advantages over standard surgical techniques, which may result in better procedural outcomes, fewer readmissions and revisions, potential reduction in overall treatment cost, reduced complications, and shorter hospital stays and recovery t... [Read More]




European Markets for Neurosurgical and Neurointerventional Products (2007)
482 Pages | 227 Exhibits | 2007 Analysis | Forecasts Through 2012
In 2006, the European neurosurgical and neurointerventional products market totaled approximately $338.9 million, with neurointerventional products accounting for 39.2% of sales; followed by image-guided and stereotactic navigation products, with 27.1%; and deep brain stimulation products, with 16.1%. The remaining sales occurred in the aneurysm clips, coils and intracranial stents (11.4%), vagus nerve stimulation (3.5%), and hydrocephalus shunts (2.2%) products markets. Over the forecast period... [Read More]




U.S. Markets for Surgical and Nonsurgical Aesthetic Products and Therapies (2007)
333 Pages | 94 Exhibits | 2007 Analysis | Forecasts Through 2011
The demand for surgical and nonsurgical aesthetic or cosmetic treatment has exploded in the United States (U.S.), with dozens of new treatments for improving the appearance of the 75 million aging Baby Boomers. From the incredible growth in Botox injections and dermal fillers such as Restylane, to the recent reapproval and growth in sales of silicone breast implants, the surgical and nonsurgical cosmetic market included nearly 11.5 million procedures in 2006, according to the American Society fo... [Read More]




U.S. Markets for Energy-Based Aesthetic Devices and Therapies (2007)
263 Pages | 58 Exhibits | 2007 Analysis | Forecasts Through 2011
Over the past decade, the field of noninvasive energy-based aesthetic treatment has exploded in the United States (U.S.), with new treatments for improving the appearance of skin in the aging Baby Boomers. Techniques such as nonablative laser-based skin resurfacing, energy-based skin tightening, cellulite treatment, and fat removal are some of the new technologies, as well as the successful and ever-improving area of laser (and other energy-based) permanent hair reduction. Today, energy-based ae... [Read More]




U.S. Surgical Procedure Volumes (2007)
494 Pages | 104 Exhibits | 2007 Analysis | Forecasts Through 2014
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient hospitalizations is decreasing in favor of patient visits to freestanding clinics and physician's offices. Of the nearly 32.7 million surgeries covered by this report in 2006, approximately 25.0% were inpatient procedures; the remaining surgeries were performed in freestanding facilities, physician's offices, or in hospitals as outpatient procedures. Outpatient settings offer ... [Read More]




Opportunities in Pulmonary Device Markets (2007)
420 Pages | 120 Exhibits | 2007 Analysis | Forecasts Through 2011
PULMONARY DEVICE MARKET TO DOUBLE TO MORE THAN $3 BILLION BY 2011 AS NEW TECHNOLOGIES DRIVE IMPROVED DIAGNOSIS AND TREATMENT OF LARGE PATIENT POPULATIONS Pulmonary disease remains one of the major untapped medical device opportunities in the U.S. Not only are most of the diagnostic technologies employed underutilized, but treatment options have been limited. Sleep apnea was the first pulmonary disease to demonstrate the market potential of pulmonary devices, and its potential is far from... [Read More]




U.S. Vascular Access Market Models (2007)
2007 Analysis | Forecasts Through 2011
This 2007 report, U.S. Vascular Access Market Models, is a data driven analysis produced from a variety of sources including: proprietary databases, population data, government statistics, insurance audits, clinical literature, manufacturer publications, SEC documents, brokerage reports, interviews with leading clinicians, interviews with industry personnel, and attendance at key congresses and meetings. Each segment is econometrically modeled and built from the ground up (using leading indicat... [Read More]




U.S. Breast Disease Diagnosis and Therapy Markets (2007)
244 Pages | 96 Exhibits | 2007 Analysis | Forecasts Through 2012
The breast disease diagnosis and therapy markets are poised for substantial and sustainable growth, according to this new report from Life Science Intelligence (LSI). The report, Breast Disease Diagnosis and Therapy Markets, 2007, finds that the $550 million U.S. digital mammography segment is expected to grow more than 50% annually during the next 3 years as digital technology replaces analog. In addition, the $167 million US vacuum-assisted biopsy segment will also experience dramatic growth r... [Read More]




Worldwide Markets and Emerging Technologies for Point-of-Care Testing (2006)
429 Pages | 124 Exhibits | 2006 Analysis
Major Topics • Trends in the global clinical diagnostics market and market analysis by segment • Factors driving growth in point-of-care testing • Hospital POC testing market analysis, including critical care testing, bedside whole blood glucose monitoring, rapid tests, POC coagulation testing, POC cardiac markers, and drugs of abuse rapid tests • Self-testing market assessment, including whole blood glucose monitoring, ... [Read More]




European Markets for Wound Dressings and Wound Cleansing/Debridement Products (2006)
355 Pages | 160 Exhibits | 2006 Analysis | Forecasts Through 2012
Over the past 20 years, dramatic advances have been made in the management of wound patients. These factors have greatly improved the ability of clinicians to overcome many of the previously irresolvable issues associated with the treatment of acute and chronic wounds. In 2005, the European wound dressings and wound cleansing/debridement products market totaled approximately $1.3 billion, with wound dressings accounting for 93% of sales and wound cleansing/debridement products accounting for the... [Read More]




European Markets for Prosthetic Vascular Grafts (2006)
360 Pages | 141 Exhibits | 2006 Analysis | Forecasts Through 2011
In Europe, more than 4.35 million deaths are attributable to cardiovascular disease (CVD) each year, while more than 48 million adults in the region live with diabetes, a condition that not only substantially increases the risk of CVD, but also is the most common cause of kidney failure. Patients with advanced CVD that results in vascular occlusion, those with aneurysms requiring repair, as well those receiving hemodialysis to manage kidney failure, often undergo prosthetic vascular graft i... [Read More]




European Markets for Minimally Invasive Cardiac Surgery and Intracoronary Diagnostic Devices (2006)
478 Pages | 175 Exhibits | 2006 Analysis | Forecasts Through 2011
Cardiovascular disease (CVD) is the leading cause of death in Europe, accounting for more than 4.35 million deaths annually. The morbidity and mortality rates associated with CVD are fueling the demand for less-invasive technologies and products to diagnose and treat advanced cases that cannot be adequately managed via medical therapy. Sales of minimally invasive cardiac surgery devices in Europe reached approximately $81.8 million in 2005. Growing at a brisk compound annual rate of 14.0... [Read More]




U.S. Markets for Interventional Peripheral Vascular Products (2006)
326 Pages | 77 Exhibits | 2006 Analysis | Forecasts Through 2009
Peripheral atherosclerosis, the most common form of peripheral vascular disease, affects approximately 8 million to 12 million people in the U.S. annually. In 2004, approximately 3.2 million diagnostic and therapeutic interventional peripheral vascular disease procedures were performed in the U.S., generating $841.4 million in corresponding product sales. Growth in these procedures is expected to occur at a compound annual rate of 5.3% during the forecast period covered by this report, rea... [Read More]




U.S. Markets for Peripheral Vascular Stents (2006)
227 Pages | 41 Exhibits | 2006 Analysis | Forecasts Through 2010
Stents are implantable devices designed to serve as endoluminal scaffolds in the recanalization of occluded or structurally compromised vascular and nonvascular circulatory pathways in various organs and tissues of the human body. Peripheral vascular applications for stenting include aortic aneurysm repair, carotid artery stenting, iliac artery stenting, femoropopliteal stenting, infrapopliteal stenting, renal artery stenting, and transjugular intrahepatic portosystemic shunting. In 2005, U.S.... [Read More]




U.S. Markets for Nonvascular Stents (2006)
150 Pages | 38 Exhibits | 2006 Analysis | Forecasts Through 2010
Stents are implantable devices designed to serve as endoluminal scaffolds in the recanalization of occluded or structurally compromised vascular and nonvascular circulatory conduits in various organs and tissues of the human body. Nonvascular applications for stenting include biliary stenting, gastrointestinal stenting, pulmonary stenting, and urologic stenting. In 2005, U.S. sales of nonvascular stents totaled approximately $152 million. Over the forecast period covered by this report, this... [Read More]




European Markets for Spinal Fusion Products (2006)
342 Pages | 85 Exhibits | 2006 Analysis | Forecasts Through 2010
Spinal fusion is a surgical procedure that stabilizes the vertebrae to alleviate debilitating pain caused by a degenerated disc after conservative treatments have failed. Spinal fusion surgery uses bone graft to enable two opposing vertebrae to fuse, or weld together. For further support, spinal instruments (or permanent implants) such as metallic plates, rods, and screws help join the vertebrae together to restore spinal stability. These implants help correct deformity and bridge spaces cr... [Read More]




European Markets for Spinal Motion-Preserving Devices (2006)
320 Pages | 103 Exhibits | 2006 Analysis | Forecasts Through 2010
An estimated 30 million people in the largest European Union (EU) countries of France, Germany, Italy, Spain and the United Kingdom suffer from back pain and over 150,000 invasive spinal fusions are performed annually. There is great demand for safer, more effective alternatives to spinal fusion, which has a ten-year reoperation rate of approximately 10%. Several new promising spinal motion-preserving technologies have emerged, including artificial discs, nucleus replacements and dynamic stabil... [Read More]




European Markets for Current and Emerging Biomaterial-Based Arthroscopy Products (2006)
331 Pages | 93 Exhibits | 2006 Analysis | Forecasts Through 2010
The European biomaterials-based arthroscopy products market, valued at approximately $550.3 million in 2005, offers considerable commercial potential. Due to the continuing growth and aging of the European population, there will be a steady demand for both new, emerging biomaterials-based arthroscopy products, as well as older, established products. Viscosupplementation products represented the largest segment of the European biomaterials-based arthroscopy products market in 2005, capturing... [Read More]




European Markets for Current and Emerging Orthopedic Biomaterials (2006)
429 Pages | 183 Exhibits | 2006 Analysis | Forecasts Through 2010
... [Read More]




Pharmacological and Device-Based Therapeutic Approaches to Pain Management (2006)
320 Pages | 63 Exhibits | 2006 Analysis | Forecasts Through 2011
Pain is the single most common reason patients seek medical care, accounting for half of all physician office visits in the U.S. Each year, more than 25 million people in the U.S. experience acute pain as a result of injury or surgery; chronic pain affects more than 50 million people. In 2005, U.S. sales of pain management products (including prescription and nonprescription analgesics/ anesthetics as well as pain management devices) totaled approximately $20.4 billion. Prescription analgesic... [Read More]




European Markets for Anesthesia and Ventilation Products (2006)
383 Pages | 106 Exhibits | 2006 Analysis | Forecasts Through 2011
The European anesthesia and ventilation products market includes ventilators, blood gas monitoring systems, pulmonary function testing systems, anesthesia delivery systems, and respiratory accessories. In 2005, sales of these devices totaled approximately $1.9 billion, with blood gas monitoring systems accounting for 32% of total sales, followed by respiratory accessories with 28%, anesthesia delivery systems with 18%, ventilators with 14%, and pulmonary function testing systems with 8%. Over ... [Read More]




U.S. Markets for Breast Disease Detection and Diagnostic Technologies (2006)
423 Pages | 60 Exhibits | 2006 Analysis | Forecasts Through 2009
With more than 200,000 diagnoses and 40,000 deaths each year, breast cancer is the most frequently diagnosed malignancy in the U.S. and is the second-leading cause of cancer mortality in women. More than 2 million women in the U.S. have been treated for breast cancer; as with other cancers, early detection and treatment of breast cancer dramatically improves survival rates. In 2004, sales of breast-specific screening and diagnostic products (e.g., biological tumor markers, breast biopsy pr... [Read More]




U.S. Markets for Electrosurgical and Thermal Ablation Products (2006)
310 Pages | 61 Exhibits | 2006 Analysis | Forecasts Through 2010
One of the major advances in surgery is the development of thermally based surgical systems and instrumentation, primarily those that utilize electrosurgery or radiofrequency (RF) as the energy form. Thermal energy is now used in general surgery as a substitute for the knife or scalpel and to enact better hemostasis (control of blood flow). This report describes traditional electrosurgical and thermal ablation products used to divide/cut destroy/ablate or modify tissue. In 2005, the U.S. m... [Read More]




U.S. Markets for Specialty Endoscopic Surgery Products (2006)
391 Pages | 99 Exhibits | 2006 Analysis | Forecasts Through 2014
In the U.S., nearly 12.3 million specialty endoscopic procedures were performed in 2005. The advantages of endoscopic surgery over open surgery include lower overall treatment costs, reduced patient trauma, shorter hospital stays, and faster recovery times. These benefits have resulted in the conversion of many types of open surgery procedures to endoscopic procedures, a continuing trend that is being driven by advancements in the array of endoscopic surgery products that includes access devic... [Read More]




U.S. Markets for Neurosurgical and Neurointerventional Surgical Products (2006)
283 Pages | 67 Exhibits | 2006 Analysis | Forecasts Through 2012
In 2005, nearly $1.1 billion was spent on neurosurgical and neurointerventional surgical products in the United States. Growing at a healthy compound annual rate of 4.1%, sales of these products are expected to reach more than $1.4 billion by the year 2012. This dynamic report from Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. neurosurgery products market and the minimally invasive neurointerventional su... [Read More]




U.S. Markets for Neurostimulation Products (2006)
248 Pages | 61 Exhibits | 2006 Analysis | Forecasts Through 2010
One of the most promising medical device markets to date is neurostimulation. This market--defined in this report as including several types of implantable neurostimulation systems (cochlear implants, cortical stimulators, deep brain stimulators, gastric nerve stimulators, spinal cord stimulators and vagus nerve stimulators)--has the ability to treat a very broad spectrum of debilitating diseases and disorders. Neurostimulation currently treats several debilitating conditions, including: ma... [Read More]




European Surgical Procedure Volumes (2006)
373 Pages | 87 Exhibits | 2006 Analysis | Forecasts Through 2011
In previous years, conventional, open surgical procedures in the European Union (EU) countries of France, Germany, Italy, Spain, and the United Kingdom (U.K.) were common practice for most indications. However, technological advancements in minimally invasive or laparoscopic surgery have been evolving and are expected to drive the trend away from open and invasive surgical procedures in the EU. Key factors include acceptance of innovative technologies, the aging population, patient demand for... [Read More]




U.S. Opportunities in Surgical Coronary Revascularization (2006)
500 Pages | 170 Exhibits | 2006 Analysis | Forecasts Through 2010
The U.S. launch of drug-eluting stents (DES) in early 2003 produced an immediate and fairly dramatic decline in coronary artery bypass graft (CABG) surgeries performed, as patients with less diffuse disease were overwhelmingly referred for interventional management. The impact on product markets was equally dramatic, and concerns regarding the future of cardiopulmonary bypass (CPB) and beating-heart products emerged. Although the surgical coronary revascularization caseload is not expected to ... [Read More]




Opportunities in Global Medical Devices and Diagnostics (2006)
604 Pages | 157 Exhibits | 2006 Analysis
The global medical device and diagnostics (MD&D) industry generated nearly $220 billion in revenues in 2005, of which nearly one-half were concentrated in four major technology segments - in vitro diagnostics (IVD), cardiovascular disease therapies, diagnostic imaging equipment, services and contrast, and orthopedic and spinal products. The aging of the global population, which will be accompanied by increases in cardiovascular disease, musculoskeletal conditions, cancer and other degenerative ... [Read More]




U.S. Markets for Wound Dressings and Wound Cleansing/Debridement Products (2005)
192 Pages | 43 Exhibits | 2005 Analysis | Forecasts Through 2014
In 2004, the U.S. market for wound dressings and wound cleansing/debridement products was valued at approximately $778 million. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 5.5%, reaching approximately $1.3 billion in the year 2014. This market encompasses advanced wound dressings, chemical/enzymatic wound debridement products, nonocclusive dressings, and wound cleansing products. Factors contributing to growth in the wound dress... [Read More]




U.S. Markets for Tissue-Engineered Skin Replacements/Substitutes and Active Wound Repair Modulators (2005)
145 Pages | 19 Exhibits | 2005 Analysis | Forecasts Through 2014
Designed for use in burn and wound patients to either temporarily cover or permanently replace areas of missing skin, skin replacements and substitutes include allografts (made from donated human tissue); autografts (made from the patient's own tissue); dermal, epidermal, and multilayer human skin equivalents that may use autologous, donor, or synthetic materials for cell repopulation at the burn or wound site; as well as xenografts (made from animal tissue). Active wound repair modulators are ... [Read More]




U.S. Markets for Compression Therapy and Pressure Reduction/Relief Products (2005)
158 Pages | 34 Exhibits | 2005 Analysis | Forecasts Through 2014
In 2004, the U.S. market for compression therapy and pressure reduction/relief products was valued at approximately $1.1 billion. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 3.8%, reaching approximately $1.6 billion in the year 2014. This market encompasses compression therapy products (e.g., compression bandages, compression stockings, and pneumatic compression therapy products) and pressure reduction/relief products (e.g., matt... [Read More]




U.S. Markets for Interventional Cardiology Products (2005)
371 Pages | 99 Exhibits | 2005 Analysis | Forecasts Through 2009
More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately 70.1 million people have at least one cardiovascular condition; these diseases/disorders kill nearly 2,600 people in the U.S. each day, and result in direct and indirect costs that exceed $393.5 billion annually. In 2004, nearly 5.2 million diagnostic and therapeutic interventional cardiology procedures were performed in the U.S. These procedures generated more than $4.... [Read More]




European Markets for Stents in Peripheral Vascular Applications (2005)
345 Pages | 109 Exhibits | 2005 Analysis | Forecasts Through 2011
In 2004, the European peripheral vascular stents market was valued at approximately $306.1 million. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 8.4%, reaching approximately $538.5 million in the year 2011. Market drivers include the aging of the population, improved screening and detection of peripheral vascular disease, technological advances, and a shift from lower-priced plastic stents to higher-priced metal stents. This 34... [Read More]




European Markets for Stents in Nonvascular Applications (2005)
238 Pages | 82 Exhibits | 2005 Analysis | Forecasts Through 2011
In 2004, the European nonvascular stenting products market was valued at approximately $81.2 million. Over the forecast period covered by this report, sales are expected to increase at a compound annual rate of 5.1%, reaching approximately $114.4 million in the year 2011. Market drivers include the aging of the population, improved screening and detection of diseases, technological advances, and a shift from lower-priced plastic stents to higher-priced metal stents. This report from Medtec... [Read More]




U.S. Markets for Arrhythmia Management Products (2005)
305 Pages | 78 Exhibits | 2005 Analysis | Forecasts Through 2017
Cardiac arrhythmias affect more than 5 million people nationwide, and result in more than 1.2 million hospitalizations and 400,000 deaths each year in the U.S. Arrhythmia management involves the use of a variety of products that enable clinicians to detect the presence of cardiac arrhythmias and determine their nature and extent, allowing the selection of appropriate treatment protocols, evaluation of chosen therapies, and establishment of patients' long-term prognoses. Products utilized in... [Read More]




European Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products (2005)
503 Pages | 231 Exhibits | 2005 Analysis | Forecasts Through 2011
Coronary artery disease is the leading cause of death in Europe. The morbidity/mortality rates associated with the disease continue to fuel the demand for percutaneous transluminal coronary angioplasty (PTCA) and coronary stenting products--particularly drug-eluting stents--to treat advanced cases that cannot be adequately managed with medical therapy. Sales of PTCA products and coronary stents and stent systems in Europe reached approximately $1.4 billion in 2004. Growing at a healthy co... [Read More]




U.S. Markets for Spinal Fusion Products (2005)
281 Pages | 33 Exhibits | 2005 Analysis | Forecasts Through 2009
It is estimated that approximately 50 million people in the United States (U.S.) suffer from back pain. In 2004, more than 1 million spine surgeries were performed in the U.S.--far more than the number of hip and knee replacements combined. Factors driving growth of the spinal surgery products market include growing numbers of people with degenerative disc disease (DDD). DDD is typically caused by gradual disc damage and often results in disc herniation and chronic, debilitating lower back p... [Read More]




U.S. Markets for Spinal Motion Preserving Devices (2005)
269 Pages | 51 Exhibits | 2005 Analysis | Forecasts Through 2009
An estimated 50 million people in the United States (U.S.) suffer from back pain. In 2004, more than 1 million spine surgeries were performed in the U.S.--far more than the number of hip and knee replacements combined. Factors driving the growth of the spine surgery products market include growing numbers of people with degenerative disc disease, which typically is caused by gradual disc damage and often results in disc herniation and chronic, debilitating lower back pain. It is most common amon... [Read More]




U.S. Markets for Arthroscopy Products (2005)
162 Pages | 52 Exhibits | 2005 Analysis | Forecasts Through 2010
Arthroscopy is defined as procedures which are performed using percutaneous instruments under the guidance of arthroscopes. The majority of arthroscopic procedures are performed on the knee (more than 1 million interventions and almost 2 million diagnoses each year). Repairing torn or damaged menisci of the knee is the most common arthroscopic treatment--the driving force in arthroscopy--with an estimated 875,000 annual meniscal repair procedures. Repair of torn anterior cruciate ligaments (A... [Read More]




U.S. Markets for Ventilators, Oxygen Therapy Systems, and Airway Management Accessories (2005)
335 Pages | 94 Exhibits | 2005 Analysis | Forecasts Through 2010
In the United States (U.S.) more than $1.3 billion was spent on ventilators, oxygen therapy systems, and airway management accessories in 2004. Growing at a healthy compound annual rate of 6.3%, sales of these products are expected to reach more than $1.9 billion by the year 2010. This dynamic report from Medtech Insight includes analyses of products and technologies, current and forecast markets, competitors, and opportunities in the U.S. ventilators market, as well as the oxygen therapy s... [Read More]




U.S. Markets for Blood Gas/Electrolyte Monitoring, Pulmonary Function Assessment, and Sleep Apnea Management Products (2005)
296 Pages | 81 Exhibits | 2005 Analysis | Forecasts Through 2010
In the United States (U.S.) nearly $1.7 billion was spent on blood gas/electrolyte monitoring, pulmonary function assessment, and sleep apnea management products in 2004. Growing at a healthy compound annual rate of 9.5%, sales of these products are expected to reach approximately $2.9 billion by the year 2010. This dynamic report from Medtech Insight includes analyses of products and technologies, current and forecast markets, competitors, and opportunities in the U.S. blood gas/electrolyt... [Read More]




U.S. Markets for Directed Energy-Based Surgical Systems (2005)
552 Pages | 95 Exhibits | 2005 Analysis | Forecasts Through 2008
Directed energy-based surgical therapy employs the controlled deposition of energy into targeted tissues to achieve a desired tissue alteration. This relatively new surgical area includes cryotherapy, laser energy, microwave energy, photodynamic therapy, radiofrequency, and ultrasound. This report focuses on the nine major surgical areas where directed energy-based techniques are prominent and growing, including: cardiovascular therapy, cosmetic (aesthetic) applications, dentistry, gyneco... [Read More]




U.S. Markets for Image-Guided Surgery Products (2005)
353 Pages | 65 Exhibits | 2005 Analysis | Forecasts Through 2009
The term "image-guided surgery" (IGS) refers to any surgical procedure involving the intraoperative use of a representation of patient anatomy obtained via imaging techniques or computerized methods. These representations are used for real-time visualization of targeted tissues and structures, as well as physical alteration with surgical tools and instruments. In 2004, the U.S. IGS products market totaled approximately $1.2 billion. Market drivers include the aging of the population, a contin... [Read More]




U.S. Markets for Diagnostic Imaging Systems (2005)
293 Pages | 41 Exhibits | 2005 Analysis | Forecasts Through 2009
Diagnostic imaging systems, which enable clinicians to visualize the anatomic structure and evaluate the functional performance of the body's internal organs and tissues, are indispensable in the practice of modern medicine. In the United States, more than 300 million diagnostic imaging procedures--including angiography, conventional X-ray-based imaging, computed tomography, magnetic resonance imaging, nuclear medicine imaging, and ultrasound imaging--were performed in 2004. These procedure... [Read More]




U.S. Markets for Computer-Aided Diagnostic Imaging Products (2005)
264 Pages | 63 Exhibits | 2005 Analysis | Forecasts Through 2009
In 2004, the worldwide computer-aided diagnostic (CAD) imaging products market was valued at $15 billion; in the same year, the U.S. CAD imaging products market was estimated at $7 billion. This market is evolving rapidly due to the emergence of new, computer-based applications that are poised to impact nearly every aspect of medical practice. In radiology, new computer-based imaging systems can identify anatomic and pathologic structures, visualize these structures in three and four dimension... [Read More]




U.S. Disease Incidence and Prevalence (2005)
284 Pages | 118 Exhibits | 2005 Analysis
As the population in the United States (U.S.) ages and life spans increase, the incidence and prevalence of major diseases and disorders are expected to significantly impact the healthcare industry. Major diseases in the U.S." " from acquired immune deficiency syndrome and reproductive disorders to cancer and cardiovascular disease" " can take their toll in terms of lost days from work, Medicare and Medicaid expenditures, and out-of-pocket costs. This dynamic report from Medtech Insight e... [Read More]




U.S. Opportunities in Heart Valve Disease Management (2005)
390 Pages | 112 Exhibits | 2005 Analysis
The United States (U.S.) heart valve market is entering a period of transformation. The aging of the population, the growing prevalence of cardiovascular disease, and the realization that valve disease is not as benign as previously thought are driving efforts to expand the treated population while reducing risks and improving outcomes. One major impetus has been the many percutaneous valve repair and ... [Read More]




Opportunities in Heart Valve Disease Management: Europe, Japan and Rest of World (2005)
548 Pages | 147 Exhibits | 2005 Analysis
Although Europe and Japan have large, aging populations subject to degenerative heart conditions, and the developing nations continue to have sizeable populations with rheumatic heart disease, these individuals are much less likely to undergo surgical treatment of their valve disease than in the U.S. The highly invasive nature of valve surgery, high product costs, and the fact that, in many cases, heart valve d... [Read More]




U.S. Opportunities in the Management of Urinary Incontinence (2005)
594 Pages | 177 Exhibits | 2005 Analysis
Recent epidemiological data indicate that urinary incontinence (UI) affects an astounding 34 million Americans, and 38 million are affected by overactive bladder (OAB). Roughly one-third of patients experience significant symptoms that may prompt them to seek treatment. Unfortunately, therapeutic options have been largely limited to the extremes of medical management or invasive surgery, creating significant undertreatment of this devastating, but not life-threatening condition. Th... [Read More]




U.S. Markets for Cardiovascular Disease Diagnostic Products (2004)
382 Pages | 102 Exhibits | 2004 Analysis | Forecasts Through 2007
More adults in the U.S. die from cardiovascular diseases/disorders than from any other cause. Nationwide, approximately 64.4 million people have at least one cardiovascular condition; these diseases/disorders kill nearly 2,600 people in the U.S. each day, and result in direct and indirect costs that exceed $368.0 billion annually. In 2003, more than 154.7 million electrocardiography, endovascular, noninvasive diagnostic imaging, and near patient in vitro testing procedures were performed in... [Read More]




U.S. Markets for Stroke Management Products (2004)
301 Pages | 65 Exhibits | 2004 Analysis | Forecasts Through 2008
Stroke--a sudden and often catastrophic disruption in the delivery of oxygen and nutrients to the tissues of the brain--is the third-leading cause of death in the U.S., following heart disease and cancer. It is estimated that there will be 282,000 fatalities due to stroke in 2004, half of which will occur outside a hospital. Products used to manage stroke patients include diagnostic imaging systems, pharmaceuticals, and surgical and interventional systems. The U.S. market for these products... [Read More]




Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies (2004)
324 Pages | 68 Exhibits | 2004 Analysis | Forecasts Through 2008
In the United States (U.S.), cardiovascular disease afflicts more than a quarter of the population, causes more than 5 million hospitalizations, and claims nearly 1 million lives each year; additionally, more than $300 billion in healthcare expenditures are incurred annually. A major portion of these expenditures is associated with the management of the most prevalent acute and chronic myocardial conditions, such as debilitating drug-refractory angina pectoris, congestive heart failure, ischemi... [Read More]




European Markets for Orthopedic Implants and Trauma Products (2004)
416 Pages | 188 Exhibits | 2004 Analysis | Forecasts Through 2008
The European orthopedic implants and trauma products market consists of reconstruction and replacement products for the hip, knee, shoulder, and small joints, as well as fracture fixation and bone growth stimulation products, bone graft substitutes and growth factors, and bone cements. In 2003, this market totaled more than $1.4 billion; key market drivers include surgeon acceptance of innovative technologies with medical-based evidence, orthopedic products receiving reimbursement code listing,... [Read More]




Trends and Opportunities in U.S. Orthopedic Markets for Implant, Reconstruction, and Trauma Products (2004)
360 Pages | 96 Exhibits | 2004 Analysis | Forecasts Through 2012
According to the American Academy of Orthopedic Surgeons, approximately 28.6 million people in the United States sustain some type of musculoskeletal injury annually, at a cost of approximately $254 billion. Many orthopedic reconstruction and trauma device manufacturers have experienced significant growth in the past several years. This robust growth is due to a number of factors including demographics and the aging population, improved technologies, and upward pricing of implants and devices... [Read More]




U.S. Markets for Critical Care Patient Management Products (2004)
414 Pages | 122 Exhibits | 2004 Analysis | Forecasts Through 2012
Critical care units are the most expensive sites in the U.S. healthcare system, accounting for 30% to 40% of an acute care hospital's total budget. Despite the costs involved, critical care is one of the fastest-growing specialties in healthcare, as hospitals continue to assign an increasing proportion of their beds to patients with life-threatening conditions who require significant levels of monitoring and specialized care. Factors such as the growing acuity of hospital inpatients, the a... [Read More]




U.S. Markets for Critical Care Patient Monitoring Products (2004)
195 Pages | 55 Exhibits | 2004 Analysis | Forecasts Through 2012
Critical care units are the most expensive sites in the U.S. healthcare system, accounting for 30% to 40% of an acute care hospital's total budget. Despite the costs involved, critical care is one of the fastest-growing specialties in healthcare, as hospitals continue to assign an increasing proportion of their beds to patients with life-threatening conditions who require significant levels of monitoring and specialized care. Factors such as the growing acuity of hospital inpatients, the a... [Read More]




U.S. Markets for Home Healthcare Products (2004)
300 Pages | 85 Exhibits | 2004 Analysis | Forecasts Through 2012
The expense and reduced length of acute care hospital stays, the availability and evolution of new healthcare technologies, the aging of the U.S. population, and the fact that most patients prefer to be treated in their homes rather than in hospitals or skilled nursing facilities, are all driving forces in the expansion of the U.S. home healthcare products and services market. In addition to the services of home healthcare agencies, the home-based treatment of patients who are chronically i... [Read More]




U.S. Markets for General and Pelvic Endoscopic Surgery Products (2004)
418 Pages | 146 Exhibits | 2004 Analysis | Forecasts Through 2013
In the U.S., more than 5 million general and pelvic endoscopic surgical procedures were performed in 2003. The advantages of endoscopic surgery over open surgery include lower overall treatment costs, reduced patient trauma, shorter hospital stays, and faster recovery times. These benefits have resulted in the conversion of many types of open surgery procedures to endoscopic procedures, a continuing trend that is being driven by advancements in the array of endoscopic surgery products that inc... [Read More]




The U.S. Aesthetics Marketplace (2004)
181 Pages | 38 Exhibits | 2004 Analysis | Forecasts Through 2012
In 2002, approximately 6.6 million people in the United States underwent cosmetic surgical and nonsurgical procedures, generating more than $861 million in associated product sales. Cosmetic procedures are rapidly gaining popularity among the baby boomer generation; as a result, sales are expected to experience a robust increase over the forecast period covered by this report. This report by Medtech Insight analyzes major market segments for aesthetic products, including topical aesthetic... [Read More]




U.S. Opportunities in Heart Failure Technologies (2004)
560 Pages | 168 Exhibits | 2004 Analysis
Heart failure is a complex, clinical syndrome characterized by multiple causes, symptoms and presentations, but which continues to be managed almost exclusively by drug therapy. The large patient caseload (estimated at 5 million Americans and growing with demographics) coupled with the progressive nature of the disease, has generated substantial interest in new, device-based treatments, many of which are at or ... [Read More]




U.S. Opportunities in the Management of Benign Uterine Conditions (2004)
305 Pages | 97 Exhibits | 2004 Analysis
Benign uterine conditions (predominantly fibroids, polyps, endometriosis, adenomyosis and menorrhagia) affect upwards of 25% of women of childbearing age in the U.S. Although most are asymptomatic, 2.6 million women seek medical treatment for these conditions annually. Therapy has traditionally relied on two extremes: medical management, comprising oral contraceptives, progestins and GnRH agonists; ... [Read More]




U.S. Opportunities in Osteoporosis Management (2004)
399 Pages | 116 Exhibits | 2004 Analysis
Osteoporosis affects an estimated 15 million Americans, predominantly postmenopausal women, with an additional 30 million considered at risk for the disease. Unfortunately, most patients are not diagnosed until they experience a fracture, as osteoporosis lacks distinct symptoms, had limited treatment options until recently, and is not considered a life-threatening condition. Thus, despite increasi... [Read More]




U.S. Opportunities in Drug Delivery Technologies (2004)
814 Pages | 170 Exhibits | 2004 Analysis
The U.S. drug delivery market is entering a watershed period. Traditional infusion products will remain the mainstay of hospital-based healthcare; however, even with gains in implantable, insulin and disposable pumps, overall growth in this mature segment will be modest. In contrast, emerging, non-infusion drug delivery technologies are poised for significant growth as they enable the delivery of ... [Read More]




Current and Emerging Wound Closure Products and Techniques in Europe and the U.S. (2003)
253 Pages | 62 Exhibits | 2003 Analysis | Forecasts Through 2007
In an effort to address the major barriers to the adoption of minimally invasive techniques in wound closure, manufacturers and researchers alike are racing to develop sutureless methods for wound closure. As a result, a variety of endoscopic suturing devices, energy-based technologies, and glues and sealants have appeared on the market in recent years. As the appropriate regulatory bodies worldwide approve more innovative products, dramatic changes may be seen in the segmentation of the wound... [Read More]




U.S. Markets for Infection Control and Biosafety Products (2003)
261 Pages | 76 Exhibits | 2003 Analysis | Forecasts Through 2010
Infectious diseases are the leading cause of death worldwide and the third-leading cause of death in the United States. Infectious diseases can affect any body system, be classified as acute or chronic, occur with or without fever, strike any age group, and exist concurrently with one another. Bacteria, parasites, and viruses are among the organisms that cause infectious diseases, many of which have only recently been identified. Although handwashing, medical waste disposal, and the use of va... [Read More]




U.S. Markets for Sports Medicine Devices and Products (2003)
262 Pages | 87 Exhibits | 2003 Analysis | Forecasts Through 2010
Each year, approximately 30 million children participate in organized sports and 150 million adults participate in non-work-related sports or recreational activities in the United States. Although these activities are generally beneficial to one's health, they do involve the risk of injury. According to the Centers for Disease Control and Prevention, approximately 4.3 million sports- and recreation-related injuries are treated in U.S. hospital emergency rooms annually. In 2001, the sports med... [Read More]




U.S. Markets for Dental Implants and Dental Bone Substitutes (2003)
174 Pages | 34 Exhibits | 2003 Analysis | Forecasts Through 2011
In 2002, the dental implants and dental bone substitutes market totaled approximately $296.5 million. Over the forecast period covered by this report, sales are expected to increase significantly, reaching nearly $1.0 billion in 2011. The market will be driven by the aging of the population, technological advances, public acceptance of the techniques, and an increasing number of dental general practitioners and specialists incorporating implantation and bone substitution into their practice. ... [Read More]




Pharmacological and Device-Based Therapeutic Approaches to Breast Disease (2003)
443 Pages | 51 Exhibits | 2003 Analysis | Forecasts Through 2011
In spite of major advances in early detection and adjuvant therapy, breast cancer, especially advanced-stage disease, remains a major clinical and human problem. There is an urgent need for new therapies and novel agents that are more effective than those currently available for the treatment of advanced breast cancer and will improve the survival rates and improve quality of life for patients. There are three principal approaches to the treatment of this disease: surgery, radiotherapy, and m... [Read More]




U.S. Markets for Diagnostic Oncology Products (2003)
333 Pages | 75 Exhibits | 2003 Analysis | Forecasts Through 2007
It is estimated that 1.3 million people in the U.S. will be diagnosed with cancer in 2003, and that 1 in 4 deaths will be due to the disease. In the fight against cancer, which is the second-leading cause of death in the U.S. after heart disease, remarkable advancements have been made in developing sophisticated tools to detect malignancies at their earliest and most treatable stages. In 2002, more than 172.5 million cancer screening and diagnostic procedures were performed utilizing imagin... [Read More]




Pharmacological and Device-Based Therapeutic Approaches to Cancer Management (2003)
361 Pages | 61 Exhibits | 2003 Analysis | Forecasts Through 2007
In 2003, an estimated 1.3 million people in the U.S. will be diagnosed with cancer and 1 in 4 deaths will be due to the disease. In addition to the tragic human toll, the cost of fighting cancer exceeds $171 billion annually in the U.S.; of this, more than $12 billion is spent on sophisticated products to treat the disease and manage its complications and side effects. These products include anticancer drugs and biopharmaceuticals; radiotherapy and photodynamic therapy products, cryoablation a... [Read More]




U.S. Opportunities in Prostate Disease Management (2003)
479 Pages | 97 Exhibits | 2003 Analysis
Prostate disease--encompassing prostate cancer, benign prostatic hyperplasia (BPH) and prostatitis--continues to account for more than one-half of the average urologist's practice. While pharmaceuticals and prostate brachytherapy have seriously eroded prostate surgery caseloads, new opportunities in less invasive, largely office-based modalities are promising to revitalize device-based prostate interventions. ... [Read More]




U.S. Markets for Adjunctive and Non-Fusion Spine Technologies (2003)
490 Pages | 125 Exhibits | 2003 Analysis
The U.S. spine market has experienced a decade of double-digit growth with expanded use of spinal fusion to treat severe, degenerative disc disease. The next decade will be even more exciting as continued, substantial market gains reflect true clinical advances in spine technologies, including prosthetic discs and nucleus replacement products, minimally invasive spinal fusion technologies, bone morphogenic proteins, intradiscal thermal therapies, and ... [Read More]




Opportunities in U.S. Spinal Fusion Markets (2003)
621 Pages | 158 Exhibits | 2003 Analysis
The U.S. spine market has experienced a decade of double-digit growth with expanded use of spinal fusion to treat severe, degenerative disc disease. The next decade will be even more exciting as continued, substantial market gains reflect true clinical advances in spine technologies, including prosthetic discs and nucleus replacement products, minimally invasive spinal fusion technologies, bone morphogenic proteins, intradiscal thermal therapies, and ... [Read More]




Opportunities in European Spinal Product Markets (2003)
563 Pages | 168 Exhibits | 2003 Analysis
Although Europe has a large, aging population subject to degenerative spine disease, the European spine market has failed to match the dramatic growth seen in the U.S. Inadequate surgeon training, unreliable fusion outcomes, expensive products, reimbursement challenges and the fact that back pain is not a life-threatening condition have contributed to this situation, which has been compounded by suppliers' focus on the fast-growing U.S. market. As a r... [Read More]




Opportunities in U.S. Peripheral Vascular Stent Markets (2003)
367 Pages | 75 Exhibits | 2003 Analysis
The overwhelming success of stenting in the coronary arteries has created strong interest in applying the technology to the peripheral vasculature, and the potential in those applications is significant. However, the opportunities are neither evenly distributed across the various applications nor are they necessarily similar in nature. While the use of drug eluting stents (DES) will be focused on specific indic... [Read More]




U.S. Markets for Point-of-Care Diagnostics (2003)
232 Pages | 58 Exhibits | 2003 Analysis | Forecasts Through 2006
Point-of-care diagnostic technology includes portable, instrument-based diagnostic devices used in near-patient hospital and alternate care settings. In 2001, U.S. sales of point-of-care diagnostic devices totaled approximately $2.8 billion and are expected to increase over the forecast period covered by this report. This report by Medtech Insight analyzes major market segments for point-of-care products used in the hospital setting and at alternate care sites. These market segments include i... [Read More]




European Critical Care: Markets, Trends, and Opportunities in Patient Monitoring Products (2003)
179 Pages | 53 Exhibits | 2003 Analysis | Forecasts Through 2007
Healthcare issues affecting the European critical care industry include managed care, personnel shortages, and new approaches to product evaluation and purchasing. Underlying these issues is the persistent increasing cost of healthcare. In 2001, the European patient monitoring products market (including hemodynamic, level-of-consciousness, neurological, and vital signs monitoring products) totaled $817 million and is expected to increase over the forecast period covered by this report. This r... [Read More]




U.S. Markets for Current and Emerging Wound Closure Technologies, 2001-2011 (2002)
233 Pages | 51 Exhibits | 2002 Analysis | Forecasts Through 2011
One of the major barriers to the adoption of minimally invasive techniques in wound closure has been the difficulty associated with performing knot tying. Suturing is still performed with a needle, thread, and significant dexterity on the part of the surgeon. To address the need for less-invasive, less time-consuming approaches to closing surgical, traumatic and other wounds, as well as to promote faster healing, a variety of innovative closure technologies have been developed, including sutur... [Read More]




U.S. Markets for Current and Emerging Orthopedic Biomaterials Products and Technologies (2002)
400 Pages | 135 Exhibits | 2002 Analysis | Forecasts Through 2010
Orthopedic biomaterials technology is taking the orthopedic industry by storm, helping to speed healing of bone, cartilage, meniscus, and ligament and tendon surgery or injury. The U.S. market for these products is booming, as diseases such as osteoporosis and injuries to the soft tissues of the joints continue to affect a growing elderly, yet still-active, population. This report details the current and emerging technologies and players impacting the markets for bone replacement materials, bo... [Read More]




U.S. Diabetes Management Markets and Technologies (2002)
265 Pages | 64 Exhibits | 2002 Analysis | Forecasts Through 2010
Diabetes, a disorder in which the body does not produce or properly use the hormone insulin (which is needed to convert sugar, starches, and other food into energy), affects 16 million Americans, 5 million of whom are unaware that they have the disorder. Diabetes is the sixth-leading cause of death by disease in the U.S. Important growth markets in diabetes include: glucose monitoring, insulin delivery, and bioartificial pancreas technology, which would essentially enable diabetics to live a ... [Read More]




Emerging Medical Marketplace Overview Latin America: Mexico (2002)
238 Pages | 50 Exhibits | 2002 Analysis
... [Read More]




Emerging Medical Marketplace Overview Latin America: Peru (2002)
184 Pages | 50 Exhibits | 2002 Analysis | Forecasts Through 2006
In 1999, Peru's population totaled approximately 25,348,046. In the same year, the country spent approximately 4.7% ($2.7 billion) of its gross domestic product on healthcare--this amounts to approximately $107 per capita. The projected healthcare expenditure for the year 2002 is $2.9 billion. Provided in this report from Medtech Insight is a detailed overview of Peru's demographics, purchasing and distribution systems, healthcare systems, and medical markets. This information is critical fo... [Read More]




Emerging Medical Marketplace Overview Latin America: Mexican Orthopedic Markets (2002)
130 Pages | 50 Exhibits | 2002 Analysis
... [Read More]




U.S. Opportunities in Interventional Coronary Revascularization (2002)
417 Pages | 89 Exhibits | 2002 Analysis | Forecasts Through 2006
Coronary stents represent one of the most successful product launches in the history of the medical products industry and the latest market developments are about to generate a second, major growth phase by largely solving the single greatest challenge associated with interventional revascularization: restenosis. The imminent impact of drug-eluting stents will enable the treatment of many patients previously requiring surgical intervention, ... [Read More]




U.S. Opportunities in Heart Valve Disease Management (2002)
250 Pages | 62 Exhibits | 2002 Analysis
Hundreds of thousands of patients in the U.S., including a large share with congestive heart failure, could potentially benefit from heart valve repair or replacement. However, because both are currently performed as open heart procedures requiring cardiopulmonary bypass, less than 94,000 individuals underwent heart valve surgery in 2001 due to its invasiveness, risks, and cost. This situation is expected to change dramatically over the nex... [Read More]




High Growth U.S. Adjunctive Coronary Transcatheter Markets (2002)
442 Pages | 128 Exhibits | 2002 Analysis | Forecasts Through 2006
The introduction of interventional coronary techniques in the late 1970's has provided physicians with a valuable and clinically effective means of treating patients with heart disease in a truly minimally invasive manner. Today, percutaneous methods of treating coronary artery disease are performed more frequently than traditional coronary artery bypass graft (CABG) surgery, and their popularity continues to increase with product refinements and improvements in clinical outcomes. Along with pri... [Read More]




U.S. Opportunities in the Management of Atrial Fibrillation (2002)
417 Pages | 114 Exhibits | 2002 Analysis | Forecasts Through 2010
Atrial fibrillation (AF) affects an estimated 2.3 million Americans at present, of which nearly 70% are 70 years of age or older. From 200,000 to 400,000 new cases are diagnosed annually, and the condition accounts for one-third of all hospital discharges with arrhythmia as a principal diagnosis. Atrial fibrillation is the most potent common risk factor for ischemic stroke (relative risk = 5, which is 2 to 7 times that of individuals without AF), and thromboembolism and cardiomyopathy are major ... [Read More]




U.S. Urology Clinician Survey (2002)
277 Pages | 138 Exhibits | 2002 Analysis
This survey report provides clients with primary research data obtained from more than 100 urologists in solo, group, and multi-specialty practices located throughout the country. For this survey, urologists discussed their current and planned use of existing and emerging urology products and procedures; rated the efficacy of, and their familiarity with, selected urology products and procedures; assessed obstacles to the adoption of new technologies; and evaluated developments impacting urologi... [Read More]




U.S. Markets for Incontinence Management Products (2002)
253 Pages | 88 Exhibits | 2002 Analysis | Forecasts Through 2006
Urinary incontinence (UI) affects approximately 15 million Americans. Total sales of products used in the diagnosis and treatment of UI were estimated at $1.37 billion in 2001. Due to the size of both current and potential UI markets, medical professionals and product manufacturers have placed significant emphasis on research into the diagnosis and treatment of this condition, which has resulted in the development of several new therapies and approaches that could potentially delay UI symptoms... [Read More]




U.S. Markets for Medical and Dental Laser Products (2002)
297 Pages | 70 Exhibits | 2002 Analysis | Forecasts Through 2006
Since its advent more than three decades ago, the laser has emerged as a powerful, versatile, and indispensable tool in the practice of medicine and dentistry. Today, a wide variety of gas, liquid (dye), solid state, and diode lasers allow healthcare professionals to perform unique and previously unfeasible procedures to selectively modify, damage, or destroy targeted tissues. In 2001, the cumulative U.S. market for laser therapy products was estimated at more than $663 million. This dynamic ... [Read More]




U.S. Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stent Products (2002)
224 Pages | 54 Exhibits | 2002 Analysis | Forecasts Through 2006
Despite major technology-driven advances in the management of coronary artery disease, more than 450,000 people die from the condition in the United States each year. The morbidity and mortality associated with the disease continue to fuel the demand for products used to treat advanced cases that cannot be adequately managed via medical therapy. In the 21st century, percutaneous intervention is considered the coronary artery disease treatment of choice, with annual sales of percutaneous transl... [Read More]




U.S. Markets for Apheresis, Hemostasis, and Stem Cell Therapy Products (2002)
261 Pages | 62 Exhibits | 2002 Analysis | Forecasts Through 2007
In 2001, the U.S. apheresis, hemostasis, and stem cell therapy products market totaled $580.2 million, a figure that is expected to more than double over the forecast period covered by this report. Technologies such as blood modification, salvaging, and substitution; stem cell expansion and transplantation; and therapeutic apheresis will drive market growth. This report from Medtech Insight presents a detailed overview of apheresis, hemostasis, and stem cell therapy technologies and markets, a... [Read More]




The Worldwide Market for Diagnostic Imaging Equipment (2002)
262 Pages | 51 Exhibits | 2002 Analysis | Forecasts Through 2006
Diagnostic imaging tools enabling clinicians to visualize the anatomic structure and evaluate the functional performance of the body's internal organs and tissues are indispensable in the practice of modern medicine. In 2001, more than a billion diagnostic imaging procedures were performed worldwide utilizing computed tomography, magnetic resonance imaging, nuclear medicine imaging, ultrasonography, and conventional X-ray-based systems. Use of--and demand for--the different diagnostic imaging ... [Read More]




Emerging Medical Marketplace Overview Latin America: Argentina (2001)
206 Pages | 50 Exhibits | 2001 Analysis
... [Read More]




Emerging Medical Marketplace Overview Latin America: Brazil (2001)
226 Pages | 50 Exhibits | 2001 Analysis
... [Read More]




Emerging Medical Marketplace Overview Latin America: Chile (2001)
218 Pages | 50 Exhibits | 2001 Analysis
... [Read More]




Emerging Medical Marketplace Overview Latin America: Colombia (2001)
180 Pages | 50 Exhibits | 2001 Analysis
... [Read More]




Emerging Medical Marketplace Overview Latin America: Brazilian Orthopedic Markets (2001)
133 Pages | 50 Exhibits | 2001 Analysis
... [Read More]




European Markets for Transcatheter Cardiovascular Therapy (2001)
362 Pages | 114 Exhibits | 2001 Analysis | Forecasts Through 2005
Despite scientific advancement in the understanding and management of cardiovascular disease, it remains the leading health problem in the European countries covered by this report: the Benelux nations of Belgium, The Netherlands, and Luxembourg; France; Germany; Italy; Spain; and the United Kingdom. Currently, more than 75 million people in these countries (more than 27% of the adult population) exhibit one or more types of cardiovascular disease. At the same time, the national incidence and p... [Read More]




European Markets for Arrhythmia Management Products (2001)
278 Pages | 76 Exhibits | 2001 Analysis | Forecasts Through 2005
Heart disease is the world's leading cause of death for both men and women among all racial and ethnic groups. Each year, arrhythmia disease claims approximately 400,000 lives and costs up to $30 billion in combined healthcare spending in France, Germany, Italy, Spain, and the United Kingdom. In 1999, cardiac rhythm management devices were used in more than 683,000 elective and emergency arrhythmia procedures on patients in these European countries. As life expectancies in the Western Europea... [Read More]




U.S. Markets for Drug and Fluid Delivery Devices (2001)
253 Pages | 73 Exhibits | 2001 Analysis | Forecasts Through 2005
Pharmacological therapy is the preferred treatment method for the management of virtually all common medical disorders that warrant therapeutic intervention. To date, the Food and Drug Administration has cleared approximately 37,000 prescription drug products for marketing in the U.S. These products account for more than 70% of the national consumption of pharmaceuticals. In the year 2000, U.S. pharmacies processed approximately 2.7 billion prescriptions; total sales of prescription and over-... [Read More]




New Strategies in Cardiovascular Disease Management Programs (2001)
139 Pages | 24 Exhibits | 2001 Analysis
According to the Centers for Disease Control and Prevention, more than 90 million Americans live with some form of chronic disease, accounting for more than 60% of the nation's healthcare spending. With large expenses at stake, payers have recognized the need to focus on the cost-effective management of chronic cardiovascular disease. Over the last decade, progress has been made in the introduction and implementation of cardiovascular disease management programs in terms of growing acceptance ... [Read More]




U.S. Markets for Clinical Laboratory Products (2001)
451 Pages | 96 Exhibits | 2001 Analysis | Forecasts Through 2005
In conjunction with the on-going evolution of healthcare delivery in the U.S., the clinical laboratory products market has also undergone broad restructuring. Suppliers are facing an increasingly challenging environment due to changing customer requirements. Although cost containment is the overriding determinant driving change in the industry, other considerations that are playing important roles include the need to maintain the quality of healthcare in the face of reduced resources; the impa... [Read More]




European Markets for Clinical Laboratory Products (2001)
487 Pages | 106 Exhibits | 2001 Analysis | Forecasts Through 2005
The European clinical laboratory products market is both highly competitive and overcrowded, with many competitors supplying similar products. Although the overcrowding has been alleviated somewhat by a spate of mergers, acquisitions, and partnerships, suppliers still face an increasingly challenging environment in which to do business. Cost containment is the overriding determinant driving change in the industry, but other considerations that are playing important roles include the pressure t... [Read More]




Japanese Markets for Wound Management Products (2001)
180 Pages | 54 Exhibits | 2001 Analysis | Forecasts Through 2005
Japan is one of the most densely populated countries in the world. The nation's 125 million inhabitants live within an area the size of Norway or California. For many years, Japan had a booming economy, and the country was considered one of the most productive markets in the world; however, in the early 1990s, Japan's economy slumped, resulting in severely depressed economic conditions throughout the country. Despite action by the Japanese government to improve the situation, the economy has ... [Read More]




Strategic Growth Opportunities in Cardiovascular Interventional Product Markets, 2000-2010 (2000)
200 Pages | 60 Exhibits | 2000 Analysis | Forecasts Through 2010
This report is a detailed market and technology assessment and forecast of the current and emerging products in interventional cardiology. The report addresses the current state of development of these technologies, including an assessment of the market size and competitor shares for companies with products on the market. The report assesses current status and outlook for development of the technologies, products and markets, providing a ten-year forecast of the evolution of the market describi... [Read More]




Osteoporosis Products: Opportunities and Trends in U.S. Markets (2000)
139 Pages | 46 Exhibits | 2000 Analysis | Forecasts Through 2004
Osteoporosis is the loss of bone mineral density, which contributes to weakened bone tissue and a propensity for fractures, and is one of the major contributors to orthopedic injuries, especially in women. Although the disease is not restricted to women, and many factors contribute to the cause of osteoporosis, the most significant factor for women is menopause. The population of postmenopausal women is rapidly increasing as the baby boom generation reaches middle age, and demographics is expe... [Read More]




Opportunities in U.S. Gynecological Medicine Markets (2000)
502 Pages | 142 Exhibits | 2000 Analysis | Forecasts Through 2004
Gynecological medicine products represent a major, dynamic, and rapidly growing market in the U.S. Factors driving this market include the aging of the female population, accompanied by advances in medical treatments for conditions that affect adult women of all ages. This has resulted in greatly increased demand for healthcare products for the management of benign uterine conditions, contraception, incontinence, infertility, and osteoporosis. New pharmaceutical compounds are expected to enj... [Read More]




U.S. Gynecology, Clinician Survey (2000)
224 Pages | 105 Exhibits | 2000 Analysis
Gynecology encompasses a variety of medical concerns, conditions, and procedures that approach the horizontal scope of primary care--many women consider their gynecologist to be their primary care physician--while simultaneously providing the vertical depth of a specialty via its interventional caseloads. With both the scope of services offered and large number of practitioners, gynecologists make an attractive target for medical companies. This report from Medtech Insight provides clients ... [Read More]




European Markets for Cardiovascular Diagnostics, 2000-2005 (2000)
400 Pages | 102 Exhibits | 2000 Analysis | Forecasts Through 2005
Cardiovascular diseases impose a heavy socioeconomic burden on European healthcare systems. In the five largest European countries, France, Germany, Italy, Spain, and the United Kingdom, a total of $110 to $115 billion is spent annually for the management of cardiovascular disorders. Of this total, approximately $40 billion is spent for treating coronary heart disease, more than $15 billion for stroke, $12 billion for hypertensive disease, and approximately $8 billion for congestive heart fai... [Read More]




Opportunities in U.S. Markets for Neonatal/Perinatal Monitoring and Treatment Products (1999)
324 Pages | 114 Exhibits | 1999 Analysis | Forecasts Through 2003
One of neonatal/perinatal medicine's major goals is to develop techniques that increase the survivability of newborns at risk from disease, congenital disorders, or abnormal conditions of birth. The development of these techniques and the products required to deliver them are the focus of this report from Medtech Insight. The demand for neonatal and perinatal products and services is driven by two factors-the number of annual births, and the share of those births that require an increased le... [Read More]




U.S. Markets for Cardiovascular and Cardiothoracic Surgery Devices (1999)
395 Pages | 121 Exhibits | 1999 Analysis | Forecasts Through 2003
The future holds strong growth for the overall cardiovascular surgery products market, however, as new technologies evolve, significant shifts in market share for several product segments are also expected. Cardiovascular surgery techniques, among the most invasive and costly therapeutic options available, are seeing increased competition from less-invasive transcatheter and endovascular alternatives. Included in this report from Medtech Insight is an overview of cardiovascular disease manageme... [Read More]




U.S. Cardiac Catheterization Laboratories: End-User Product and Procedure Utilization Assessment (1999)
346 Pages | 201 Exhibits | 1999 Analysis
The cardiac catheterization laboratory, or cath lab, is one of the busiest and most device-intensive areas of the hospital. This report provides product suppliers with information obtained directly from 119 cath lab directors concerning procedure volumes and trends, product and supplier preferences, product purchase decision-making responsibilities, and factors impacting cath lab operations and performance. Some of the specific findings that came directly from the survey include: *The ave... [Read More]




Disease Incidence and Prevalence: Europe, Japan, Russian Federation and Australia (1998)
299 Pages | 154 Exhibits | 1998 Analysis
Geographic expansion represents one of today's most important growth opportunities for medical device manufacturers. Which markets are most appropriate for your company? Only with reliable patient population data can you make informed strategic planning decisions for: gauging international market opportunities; making sales and revenue projections; and distribution and sales territory decisions. This reference resource compiled by Medtech Insight profiles 20 international markets, ranging f... [Read More]




Opportunities in Global Medical Devices & Diagnostics (2010)
570 Pages | 154 Exhibits | 2010 Analysis | Forecasts Through 2014
The global medical device and diagnostics (MD&D) industry experienced negligible growth in 2009 as the worldwide economic downturn produced cutbacks in hospital capital budgets and reductions in selected hospital admissions and elective surgeries. Uncertainty regarding changes in the U.S. health care system, coupled with continued severe cost constraints on global health care systems in general, have sustained this trend into early 2010. Although demographics and the growing prevalence of a... [Read More]




Contact Us

Need help finding medtech research? Let us help you!